syndrome	score	normalized_score
DRAVET SYNDROME	2.6958216999999998	100.0
RECURRENT ACUTE PANCREATITIS	2.3763921490000004	88.15093924794806
HEREDITARY ANGIOEDEMA TYPE 1	1.9032674999999997	70.60064469397214
AFRICAN IRON OVERLOAD	1.8018226700000002	66.83760539504524
CHILDHOOD ABSENCE EPILEPSY	1.5207408500000001	56.411032302321786
HEPATOCELLULAR CARCINOMA	1.4720719	54.605684789910256
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	1.463977309	54.30542045863048
LYMPHEDEMA, HEREDITARY, III	1.3763795539999997	51.05603067146465
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	1.345413664	49.90736828032804
AUTOIMMUNE HEPATITIS	1.33509498	49.524602461653906
+173470 INTEGRIN, BETA-3; ITGB3;;PLATELET GLYCOPROTEIN IIIA; GP3A;;GP IIIA;;PLATELET FIBRINOGEN RECEPTOR, BETA SUBUNIT;;CD61THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE, INCLUDED; NAIT, INCLUDED;;POSTTRANSFUSION PURPURA, INCLUDED; PTP, INCLUDED	1.333333	49.459242797845285
SECKEL SYNDROME 10; SCKL10	1.25934579	46.714728574222846
MYOCLONIC-ASTASTIC EPILEPSY	1.220712254	45.28163913807801
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	1.2027163699999999	44.614091874102805
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	1.19979725	44.50580874840499
%210500 BILIARY ATRESIA, EXTRAHEPATIC; EHBA	1.19721556	44.41004240005933
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1955945600000002	44.34991231059533
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.193694	44.279412099101364
LYMPHATIC MALFORMATION 1	1.1421568	42.367668455224624
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	1.1360063939999998	42.13952258044365
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	1.121970679	41.61887557326213
HEPATOCELLULAR CARCINOMA	1.1145833	41.34484487605394
BILATERAL POLYMICROGYRIA	1.1065655239999996	41.04742995428814
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	1.09331874	40.556047901832684
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	1.0849554000000001	40.24581447652863
PULMONARY ARTERIOVENOUS MALFORMATION	1.083874719	40.205727218532296
CRANIOECTODERMAL DYSPLASIA 1	1.07100188	39.72821644695568
MOSAIC TRISOMY 1	1.06276051	39.42250743066576
WILSON DISEASE	1.04164923	38.639396292418006
MONOSOMY 22Q13.3	1.0407671429999996	38.6066757679115
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	1.040758319	38.606348446560844
HEPARIN-INDUCED THROMBOCYTOPENIA	1.03125	38.253642664869126
MEVALONIC ACIDURIA; MEVA	1.028271304	38.14314960073213
TEMPI SYNDROME	1.027027	38.09699283895519
COMPLEX REGIONAL PAIN SYNDROME	1.0263158	38.070611272251426
COMBINED IMMUNODEFICIENCY-ENTEROPATHY SPECTRUM	1.0204082	37.85147215040224
LOWRY-MACLEAN SYNDROME	1.0199970289999998	37.836219991848864
TRANSSEXUALITY	1.0172414	37.734001473465405
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	1.017013454	37.72554594393242
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	1.01497094	37.64978002810794
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.00934579	37.44111823122427
PREECLAMPSIA	1.0072002599999998	37.36153099442741
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	1.0034966129999998	37.224146277923346
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	1.002951059	37.203909257055095
ATONIC-ASTATIC SYNDROME OF FOERSTER	1.0014771	37.14923357134487
DISTAL 16P11.2 MICRODELETION SYNDROME	1.0010869729999998	37.13476202821573
PITUITARY DERMOID AND EPIDERMOID CYSTS	1.000541419	37.11452500734748
268040 RETINOHEPATOENDOCRINOLOGIC SYNDROME;;RHE SYNDROME	1.0	37.0944413719943
AGENESIS OF CEREBRAL WHITE MATTER	1.0	37.0944413719943
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.0944413719943
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	1.0	37.0944413719943
ENTEROKINASE DEFICIENCY	1.0	37.0944413719943
CARDIAC-UROGENITAL SYNDROME; CUGS	1.0	37.0944413719943
CONGENITAL MACROGLOSSIA	1.0	37.0944413719943
AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE; AILJK	1.0	37.0944413719943
TETRAGAMETIC CHIMERISM	1.0	37.0944413719943
PRIMARY SCLEROSING CHOLANGITIS	0.99823066	37.028808693097176
HYPERCHOLESTEROLEMIA DUE TO CHOLESTEROL 7ALPHA-HYDROXYLASE DEFICIENCY	0.9759634	36.20281712251223
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	34.6625579874218
ISOLATED BILIARY ATRESIA	0.8841608190000001	32.797451663809966
JUVENILE POLYPOSIS SYNDROME	0.875	32.45763620049502
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.843344419	31.283390106994098
MARTINEZ-FRIAS SYNDROME	0.833333	30.912022111848124
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.8047616	29.852181989632324
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.77802685	28.860471373162405
LAFORA DISEASE	0.7730060599999999	28.674227972866305
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.58561083620627
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.750483724	27.838774500553953
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.73637821	27.31553833845911
EARLY MYOCLONIC ENCEPHALOPATHY	0.7087289139999999	26.28990314901019
SOMATOSTATINOMA	0.7064654800000001	26.205942329197818
AGEL AMYLOIDOSIS	0.7014771	26.020901159746586
LYSINURIC PROTEIN INTOLERANCE	0.6844092900000001	25.387780282353244
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.684326394	25.38470530154127
ANGIOEDEMA, HEREDITARY, TYPE III	0.6635850999999999	24.615318587278974
MEIGE DISEASE	0.6604669000000001	24.499650700192827
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.65825675	24.417666420594507
SLC35A2-CDG	0.6399752640000002	23.73952490997458
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.6317565639999999	23.43465682467056
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.622449579	23.089419415238034
RING CHROMOSOME 13 SYNDROME	0.61504801	22.814862347906764
DUPLICATION/INVERSION 15Q11	0.611652419	22.688904796633995
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.60795866	22.551886869966218
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59421851	22.04220368134881
GRAFT VERSUS HOST DISEASE	0.59266153	21.98444837802144
ALAGILLE SYNDROME 1; ALGS1	0.59108942	21.926131835796113
ROLANDIC EPILEPSY	0.5906213	21.908767185901056
SICKLE CELL ANEMIA	0.5870825999999999	21.777501086217978
GALLBLADDER NEUROENDOCRINE TUMOR	0.5839289000000001	21.660516346463126
METACHROMATIC LEUKODYSTROPHY	0.582375619	21.60289825547439
MECKEL SYNDROME	0.5787148999999999	21.46710592914954
AICARDI-GOUTIÈRES SYNDROME	0.5777993830000001	21.433145337467984
MECKEL SYNDROME, TYPE 6; MKS6	0.5692983	21.117802412526025
LATHOSTEROLOSIS	0.5665111890000001	21.014416086939285
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.565363104	20.971828515216718
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.56068381	20.798252718271392
DIAPHANOSPONDYLODYSOSTOSIS	0.559369054	20.749482578910914
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.5591847300000001	20.742645183099466
PETERS-PLUS SYNDROME; PTRPLS	0.5576555830000001	20.685922329358807
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.5552631600000001	20.597176734648297
PULMONARY FIBROSIS-HEPATIC HYPERPLASIA-BONE MARROW HYPOPLASIA SYNDROME	0.5425042600000001	20.123892466627154
MOWAT-WILSON SYNDROME; MOWS	0.5374115690000001	19.934981938901974
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.5357143	19.872022693488965
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5348101000000001	19.838481899600414
THROMBOCYTOPENIA 1	0.5333330000000001	19.783689700249838
HEREDITARY ANGIOEDEMA	0.5302521	19.66940543582686
ACQUIRED ANGIOEDEMA	0.5302521	19.66940543582686
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.54977215295804
SPLENOPORTAL VASCULAR ANOMALIES	0.52536235	19.48802289112815
ALAGILLE SYNDROME	0.52392578	19.434734129486383
AICARDI-GOUTIERES SYNDROME 5	0.523055044	19.4024346639839
MEDULLOBLASTOMA	0.5229508740000001	19.39857053602618
PAROXYSMAL HEMICRANIA	0.5227273	19.39027718339088
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.520228924	19.29760132133368
INHERITED CREUTZFELDT-JAKOB DISEASE	0.5175744290000001	19.19913431218393
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.516674554	19.1657539517543
MOSAIC TRISOMY 9	0.515470954	19.12110708211897
NUCHAL BLEB, FAMILIAL	0.5149254	19.100870061250713
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.51301586	19.030036741673236
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.51128216	18.965726108666612
CREST SYNDROME	0.50862069	18.867000365788286
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.5073166090000001	18.81862620958946
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	18.80844901574908
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.503496613	18.676925591926206
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.502018519	18.62209652070091
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.501086973	18.587541342218593
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.500541419	18.567304321350335
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.54722068599715
PSEUDOXANTHOMA ELASTICUM; PXE	0.5	18.54722068599715
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.5	18.54722068599715
NPHP3-RELATED MECKEL-LIKE SYNDROME	0.5	18.54722068599715
BRANCHIOOTORENAL SYNDROME 1	0.5	18.54722068599715
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.54722068599715
PORTAL VEIN, CAVERNOUS TRANSFORMATION OF	0.5	18.54722068599715
MATTHEW-WOOD SYNDROME	0.5	18.54722068599715
INHALATIONAL ANTHRAX	0.5	18.54722068599715
PRIMARY BILIARY CHOLANGITIS	0.49442811	18.340534539060947
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.48500134399999995	17.99085392034644
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.479248944	17.77747185579818
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.456215183	16.923047358807153
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.456172413	16.92146082954967
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.45	16.692498617397437
SPINOCEREBELLAR ATAXIA TYPE 10	0.44863226	16.641763066155306
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.44279431	16.42520757214767
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.434976719	16.13521840112794
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.42766089	15.863841811199904
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.426260619	15.8118995406855
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.4242421	15.737023705981743
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.42283356899999996	15.684775035381607
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.41931104999999996	15.55410916085437
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.414724933	15.383989712672767
SARCOIDOSIS	0.41207636999999997	15.285742747749232
KLATSKIN TUMOR	0.41172834	15.272832769318537
PMM2-CDG	0.41116820299999995	15.25205480021175
IMMUNE DEFICIENCY DISEASE	0.4047616	15.014405440834608
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.40430155000000007	14.997340143081425
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.39879430399999993	14.793051929213268
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.39458529	14.636920906156368
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.39458396	14.636871570549346
SPINOCEREBELLAR ATAXIA TYPE 42	0.39401681	14.615833458125218
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.39154326	14.524078502669521
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.389601104	14.452035310792253
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.37616221299999997	13.953527156488132
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.375541419	13.930499149851046
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.372626199	13.82236069247458
COG4-CDG	0.369205904	13.695486760122154
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.523146208074518
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.36356845899999995	13.486368887081813
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.36035523399999997	13.367176100704286
CONGENITAL ENTEROVIRUS INFECTION	0.35816579	13.285959898609024
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.26191787832259
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.26191787832259
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.35683145299999997	13.23646341299204
CENTRALOPATHIC EPILEPSY	0.35470090000000004	13.157431739643616
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.35022597	12.991436711114835
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.35002877299999996	12.9841217985596
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.34964553	12.969905613564874
DANDY-WALKER SYNDROME	0.3474175	12.88725808535483
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.3474175	12.88725808535483
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.3474175	12.88725808535483
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.347132299	12.876678713581095
CHYLOMICRON RETENTION DISEASE	0.34660036	12.856946733532117
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.343344419	12.736169420996946
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.34323261400000005	12.732022076979352
OVARIAN HYPERSTIMULATION SYNDROME	0.3418371	12.680256264722553
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.626029755602906
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.33949956899999995	12.593546858087832
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.33859616	12.5600354059024
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.33831527	12.549615948265421
EPIDERMAL NEVUS SYNDROME	0.335783314	12.455694454866952
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.335779179	12.455541069351879
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.33503688	12.428005902615888
DUODENAL NEUROENDOCRINE TUMOR	0.33397086	12.388462486224515
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.333878554	12.385038446719234
CODAS SYNDROME	0.333878554	12.385038446719234
MITCHELL-RILEY SYNDROME; MTCHRS	0.3333333	12.364812554183388
IMMUNODEFICIENCY 46; IMD46	0.333333	12.364801425850976
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.333333	12.364801425850976
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.364801425850976
NEUROMYELITIS OPTICA	0.333333	12.364801425850976
16P12.1P12.3 TRIPLICATION SYNDROME	0.333333	12.364801425850976
PSEUDO-VON WILLEBRAND DISEASE	0.333333	12.364801425850976
APOLIPOPROTEIN A-I; APOA1	0.333333	12.364801425850976
ACITRETIN/ETRETINATE EMBRYOPATHY	0.333333	12.364801425850976
CHOLANGIOCARCINOMA	0.333333	12.364801425850976
PLACENTAL INSUFFICIENCY	0.333333	12.364801425850976
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.364801425850976
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.364801425850976
TRISOMY 8P	0.33140152900000003	12.293154588079771
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 3	0.33018661000000005	12.24808784646255
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.32847085000000004	12.184442687734135
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.32412051	12.02306925565589
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.321413119	11.922640098935329
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.32001585	11.870809185933922
ARGININOSUCCINIC ACIDURIA	0.31638885299999997	11.736267758361022
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.31622816	11.730306941293632
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.313329614	11.622786996632604
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.308510794	11.44403556066041
ALSTROM SYNDROME; ALMS	0.307183194	11.394788980294951
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.30557977	11.335310862732502
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.3055556	11.33441429008454
WILSON DISEASE	0.30493574	11.311420929655698
LEPTOSPIROSIS	0.30106183	11.167720402280313
SCLEROSING CHOLANGITIS, NEONATAL	0.29839536	11.068809187195134
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.2982093	11.061907395433462
HEMOCHROMATOSIS, NEONATAL	0.29807505	11.05692746667927
CHOLANGIOCARCINOMA	0.29693016	11.014458411696888
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.294067164	10.908257174426634
PALLISTER-HALL SYNDROME	0.294023854	10.906650614170811
PEUTZ-JEGHERS SYNDROME	0.291667	10.819224431645463
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.28975221900000003	10.748196700100754
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	0.28888256	10.715937185311626
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	0.28295358	10.496004984305898
POTOCKI-LUPSKI SYNDROME	0.281779513	10.452453624807605
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.28132551000000006	10.435612637141398
MENTAL RETARDATION, BUENOS AIRES TYPE	0.28125	10.432811635873398
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.281158884	10.429431738753346
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.281158884	10.429431738753346
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.28062515000000005	10.409633174182108
EISENMENGER SYNDROME	0.27801968	10.312984720020618
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.2763158	10.249780243255703
VIPOMA	0.27313218000000006	10.131685637814996
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.272763619	10.11801407340849
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 1	0.27221556	10.097684130964597
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 2	0.27221556	10.097684130964597
BARE LYMPHOCYTE SYNDROME, TYPE II	0.2714286	10.068492289382492
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.2712766	10.06285393429395
GCGR-RELATED HYPERGLUCAGONEMIA	0.2712766	10.06285393429395
POEMS SYNDROME	0.2704082	10.030641121406509
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.26882296	9.971837529165969
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.26683558	9.898116778272096
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.26566238999999997	9.854597950598883
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.26491556899999996	9.82689504279901
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.26490139	9.826369080714798
8P INVERTED DUPLICATION/DELETION SYNDROME	0.263790599	9.785164909088758
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.261508394	9.700507789517385
GLUTAMINE DEFICIENCY, CONGENITAL	0.260358469	9.657851964022695
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.259667204	9.632209875007684
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.259237069	9.61625425746814
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.259237069	9.61625425746814
118900 CIRRHOSIS, FAMILIAL	0.25869565	9.596170622114958
PEHO SYNDROME; PEHO	0.25746461299999995	9.550505992291699
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.2570327	9.5344844208354
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.25646786400000005	9.51353214494861
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.25616656899999996	9.502355775235431
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.256101154	9.499929242353083
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.255629954	9.4824503415786
GLYCOGEN STORAGE DISEASE VI	0.25562514999999997	9.482272139882248
CHILDHOOD APRAXIA OF SPEECH	0.2555556	9.479692221484827
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.2555556	9.479692221484827
LAMBERT SYNDROME	0.25526316	9.46884432305
LAMBERT SYNDROME	0.25526316	9.46884432305
KETOADIPICACIDURIA	0.25505497299999996	9.461121742584087
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 1	0.25498226999999996	9.458424865413019
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.254042054	9.42354807812401
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.25396799999999997	9.420801086362648
ACRAL SELF-HEALING COLLODION BABY	0.25396799999999997	9.420801086362648
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.253909089	9.418615815726984
RAPIDLY INVOLUTING CONGENITAL HEMANGIOMA	0.25327869	9.395231516980518
NON-INVOLUTING CONGENITAL HEMANGIOMA	0.25327869	9.395231516980518
AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL	0.25327869	9.395231516980518
KASABACH-MERRITT SYNDROME	0.25327869	9.395231516980518
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.252564073	9.368723198570589
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.252450614	9.364514500346964
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.25205413000000004	9.349807147854031
DISTAL TRISOMY 5Q	0.25190476	9.344266351146295
GLYCOGEN STORAGE DISEASE IXB	0.25170358	9.336803691431077
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.25064280000000005	9.297454649912495
LOWE OCULOCEREBRORENAL SYNDROME	0.250541419	9.293693978351758
GM2 GANGLIOSIDOSIS, AB VARIANT	0.250541419	9.293693978351758
HYPEREKPLEXIA 1; HKPX1	0.25	9.273610342998575
MEDULLARY THYROID CARCINOMA	0.25	9.273610342998575
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.25	9.273610342998575
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.25	9.273610342998575
KETAMINE-INDUCED BILIARY DILATATION	0.25	9.273610342998575
NEUROFIBROMA	0.25	9.273610342998575
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.25	9.273610342998575
RADIO-ULNAR SYNOSTOSIS-AMEGAKARYOCYTIC THROMBOCYTOPENIA SYNDROME	0.25	9.273610342998575
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.273610342998575
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.248612884	9.222156049860422
PEHO SYNDROME	0.248513754	9.218478877887213
NAVAJO NEUROHEPATOPATHY	0.24767835400000002	9.187490181565051
MYH9-RELATED DISEASE	0.24558827000000003	9.109959683164508
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.24425798	9.060613318751757
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.243045154	9.015624215800326
GAUCHER DISEASE TYPE 1	0.23999372000000002	8.902432976186816
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.2399687	8.90150487326369
BENIGN SCHWANNOMA	0.237037	8.792755099493412
FIBROSCLEROSIS, MULTIFOCAL	0.237037	8.792755099493412
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.234614804	8.702905091979934
LENNOX-GASTAUT SYNDROME	0.23257130999999998	8.627102823602911
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.23069506	8.557504377978708
ATAXIA-PANCYTOPENIA SYNDROME	0.22919184000000004	8.5017432718195
ADNP SYNDROME	0.22904502899999996	8.496297399787233
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.22888575399999997	8.490389182637708
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.2285714	8.478728396614658
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.228208819	8.465278656967559
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.22801686000000002	8.458158045096233
GRFOMA	0.22774208000000004	8.447965234496037
PPOMA	0.22774208000000004	8.447965234496037
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.22751569000000002	8.43956742391383
POLYARTERITIS NODOSA	0.227027	8.42143974135975
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	8.380715608899507
HALOTHANE HEPATITIS	0.22567136	8.371153032858219
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME	0.22472750000000002	8.33614107342485
BETA-THALASSEMIA INTERMEDIA	0.22309419	8.275554351387557
PYKNOACHONDROGENESIS	0.22272730000000002	8.261944771792587
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.22066354	8.185390747466718
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.2192308	8.132244057535408
PEDIATRIC HEPATOCELLULAR CARCINOMA	0.21837028	8.10032354884598
TETRASOMY 9P	0.21658819299999998	8.034218027104686
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.21554631300000004	7.995570070528036
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.21548435400000002	7.993271736035067
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.212555703	7.884635063216533
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.212214454	7.871976622192782
FRONTORHINY	0.21204820000000002	7.865809522936923
ADENYLOSUCCINATE LYASE DEFICIENCY	0.21144532900000002	7.843446359972547
%211890 CAMPOMELIA, CUMMING TYPE;;CERVICAL LYMPHOCELE WITH BOWED LONG BONES;;CUMMING SYNDROME	0.21111110000000002	7.831048321927227
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.20940109400000004	7.767616604614469
LEISHMANIASIS	0.20890384	7.7491712452644785
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.20696674	7.677315602882788
NON-DISTAL MONOSOMY 20Q	0.20687352899999997	7.6738579929080615
CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZSYNDROME AND MECKEL SYNDROME	0.20666700000000002	7.666196915025947
GLUCAGONOMA	0.20646548000000003	7.658721643200664
AICARDI SYNDROME; AIC	0.20636530000000003	7.655005522064016
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.20393701	7.564929461024815
FRONTONASAL DYSPLASIA 1; FND1	0.20393701	7.564929461024815
CARCINOID SYNDROME	0.20392157000000002	7.564356722850032
MALARIA	0.20327869	7.540509448380804
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.20327869	7.540509448380804
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.202781293	7.522058784525698
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.202018519	7.493764109102617
ISOLATED POLYCYSTIC LIVER DISEASE	0.20170358000000002	7.482081622831363
CRYOGLOBULINEMIC VASCULITIS	0.20170358000000002	7.482081622831363
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.20147710000000002	7.473680473749433
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.201086973	7.459208930620301
TETRASOMY 5P	0.201086973	7.459208930620301
TUBEROUS SCLEROSIS COMPLEX	0.2010849	7.4591320338433365
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.200541419	7.438971909752044
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.200541419	7.438971909752044
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.200541419	7.438971909752044
BRANCHIOSKELETOGENITAL SYNDROME	0.200541419	7.438971909752044
LYMPHATIC MALFORMATION 7; LMPHM7	0.20018670000000002	7.425813806603013
MODY	0.2	7.41888827439886
BLEPHAROCHALASIS, SUPERIOR	0.2	7.41888827439886
SCARF SYNDROME	0.2	7.41888827439886
HEPATIC ADENOMAS, FAMILIAL	0.2	7.41888827439886
BLEPHAROCHALASIS AND DOUBLE LIP	0.2	7.41888827439886
SOLITARY BONE CYST	0.2	7.41888827439886
EOSINOPHILIC FASCIITIS	0.2	7.41888827439886
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.41888827439886
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.2	7.41888827439886
DYSFERLIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R2	0.2	7.41888827439886
MYOTONIA FLUCTUANS	0.2	7.41888827439886
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.41888827439886
CLEFT VELUM	0.2	7.41888827439886
CARNEY COMPLEX	0.2	7.41888827439886
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	7.41888827439886
AXIAL OSTEOMALACIA	0.2	7.41888827439886
OCULOAURICULOFRONTONASAL SYNDROME	0.2	7.41888827439886
SMITH-LEMLI-OPITZ SYNDROME	0.196958673	7.306071948304297
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.19667374	7.29550251784085
CARCINOMA OF GALLBLADDER AND EXTRAHEPATIC BILIARY TRACT	0.19320676	7.1668968314929735
PERIPARTUM CARDIOMYOPATHY	0.1929828	7.158589160403301
NON-HISTAMINIC ANGIOEDEMA	0.19190030000000002	7.118434427618118
NEPHRONOPHTHISIS 18; NPHP18	0.1888892	7.006739355202907
LIVER FAILURE, INFANTILE, TRANSIENT	0.18781141000000004	6.966759337236586
AICARDI SYNDROME	0.18401081	6.825778203358182
GRACILE SYNDROME	0.18312063999999997	6.7927578444820735
JUVENILE MYOCLONIC EPILEPSY	0.18297529999999998	6.787366538373068
HELLP SYNDROME	0.18237036000000004	6.764926627009496
MICROSPORIDIOSIS	0.181663919	6.7387215927522215
MYOCLONIC EPILEPSY OF INFANCY	0.181285814	6.724695998997262
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.181285814	6.724695998997262
SCHINZEL-GIEDION SYNDROME	0.18098114	6.713394287166693
CAROLI DISEASE, ISOLATED	0.17972128000000004	6.666660484259773
H SYNDROME	0.17871520000000002	6.629340508684237
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.17783460999999998	6.59667551455647
YELLOW NAIL SYNDROME	0.17777810000000002	6.5945793076745405
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.177738004	6.593091968953289
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.17771637	6.592289467808647
UNILATERAL POLYMICROGYRIA	0.17731387	6.577358955156419
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.177059543	6.567924837165605
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.17699127	6.565392288369814
MONOSOMY X	0.17672501000000002	6.555515522410108
MOSAIC MONOSOMY X	0.17672501000000002	6.555515522410108
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.17672501000000002	6.555515522410108
TURNER SYNDROME	0.17672501000000002	6.555515522410108
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.176255884	6.538113555507029
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.176237683	6.537438399579617
MUCOLIPIDOSIS TYPE II	0.17577799000000002	6.5203863445420005
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.17498253000000002	6.490879200208235
ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3	0.17448916	6.472577915668533
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.174231054	6.463003617783773
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.173245433	6.4264425573842665
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.172013119	6.380730557959378
AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE	0.1719299	6.3776435956428426
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.171867193	6.37531751450773
COMBINED SAPOSIN DEFICIENCY	0.17022601999999998	6.314439118877928
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.16988399999999998	6.301752078039879
LEIGH SYNDROME; LS	0.169231073	6.277532115718188
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.16911731400000002	6.273312289162152
DISTAL MONOSOMY 12Q	0.169117014	6.273301160829741
13Q12.3 MICRODELETION SYNDROME	0.16857176000000001	6.253075268293895
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.168248754	6.2410935411640915
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.167571403	6.2159675842063296
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.167571403	6.2159675842063296
LIGNEOUS CONJUNCTIVITIS	0.167212254	6.202645152682019
MÉNÉTRIER DISEASE	0.166667	6.182419260146175
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2; ADMIO2	0.166667	6.182419260146175
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.166667	6.182419260146175
RIN2 SYNDROME	0.166667	6.182419260146175
FAMILIAL IDIOPATHIC STEROID-RESISTANT NEPHROTIC SYNDROME	0.166667	6.182419260146175
DERMATOLEUKODYSTROPHY	0.166667	6.182419260146175
NEOVASCULAR GLAUCOMA	0.166667	6.182419260146175
HYPERPLASTIC POLYPOSIS SYNDROME	0.166667	6.182419260146175
NEPHROTIC SYNDROME, TYPE 15; NPHS15	0.166667	6.182419260146175
ASCHER SYNDROME	0.166667	6.182419260146175
CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 1	0.166667	6.182419260146175
HERPES SIMPLEX VIRUS STROMAL KERATITIS	0.166667	6.182419260146175
NEUROTROPHIC KERATOPATHY	0.166667	6.182419260146175
AMOEBIC KERATITIS	0.166667	6.182419260146175
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	6.182419260146175
CEREBROOCULONASAL SYNDROME	0.166667	6.182419260146175
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.16564161000000002	6.144382990907745
SCALP-EAR-NIPPLE SYNDROME	0.1655843	6.142257108472716
SCALP-EAR-NIPPLE SYNDROME; SENS	0.1655843	6.142257108472716
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.16488410000000003	6.116283580624047
RARE HEREDITARY HEMOCHROMATOSIS	0.16475635	6.111544765738773
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.161068889	5.9747604598627575
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.160983554	5.971595005708279
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.16025640000000002	5.944621634286868
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.15950570000000003	5.916774837148912
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.15950570000000003	5.916774837148912
%123550 CRYOGLOBULINEMIA, FAMILIAL MIXED;;MELTZER SYNDROME	0.1594828	5.915925374441493
FAMILIAL PANCREATIC CARCINOMA	0.15932823000000002	5.9101916866386235
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.15882677	5.891590308068224
WOLF-HIRSCHHORN SYNDROME	0.15852808300000001	5.880510680658147
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.15828829399999997	5.871615841655996
ADAMS-OLIVER SYNDROME	0.157993859	5.860693939810633
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.156635219	5.810295947984987
JOUBERT SYNDROME 2	0.156611954	5.809432945806468
DISTAL TRISOMY 14Q	0.1549052	5.746121859617051
PGM3-CDG	0.15479621899999998	5.74207927030189
WOLFRAM-LIKE SYNDROME	0.15476179999999998	5.740802516724306
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.15420466	5.720135719658314
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.15400113999999998	5.712586258950285
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.152710199	5.664699523711082
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15266181399999998	5.662904709165298
ENHANCED S-CONE SYNDROME	0.15147769	5.618980290870127
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.15077671	5.592977829357188
BECKWITH-WIEDEMANN SYNDROME	0.15005528	5.56621678651819
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.14970512000000002	5.553227796927372
PYRUVATE KINASE DEFICIENCY OF RED CELLS	0.14786326000000002	5.4849050291419505
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.14769091	5.478511802171488
HSD10 DISEASE	0.147325833	5.464969474798723
JOHANSON-BLIZZARD SYNDROME; JBS	0.1472222	5.461125266556019
XANTHINURIA, TYPE I	0.14664487999999998	5.439709903663139
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.1464647	5.433026227216734
ACERULOPLASMINEMIA	0.14623886	5.424648818577282
NIEMANN-PICK DISEASE TYPE B	0.14599503	5.415604080937549
COFFIN-SIRIS SYNDROME 1; CSS1	0.145857613	5.410506674087533
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.14549495399999998	5.397054041074007
THYROCEREBRORENAL SYNDROME	0.145486809	5.396751906849032
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.1454082	5.3938359499072215
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.14526663999999997	5.388584860786602
NEUROFIBROMATOSIS TYPE 1	0.14487551899999998	5.374076445782746
IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION	0.14285699999999998	5.299200611078989
RETINITIS PIGMENTOSA 27; RP27	0.14285699999999998	5.299200611078989
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	0.14285699999999998	5.299200611078989
RETINITIS PIGMENTOSA 11	0.14285699999999998	5.299200611078989
POSTERIOR URETHRAL VALVE	0.14285699999999998	5.299200611078989
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.14285699999999998	5.299200611078989
STEINERT MYOTONIC DYSTROPHY	0.14285699999999998	5.299200611078989
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.14285699999999998	5.299200611078989
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.299200611078989
HAND-FOOT-GENITAL SYNDROME; HFG	0.14285699999999998	5.299200611078989
IRVAN SYNDROME	0.14285699999999998	5.299200611078989
IDIOPATHIC ANTERIOR UVEITIS	0.14285699999999998	5.299200611078989
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.14285699999999998	5.299200611078989
LYMPHEDEMA, HEREDITARY, II	0.14215680000000003	5.273227083230321
SECONDARY INTESTINAL LYMPHANGIECTASIA	0.1411684	5.23656293737824
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.14110335400000001	5.234150092344758
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.14079355999999998	5.2226584569743615
AL AMYLOIDOSIS	0.14026438000000002	5.203028820489131
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.13990191000000002	5.189583198325024
WILLIAMS SYNDROME	0.13931065	5.167650738919418
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.13875178000000002	5.146919768469852
TRIPLOIDY	0.13875178	5.146919768469851
TRICHOHEPATOENTERIC SYNDROME 1	0.13866399000000001	5.143663247461804
HENNEKAM SYNDROME	0.13768891899999997	5.10749353341877
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.13679965300000002	5.074506707917665
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1367931	5.0742636280433535
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.13661645400000003	5.067711043352757
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.136382004	5.0590142515730925
CINCA SYNDROME	0.135869824	5.040015220591184
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.134711683	4.9970546271661815
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.134315194	4.98234708920104
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.134261954	4.980372181142395
16P13.2 MICRODELETION SYNDROME	0.133977313	4.96981358225583
CASTLEMAN DISEASE	0.13354185	4.953660325532657
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.13260274399999997	4.918824713073568
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.132178984	4.903105572597773
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.13196674	4.895232499983216
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.13098643299999999	4.858868559445159
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.130842763	4.853539201053246
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.13070636400000002	4.8484795563445475
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.1302521	4.831628887029139
INTESTINAL LYMPHANGIECTASIA	0.13005730000000001	4.824402889849875
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.12957786000000002	4.806618330878487
TRICHOTHIODYSTROPHY	0.129516364	4.8043371711118725
BERNARD-SOULIER SYNDROME	0.128820109	4.778509980834414
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.12849661299999998	4.76651007742834
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.12835239999999998	4.761160576754761
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.127972003	4.747049962540179
FUCOSIDOSIS	0.127790553	4.740319176153231
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.12771037300000002	4.7373449438440245
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.127446179	4.727544815000191
3Q27.3 MICRODELETION SYNDROME	0.12690476	4.707461179647008
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.12649583	4.692292149736757
PITT-HOPKINS-LIKE SYNDROME	0.12647789899999998	4.691627009308516
GIANT CELL ARTERITIS	0.1264771	4.691597370849861
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.126086973	4.677125827720728
TRANSALDOLASE DEFICIENCY	0.12572612000000002	4.6637401872683215
COHEN SYNDROME	0.125541419	4.6568888068524705
HERMANSKY-PUDLAK SYNDROME	0.125	4.6368051714992875
PRIMARY ERYTHROMELALGIA	0.125	4.6368051714992875
VACTERL/VATER ASSOCIATION	0.125	4.6368051714992875
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.125	4.6368051714992875
PANCREATIC INSUFFICIENCY, COMBINED EXOCRINE	0.125	4.6368051714992875
GENITOPALATOCARDIAC SYNDROME	0.125	4.6368051714992875
BLEEDING DISORDER, PLATELET-TYPE, 19; BDPLT19	0.125	4.6368051714992875
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.125	4.6368051714992875
THROMBOCYTOPENIA WITH CONGENITAL DYSERYTHROPOIETIC ANEMIA	0.125	4.6368051714992875
BLEEDING DISORDER, PLATELET-TYPE, 16; BDPLT16	0.125	4.6368051714992875
PSEUDOXANTHOMA ELASTICUM	0.125	4.6368051714992875
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.125	4.6368051714992875
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.124672414	4.624653551828001
SOLAR URTICARIA	0.12406020000000001	4.601943815497888
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.12388457300000003	4.595429030043049
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.123325454	4.57468882307758
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.1231592	4.56852172382172
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.12293675	4.56027006533852
LYMPHANGIOLEIOMYOMATOSIS	0.12276351899999999	4.553844158165208
GREENBERG DYSPLASIA	0.12222209999999999	4.533760522812024
SPINOCEREBELLAR ATAXIA TYPE 37	0.1211226	4.492975184523517
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.12061402900000001	4.4741100273805205
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.12005800999999999	4.453484813183305
SPINOCEREBELLAR ATAXIA 13	0.11999031000000002	4.450973519502422
WILD TYPE ATTR AMYLOIDOSIS	0.11985618	4.445998042081197
CEREBELLAR ATAXIA, CAYMAN TYPE	0.119758264	4.442365902759816
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.11869880399999999	4.403065825903842
SYSTEMIC CAPILLARY LEAK SYNDROME	0.11815260000000001	4.382804693648694
CONGENITAL ANALBUMINEMIA	0.1173974	4.354790971524563
HOYERAAL-HREIDARSSON SYNDROME	0.11641234399999999	4.318250869484432
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.116269469	4.312951001173409
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.116204229	4.3105309598183
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.115970954	4.301877754007248
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.115970954	4.301877754007248
FRYNS SYNDROME; FRNS	0.115589429	4.2877252972627975
LYSOSOMAL ACID LIPASE DEFICIENCY	0.115368284	4.279522047025589
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.1150926	4.269295703050392
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.11489887999999998	4.262109767867807
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.11484286400000002	4.260031885639916
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.114607613	4.2513053812127115
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.11458330000000001	4.250403504059634
GOOD SYNDROME	0.11438968999999999	4.243221649265602
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.11428187000000001	4.239222126596875
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.1140845	4.231900796703284
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.11352063999999999	4.21098472499127
DEHYDRATED HEREDITARY STOMATOCYTOSIS	0.11323059000000002	4.200225482271325
IMMUNODEFICIENCY 23; IMD23	0.11313365399999999	4.196629695502488
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.11287814000000002	4.1871515464097655
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.11258809999999998	4.176392674634231
REFSUM DISEASE	0.11258809999999998	4.176392674634231
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.11219797299999999	4.1619211315051
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.11195645	4.152961970741612
DOWN SYNDROME	0.11190470000000001	4.1510423334006115
MICROVILLUS INCLUSION DISEASE	0.11165655399999999	4.141837496151916
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.11165241899999999	4.1416841106368425
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.11165241899999999	4.1416841106368425
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.11161700000000001	4.140370262617888
WELL-DIFFERENTIATED LIPOSARCOMA	0.11111099999999999	4.121600475283659
RADIO-RENAL SYNDROME	0.11111099999999999	4.121600475283659
ALBERS-SCHÖNBERG OSTEOPETROSIS	0.11111099999999999	4.121600475283659
AUTOIMMUNE HEMOLYTIC ANEMIA, COLD TYPE	0.11111099999999999	4.121600475283659
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.11111099999999999	4.121600475283659
NEUTROPHIL CHEMOTACTIC RESPONSE	0.11111099999999999	4.121600475283659
COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE; C3D	0.11111099999999999	4.121600475283659
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.11111099999999999	4.121600475283659
SEVERE CONGENITAL NEMALINE MYOPATHY	0.11111099999999999	4.121600475283659
LIPODYSTROPHY, PARTIAL, ACQUIRED, WITH LOW COMPLEMENT COMPONENT C3, WITH OR WITHOUT GLOMERULONEPHRITIS; APLDC3	0.11111099999999999	4.121600475283659
AUTOIMMUNE HEMOLYTIC ANEMIA	0.11111099999999999	4.121600475283659
SECONDARY POLYCYTHEMIA	0.11111099999999999	4.121600475283659
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.11102279000000001	4.118328374610235
MILROY DISEASE	0.10964910000000001	4.067372111441941
CITRULLINEMIA TYPE II	0.10942911300000001	4.0592118165678395
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.10860776400000002	4.028744334241394
3P25.3 MICRODELETION SYNDROME	0.10762911	3.9924417108149255
BETA-THALASSEMIA MAJOR	0.10752725999999999	3.9886636419611876
HEMOCHROMATOSIS TYPE 4	0.10743544	3.9852576303544116
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 4	0.10721380000000001	3.977036018368723
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 3	0.10721380000000001	3.977036018368723
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.1070381	3.970518525019663
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.10677287	3.9606799663345695
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10675886400000001	3.9601604215887134
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.106166569	3.938189569436288
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.1058999	3.928297631850059
COG5-CDG	0.10563262900000002	3.918383363410126
HARDIKAR SYNDROME	0.10557271000000001	3.916160701577557
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.105527824	3.914495680482134
BUDD-CHIARI SYNDROME	0.10533976	3.907519551459951
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4	0.10450580000000001	3.8765842711333627
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.10438218000000002	3.871998656290957
NOCARDIOSIS	0.10428291900000002	3.868316624945931
MELIOIDOSIS	0.10374150000000001	3.848232989592747
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.10349661300000002	3.8391490431284834
19P13.13 MICRODELETION SYNDROME	0.103388773	3.835148778570927
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 8	0.1029573	3.8191435286688287
%600223 SPINOCEREBELLAR ATAXIA 4; SCA4;;SPINOCEREBELLAR ATAXIA, AUTOSOMAL DOMINANT, WITH SENSORY AXONAL NEUROPATHY	0.1028139	3.813824185776085
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.10266750000000001	3.8083935595592253
WALDENSTRÖM MACROGLOBULINEMIA	0.10253628	3.8035260269623916
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.10233086400000001	3.7959062351935224
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.102249134	3.792874506500189
ACROCEPHALOSYNDACTYLY	0.10195418	3.781933352639754
CONGENITAL ISOLATED ACTH DEFICIENCY	0.10096379999999999	3.7451957597937584
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.10053007300000001	3.729106899020808
INSULIN-RESISTANCE SYNDROME TYPE B	0.10050099	3.7280280813823854
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.10032689400000001	3.7215700875172875
BARDET-BIEDL SYNDROME 1; BBS1	0.10025271399999999	3.718818421856312
SYNDROMIC DIARRHEA	0.099040084	3.6738365894153904
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.098953104	3.670610114904855
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.0984556	3.6521554819445226
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.098393854	3.6498650485675674
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.098393854	3.6498650485675674
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.6397752121366187
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.6397752121366187
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.6397752121366187
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.6397752121366187
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.6397752121366187
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.097763719	3.626490542753625
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.09744489	3.614663759105434
KAWASAKI DISEASE	0.09679204999999999	3.5904470240001407
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.09593308300000002	3.558584122978164
KAPOSI SARCOMA	0.0957671	3.552427076315915
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.09575837000000001	3.5521032418427385
SIALURIA	0.095592523	3.545951240024517
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.095558899	3.544703976527825
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.0955556	3.5445816019657386
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.09531049000000001	3.5354893834410497
KAGAMI-OGATA SYNDROME	0.095242873	3.5329811685987993
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.09480348000000001	3.5166821307210347
ENTERIC ANENDOCRINOSIS	0.0946844	3.5122649246424573
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.09444440000000001	3.503362258713179
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.09444440000000001	3.503362258713179
BLAU SYNDROME	0.09415590000000001	3.4926605123773586
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.09354038	3.469828141824068
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.093473173	3.467335135702781
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.0933249	3.461835031597231
NEPHRONOPHTHISIS 19; NPHP19	0.09322408	3.4580951700181064
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.093025213	3.4507183097457816
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.09286754400000001	3.4448696662691014
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.09282763999999999	3.443389449680593
MECKEL SYNDROME, TYPE 5	0.09263160000000001	3.4361174553940277
COACH SYNDROME	0.092521673	3.4320397747373277
MUCOLIPIDOSIS IV; ML4	0.092387954	3.427079543131506
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.09207311000000001	3.415400580832183
MONOSOMY 18Q	0.09199607300000001	3.4125429363522084
NEONATAL HEMOCHROMATOSIS	0.09166669999999999	3.4003250289141898
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.09145051900000001	3.3923059154839517
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.09137259400000002	3.3894153311400386
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.0909091	3.3722222801307677
SPINOCEREBELLAR ATAXIA TYPE 12	0.0909091	3.3722222801307677
DDOST-CDG	0.09073187900000002	3.365648366136381
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.09046176	3.3556284527274194
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.09017040400000001	3.3448207646670407
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.0900735	3.3412261649203288
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.089585314	3.3231171779647
GLIOBLASTOMA	0.08947421900000001	3.318996171000479
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.089369319	3.315104964100556
CIRRHOSIS, FAMILIAL	0.08859646000000002	3.286436191236239
SPINOCEREBELLAR ATAXIA TYPE 2	0.08846161	3.281434005817225
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.08835728300000001	3.277564054032209
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0881577	3.2701606341398617
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08792732	3.261614816736582
CHROMOSOME 1P36 DELETION SYNDROME	0.08785428299999999	3.2589055500220954
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.0878137	3.2574001463078956
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.08662845999999999	3.213434330616153
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.08661199000000001	3.212823385166757
THANATOPHORIC DYSPLASIA TYPE 1	0.086391919	3.2046599743595805
THANATOPHORIC DYSPLASIA	0.086391919	3.2046599743595805
THANATOPHORIC DYSPLASIA TYPE 2	0.086391919	3.2046599743595805
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.08636611	3.2037026039222107
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.085794449	3.182497158473055
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.08552910999999999	3.1726545564938515
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-NEGATIVE	0.08503688000000001	3.154395559617315
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE I; CDG1	0.08503688000000001	3.154395559617315
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE II; CDG2	0.08503688000000001	3.154395559617315
CHRONIC GRANULOMATOUS DISEASE	0.08503688000000001	3.154395559617315
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.08503688000000001	3.154395559617315
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	0.08503688000000001	3.154395559617315
VON HIPPEL-LINDAU DISEASE	0.08481040000000001	3.145994410535385
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.084802034	3.145684078438867
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.084692319	3.1416142618037393
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.08465600000000001	3.1402670287875503
BURKITT LYMPHOMA	0.08465600000000001	3.1402670287875503
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.084566769	3.1369570546894847
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.084087519	3.1191795436619567
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.0839898	3.115554711945527
ILEAL NEUROENDOCRINE TUMOR	0.08397086000000001	3.1148521432259417
JEJUNAL NEUROENDOCRINE TUMOR	0.08397086000000001	3.1148521432259417
%300712 CRANIOFACIOSKELETAL SYNDROME	0.08387885400000002	3.1114392320530704
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.08347680000000002	3.0965252635216944
BULLOUS IMPETIGO	0.08333330000000001	3.091202211184813
MYCETOMA	0.08333330000000001	3.091202211184813
APLASIA CUTIS CONGENITA WITH INTESTINAL LYMPHANGIECTASIA	0.08333330000000001	3.091202211184813
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.08333330000000001	3.091202211184813
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.08333330000000001	3.091202211184813
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.08333330000000001	3.091202211184813
PENTALOGY OF CANTRELL	0.08333330000000001	3.091202211184813
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.08333330000000001	3.091202211184813
OVERHYDRATED HEREDITARY STOMATOCYTOSIS	0.08333330000000001	3.091202211184813
184705 STEINFELD SYNDROME	0.08333330000000001	3.091202211184813
PAPILLON-LEFÈVRE SYNDROME	0.08333330000000001	3.091202211184813
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.08333330000000001	3.091202211184813
FAMILIAL MELANOMA	0.08333330000000001	3.091202211184813
CONGENITAL ALVEOLAR CAPILLARY DYSPLASIA	0.08333330000000001	3.091202211184813
RED CELL PHOSPHOLIPID DEFECT WITH HEMOLYSIS	0.08333330000000001	3.091202211184813
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.08333330000000001	3.091202211184813
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.08312401900000001	3.0834390494000408
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.082986899	3.078352659599113
DILATED CARDIOMYOPATHY WITH ATAXIA	0.082863189	3.073763706256983
NEURAMINIDASE DEFICIENCY	0.082572849	3.0629937061490384
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.08254825	3.062081219985729
ALPORT SYNDROME	0.08222609	3.050130874753327
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.08145056399999999	3.0213631710138693
RHEUMATOID ARTHRITIS	0.081136	3.0096945951581295
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.08020179000000001	2.975040597083999
CRIGLER-NAJJAR SYNDROME TYPE 1	0.080077779	2.9704404783150165
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.08005585900000001	2.969627368160143
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.08004929000000001	2.9693836947747703
SALT-AND-PEPPER SYNDROME	0.079611304	2.953136848776015
CHRISTIANSON SYNDROME	0.07920182	2.937947268545246
ETHYLMALONIC ENCEPHALOPATHY	0.078941619	2.9282952578058117
GRISCELLI SYNDROME TYPE 2	0.07893675900000001	2.928114978820744
DISORDER OF BILE ACID SYNTHESIS	0.07877537	2.9221283440221586
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2; BRIC2	0.07824334	2.9023929883790163
YUNIS-VARON SYNDROME	0.07823146400000001	2.901952454793283
SIMPSON-GOLABI-BEHMEL SYNDROME	0.07815616300000001	2.8991592062635307
ALG11-CDG	0.07791424300000001	2.8901853190068176
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.07777780000000001	2.885124042142699
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.07777780000000001	2.885124042142699
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.07777780000000001	2.885124042142699
MPI-CDG	0.0777778	2.885124042142698
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.07772881400000001	2.88330693383765
TRISOMY 1Q	0.07768591	2.881715433925026
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0776216	2.8793298904003928
HISTIOCYTOID CARDIOMYOPATHY	0.07761060900000001	2.8789221853952736
RETINITIS PIGMENTOSA 59; RP59	0.077595169	2.87834944722049
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.07749784300000001	2.8747391936195195
NEUTRAL LIPID STORAGE MYOPATHY	0.07747094	2.8737412418632884
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.8736564439703125
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.07736239	2.8697146402523583
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.07715875999999999	2.8621610991557787
FETAL PARVOVIRUS SYNDROME	0.07702759	2.857295421281015
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.07696395	2.8549347310321007
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	2.8534194231020553
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	2.8534194231020553
ZOLLINGER-ELLISON SYNDROME	0.07669176000000001	2.8448379950350584
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.07643714300000001	2.8353931196562447
LYSINURIC PROTEIN INTOLERANCE; LPI	0.07641087	2.8344185373980784
GAUCHER DISEASE, PERINATAL LETHAL	0.07639538900000001	2.8338442783511986
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.076140499	2.824389276189891
17Q23.1Q23.2 MICRODELETION SYNDROME	0.07582955999999999	2.812855167684124
AMISH INFANTILE EPILEPSY SYNDROME	0.07560445	2.8045048379868747
NEPHROPATHY, PROGRESSIVE TUBULOINTERSTITIAL, WITH CHOLESTATIC LIVERDISEASE	0.07535017000000001	2.795072463434804
CRYPTOCOCCOSIS	0.075099769	2.785783978220815
AMYLOIDOSIS	0.0748664	2.7771272855322744
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA	0.07462028	2.767997601621799
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.07437965900000001	2.759071900044429
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.07437965900000001	2.759071900044429
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.07421915300000001	2.7531180196375753
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 74	0.07383824000000001	2.738988264691245
OROFACIODIGITAL SYNDROME I; OFD1	0.073776729	2.7367065485080118
SLC39A8-CDG	0.073292719	2.718752467939553
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.07321722	2.7159518747104086
BECKWITH-WIEDEMANN SYNDROME	0.07313218	2.7127973634161346
MASTOCYTOSIS	0.07313218	2.7127973634161346
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.07313218	2.7127973634161346
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.07313218	2.7127973634161346
TURCOT SYNDROME WITH POLYPOSIS	0.0729057	2.704396214334205
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07289361	2.7039477425380176
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.07251557300000001	2.6899246712050733
SMITH-MAGENIS SYNDROME; SMS	0.072403533	2.685768609993755
DK1-CDG	0.07229184999999999	2.681625791498006
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.072194524	2.6780155378970356
CEREBROFACIOARTICULAR SYNDROME	0.072112004	2.6749545045950183
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07197415400000001	2.6698410358518894
NETHERTON SYNDROME; NETH	0.07197415400000001	2.6698410358518894
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07197415400000001	2.6698410358518894
IMMUNOGLOBULIN A VASCULITIS	0.07197001900000001	2.6696876503368165
GRISCELLI SYNDROME, TYPE 2; GS2	0.07197001900000001	2.6696876503368165
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.07197001900000001	2.6696876503368165
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.071470033	2.6511409489729982
CRYPTOSPORIDIOSIS	0.07142860000000001	2.6496040149836326
ADULT ACUTE RESPIRATORY DISTRESS SYNDROME	0.07142860000000001	2.6496040149836326
RETINITIS PIGMENTOSA 83; RP83	0.07142860000000001	2.6496040149836326
RETINITIS PIGMENTOSA 76; RP76	0.07142860000000001	2.6496040149836326
CARBOXYPEPTIDASE N DEFICIENCY	0.07142860000000001	2.6496040149836326
PULMONARY EDEMA OF MOUNTAINEERS	0.07142860000000001	2.6496040149836326
IDIOPATHIC PANUVEITIS	0.07142860000000001	2.6496040149836326
RETINITIS PIGMENTOSA 13; RP13	0.07142860000000001	2.6496040149836326
RETINITIS PIGMENTOSA 77; RP77	0.07142860000000001	2.6496040149836326
FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1	0.07142860000000001	2.6496040149836326
RETINITIS PIGMENTOSA 78; RP78	0.07142860000000001	2.6496040149836326
ACQUIRED ANGIOEDEMA	0.07142860000000001	2.6496040149836326
GARDNER SYNDROME	0.07142860000000001	2.6496040149836326
RETINITIS PUNCTATA ALBESCENS	0.07142860000000001	2.6496040149836326
BIRDSHOT CHORIORETINOPATHY	0.07142860000000001	2.6496040149836326
MULTIPLE ENDOCRINE NEOPLASIA TYPE 1	0.07142860000000001	2.6496040149836326
INTERMEDIATE UVEITIS	0.07142860000000001	2.6496040149836326
ALAGILLE SYNDROME 2	0.07142860000000001	2.6496040149836326
PSORIASIS 14, PUSTULAR	0.07142860000000001	2.6496040149836326
MICROPHTHALMIA, ISOLATED 5	0.07142860000000001	2.6496040149836326
MULTIPLE ENDOCRINE NEOPLASIA TYPE 4	0.07142860000000001	2.6496040149836326
JOUBERT SYNDROME 6	0.071320954	2.645610946747703
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.071002219	2.633787649977
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.070875373	2.6290823684667277
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.070697973	2.622501814567336
HEMOCHROMATOSIS TYPE 2	0.07058827	2.6184324430655037
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.070336344	2.609087388828423
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.07016619	2.602775621251213
ALPHA-THALASSEMIA	0.07003656	2.597967068816161
RHABDOID TUMOR	0.06994539	2.5945851685962764
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.0699346	2.594184919573873
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.069617759	2.5824318796751284
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.06929817299999999	2.570577015534818
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.069184414	2.5663571889787815
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.06918196900000001	2.5662664930696275
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.06913730900000001	2.564609855317954
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.068952953	2.5577712724843784
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.06878306000000001	2.5514691865563663
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.5481544272753647
SENIOR-LOKEN SYNDROME	0.068689354	2.5479932148331623
AUTOSOMAL RECESSIVE ATAXIA DUE TO PEX10 DEFICIENCY	0.0683405	2.5350526705827767
SPINOCEREBELLAR ATAXIA TYPE 26	0.0683405	2.5350526705827767
LAURENCE-MOON SYNDROME	0.06814379999999999	2.527756193964905
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.06787324	2.5177199219072985
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.06770741300000001	2.511568661977905
MYELOPEROXIDASE DEFICIENCY	0.06768247999999999	2.5106437862711766
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.06767692300000001	2.5104376524604732
GLYCOGEN STORAGE DISEASE IV	0.06754573999999999	2.50557149235797
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.06745836	2.502330180070885
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.067208119	2.493047629967516
EPENDYMOMA	0.067208119	2.493047629967516
SUBEPENDYMOMA	0.067208119	2.493047629967516
GLYCOGEN STORAGE DISEASE IXC	0.0669524	2.483561876514311
GAUCHER DISEASE	0.06679012999999999	2.4775425615128777
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.066703819	2.474340903183619
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.4729639946143323
ADENOCARCINOMA OF THE ANAL CANAL	0.0666667	2.4729639946143323
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.4729639946143323
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.4729639946143323
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.0666667	2.4729639946143323
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0666667	2.4729639946143323
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.4729639946143323
SQUAMOUS CELL CARCINOMA OF THE ANAL CANAL	0.0666667	2.4729639946143323
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.4729639946143323
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.4729639946143323
NEPHROBLASTOMA	0.0666667	2.4729639946143323
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.4729639946143323
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.4729639946143323
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.0666667	2.4729639946143323
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.4729639946143323
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.4729639946143323
MUIR-TORRE SYNDROME	0.0666667	2.4729639946143323
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.4729639946143323
TRANSALDOLASE DEFICIENCY	0.066520494	2.4675405647190987
REYNOLDS SYNDROME	0.06644391000000001	2.464699724021066
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0662919	2.459060997988109
HEMOCHROMATOSIS, TYPE 1	0.065979	2.4474541472828117
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.06589500899999999	2.4443385480575364
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.065555029	2.431727179879886
1P36 DELETION SYNDROME	0.06548527300000001	2.429139620027542
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.06548385000000001	2.429086834637469
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.06533011899999999	2.423384269070911
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.065089744	2.414467692726118
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.404268798637536
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.063748	2.3646964485818924
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.0637064	2.3631533198208174
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.062842929	2.3311233454349005
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.06279881000000001	2.32948677577601
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.0627413	2.327353474452706
COCAINE EMBRYOFETOPATHY	0.0627273	2.326834152273498
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.06210219	2.303646046027451
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.06200055	2.299875767006401
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.06190225	2.296229383419534
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.061614053	2.2855388766994498
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.061535440000000004	2.2826227713798732
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.061512413	2.2817685976784
49,XXXYY SYNDROME	0.06142855999999999	2.278658117486034
49,XYYYY SYNDROME	0.06142855999999999	2.278658117486034
HEREDITARY ELLIPTOCYTOSIS	0.061202	2.270254000848795
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.06088831	2.2586178455348143
CHILDHOOD-ONSET AUTOSOMAL RECESSIVE SLOWLY PROGRESSIVE SPINOCEREBELLAR ATAXIA	0.06083495	2.2566384861432045
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.06083495	2.2566384861432045
HOLOPROSENCEPHALY	0.060754173	2.253642108452499
YUNIS-VARON SYNDROME	0.06075262	2.253584500785048
SPINOCEREBELLAR ATAXIA 1	0.06074545	2.253318533640411
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.060529313	2.2453010523655927
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.060529313	2.2453010523655927
NOONAN SYNDROME	0.060433680000000004	2.2417535996538644
PHELAN-MCDERMID SYNDROME	0.060085933	2.228854118950078
RFT1-CDG	0.05982325300000001	2.2191101510904825
BLAU SYNDROME	0.0597643	2.216923322488279
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.059667200000000004	2.2133214522310585
DUBIN-JOHNSON SYNDROME	0.05959834000000001	2.210767128998183
GRISCELLI SYNDROME	0.059533503	2.2083620367029466
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.05944234	2.204980396144152
FOUNTAIN SYNDROME	0.059364919	2.2021085073986906
CORNELIA DE LANGE SYNDROME	0.059364919	2.2021085073986906
FOUNTAIN SYNDROME	0.059364919	2.2021085073986906
ADAMS-OLIVER SYNDROME 1; AOS1	0.059052213	2.19050885301502
8Q24.3 MICRODELETION SYNDROME	0.059052213	2.19050885301502
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.059014789	2.189120630641114
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.058964519	2.1872558930733437
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.058900014	2.1848631161326435
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.0588235	2.1820248720455067
HYDROPS FETALIS, NONIMMUNE, WITH GRACILE BONES AND DYSMORPHIC FEATURES	0.0588235	2.1820248720455067
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA	0.0588235	2.1820248720455067
HYDROPS FETALIS, NONIMMUNE	0.0588235	2.1820248720455067
MELKERSSON-ROSENTHAL SYNDROME	0.0588235	2.1820248720455067
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.0588235	2.1820248720455067
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.0588235	2.1820248720455067
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.05854733300000001	2.1717806114551275
WHITE-SUTTON SYNDROME; WHSUS	0.058510794	2.170425217661836
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.058510794	2.170425217661836
17P11.2 MICRODUPLICATION SYNDROME	0.058510794	2.170425217661836
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.0584691	2.168878602023272
CITRULLINEMIA, CLASSIC	0.058417803000000004	2.166975768464213
PYRUVATE CARBOXYLASE DEFICIENCY	0.058346153000000005	2.1643179517399096
WITTEVEEN-KOLK SYNDROME	0.058032972999999995	2.152700714591028
COFFIN-SIRIS SYNDROME 6; CSS6	0.058005914000000006	2.1516969761019435
PORPHYRIA CUTANEA TARDA	0.05791213	2.148218111012312
DUBIN-JOHNSON SYNDROME	0.05789476	2.147573780565681
DE BARSY SYNDROME	0.057833414	2.145298184965274
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.057777909999999995	2.1432392950913632
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.057562800000000004	2.1352599098078335
CYSTIC FIBROSIS	0.05725918000000001	2.123997295518469
PANNER DISEASE	0.0572101	2.122176700335931
EVEN-PLUS SYNDROME	0.057114163999999995	2.1186180080084673
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.057032700000000006	2.1155961464365394
COG2-CDG	0.056670094	2.102145479428406
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.056642573	2.1011246033074076
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.056642573	2.1011246033074076
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.056628979999999995	2.1006203785658375
MECKEL SYNDROME, TYPE 1; MKS1	0.05656861	2.0983809871402106
RENAL CYSTS AND DIABETES SYNDROME; RCAD	0.05655317	2.097808248965427
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.05651325000000001	2.096327438865857
EPISODIC ATAXIA, TYPE 6	0.056292618999999995	2.0881432551715124
219400 CYANOSIS AND HEPATIC DISEASE	0.056122500000000006	2.08183278589975
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.056101154	2.0810409679542237
FLOATING-HARBOR SYNDROME	0.056101154	2.0810409679542237
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.056097019000000005	2.0808875824391504
LATHOSTEROLOSIS	0.056069243000000005	2.079857247235602
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.05591029	2.0739609744961993
THROMBOCYTOPENIA WITH ELEVATED SERUM IGA AND RENAL DISEASE	0.05591029	2.0739609744961993
IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6	0.05591029	2.0739609744961993
NEPHROTIC SYNDROME, TYPE 7; NPHS7	0.05591029	2.0739609744961993
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.060803947085967
FAMILIAL DEVELOPMENTAL DYSPHASIA	0.055555600000000004	2.060803947085967
FLOATING-HARBOR SYNDROME	0.055555600000000004	2.060803947085967
BILIARY CIRRHOSIS, PRIMARY	0.055555600000000004	2.060803947085967
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.060803947085967
GITELMAN SYNDROME	0.055555600000000004	2.060803947085967
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	2.060803947085967
MICROANGIOPATHY AND LEUKOENCEPHALOPATHY, PONTINE, AUTOSOMAL DOMINANT	0.055555600000000004	2.060803947085967
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.060803947085967
DYSPHASIA, FAMILIAL DEVELOPMENTAL	0.055555600000000004	2.060803947085967
SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2	0.055555600000000004	2.060803947085967
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.060803947085967
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.060803947085967
CYSTIC FIBROSIS	0.055555600000000004	2.060803947085967
XQ12-Q13.3 DUPLICATION SYNDROME	0.05524035999999999	2.049110295387859
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.055081913999999996	2.043232829530232
MECKEL SYNDROME, TYPE 4; MKS4	0.05504124	2.0417240502218674
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.054777714000000005	2.0319487004648717
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.054743504	2.0306796996255354
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.054654254	2.0273690207330852
SILVER-RUSSELL SYNDROME; SRS	0.054522853999999996	2.022494811136805
300270 ADRENOMYODYSTROPHY	0.054335754	2.015554441156105
POLYCYSTIC LIVER DISEASE 2	0.054335180000000004	2.015533148946757
AMERICAN TRYPANOSOMIASIS	0.054335180000000004	2.015533148946757
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.053718573	1.992660456735696
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.0536499	1.990113070163357
EPISODIC ATAXIA, TYPE 2	0.053571499999999994	1.9872048659597925
KIKUCHI-FUJIMOTO DISEASE	0.053516440000000005	1.9851624460178507
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.05325959	1.9756347387514541
JOUBERT SYNDROME 23; JBTS23	0.053177154	1.9725768213825121
GRANULOMATOSIS WITH POLYANGIITIS	0.053173019	1.9724234358674393
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.053173019	1.9724234358674393
LEUKOCYTE ADHESION DEFICIENCY	0.053173019	1.9724234358674393
SPINOCEREBELLAR ATAXIA 18	0.053010949999999994	1.9664115768487211
9Q33.3Q34.11 MICRODELETION SYNDROME	0.052728978999999995	1.9559520201206184
GOODPASTURE SYNDROME	0.0526316	1.9523398005142554
NEPHRONOPHTHISIS 13	0.0526316	1.9523398005142554
SENIOR-LOKEN SYNDROME 8; SLSN8	0.0526316	1.9523398005142554
ACUTE MONOBLASTIC LEUKEMIA	0.0526316	1.9523398005142554
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.0526316	1.9523398005142554
MELKERSSON-ROSENTHAL SYNDROME	0.0526316	1.9523398005142554
DERMATOMYOSITIS	0.0526316	1.9523398005142554
NAIL-PATELLA SYNDROME	0.0526316	1.9523398005142554
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0526316	1.9523398005142554
KAPUR-TORIELLO SYNDROME	0.0526316	1.9523398005142554
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.0526316	1.9523398005142554
LACRIMAL DUCT DEFECT	0.0526316	1.9523398005142554
POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD6	0.0526316	1.9523398005142554
%247800 LYMPHOPENIC HYPERGAMMAGLOBULINEMIA, ANTIBODY DEFICIENCY, AUTOIMMUNEHEMOLYTIC ANEMIA, AND GLOMERULONEPHRITIS	0.0526316	1.9523398005142554
ROBERTS SYNDROME; RBS	0.0526316	1.9523398005142554
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.0526316	1.9523398005142554
CONGENITAL MEMBRANOUS NEPHROPATHY DUE TO FETOMATERNAL ANTI-NEUTRAL ENDOPEPTIDASE ALLOIMMUNIZATION	0.0526316	1.9523398005142554
POLYCYSTIC LIVER DISEASE 3 WITH OR WITHOUT KIDNEY CYSTS; PCLD3	0.0526316	1.9523398005142554
POLYCYSTIC KIDNEYS	0.0526316	1.9523398005142554
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.0526316	1.9523398005142554
POLYCYSTIC LIVER DISEASE 4 WITH OR WITHOUT KIDNEY CYSTS; PCLD4	0.0526316	1.9523398005142554
POLYCYSTIC KIDNEY DISEASE 2	0.0526316	1.9523398005142554
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.0526316	1.9523398005142554
%174770 ACTINIC PRURIGOPOLYMORPHIC LIGHT ERUPTION, HEREDITARY; HPLE;;JUVENILE SPRING ERUPTION OF EARS, INCLUDED	0.0526316	1.9523398005142554
POLYCYSTIC KIDNEY DISEASE 3	0.0526316	1.9523398005142554
PEUTZ-JEGHERS SYNDROME	0.0526316	1.9523398005142554
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.0526316	1.9523398005142554
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.0526316	1.9523398005142554
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.0526316	1.9523398005142554
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.0526316	1.9523398005142554
VISCERAL STEATOSIS, CONGENITAL	0.052187369	1.9358612997291327
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.051972683	1.9278976424887448
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.051441924	1.9082094338805866
CEPHALIN LIPIDOSIS	0.05140688	1.9069094962771465
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.05123706399999999	1.9006102666211193
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.051144223	1.8971663815897026
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.051115613000000004	1.89610510962205
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.05074541	1.8823726361428132
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.050602804	1.8770827462365187
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.050602804	1.8770827462365187
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.050570059	1.8758680887537929
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.05043650399999999	1.8709139406363557
RETINAL VENOUS BEADING	0.050287389999999994	1.8653826401056124
12Q14 MICRODELETION SYNDROME	0.050069314000000004	1.8572932327089737
MEDNIK SYNDROME	0.05	1.854722068599715
IRIDA SYNDROME	0.05	1.854722068599715
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.049569269000000006	1.838744342773115
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.04955366900000001	1.8381656694877118
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.049538873000000004	1.8376168201331717
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.04952376	1.8370562118407165
IMMUNODEFICIENCY 47	0.049208009	1.8253436048830678
MCLEOD SYNDROME; MCLDS	0.0490852	1.820788073632615
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076854	1.8204784834249241
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.04907410999999999	1.820376696277799
MICROHYDRANENCEPHALY; MHAC	0.04891057	1.8143102713358235
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.048879673	1.8131641643807528
NEONATAL ADRENOLEUKODYSTROPHY	0.048773709	1.8092334889952106
ADULT-ONSET STILL DISEASE	0.048760649999999996	1.808749072685334
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.048708949999999994	1.8068312900664014
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.048705973	1.8067208599144373
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.048700273	1.806509421598617
LISSENCEPHALY 2; LIS2	0.048693654	1.8062638934911759
DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1	0.04865153999999999	1.8047016981872352
SUSAC SYNDROME	0.048606510000000006	1.803031335492255
LYSOSOMAL ACID LIPASE DEFICIENCY	0.048459920000000004	1.797593661331534
CONGENITAL HYPOTHYROIDISM	0.048272854000000004	1.7906545525618407
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.048272854000000004	1.7906545525618407
DEXTROCARDIA	0.048164554	1.7866372245612536
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.048160419	1.7864838390461806
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.048130104	1.7853593210559884
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.047762500000000006	1.771723256029878
FEINGOLD SYNDROME	0.047619	1.7664002036929967
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.047619	1.7664002036929967
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.047619	1.7664002036929967
MEACHAM SYNDROME	0.047619	1.7664002036929967
CEROID STORAGE DISEASE	0.047619	1.7664002036929967
LARYNGOTRACHEOESOPHAGEAL CLEFT TYPE 4	0.047619	1.7664002036929967
PAGOD SYNDROME	0.047619	1.7664002036929967
TUFTSIN DEFICIENCY	0.047619	1.7664002036929967
SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITALCATARACTS, AND MYOPIA	0.047619	1.7664002036929967
SPINOCEREBELLAR ATAXIA 42	0.047619	1.7664002036929967
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.047619	1.7664002036929967
LISSENCEPHALY, X-LINKED, 2	0.04760013900000001	1.7657005654342794
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.04747941	1.76122219062188
MAPLE SYRUP URINE DISEASE; MSUD	0.047473019000000005	1.7609851200470716
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.0474338	1.7595303131509032
SIALIDOSIS TYPE 2	0.047413613	1.7587814876629269
CHANARIN-DORFMAN SYNDROME	0.047009270000000006	1.743782609955251
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.046974800000000004	1.7425039645611582
THYROCEREBRORETINAL SYNDROME	0.046963909	1.7420999690001753
LASSA FEVER	0.046955608999999995	1.7417920851367878
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.04685405	1.7380248107654896
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.046720953999999995	1.7330876889966425
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.046690683	1.7319648031618708
BETA-THALASSEMIA	0.04666707	1.731088892117754
SPINOCEREBELLAR ATAXIA 2; SCA2	0.04666095	1.7308618741365573
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.046550918999999996	1.7267803356579556
COFFIN-SIRIS SYNDROME 2; CSS2	0.046470033	1.7237799146731407
MUCOPOLYSACCHARIDOSIS TYPE 7	0.04644469999999999	1.7228402011898636
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.046293464	1.7172301862545285
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.046135319	1.7113638858237548
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.046115803000000004	1.7106399507059389
CEDNIK SYNDROME	0.046042373000000004	1.7079161058759937
CEREBROTENDINOUS XANTHOMATOSIS	0.046019419000000006	1.7070646400687408
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.045995919	1.7061929206964987
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.045995919	1.7061929206964987
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.045928614	1.7036962793199568
WIEDEMANN-STEINER SYNDROME	0.045924479000000004	1.7035428938048836
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.045924479000000004	1.7035428938048836
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0458128	1.6994002236869004
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.045775053999999996	1.6980000569028728
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.04565769	1.6936465048856906
TYROSINEMIA, TYPE I; TYRSN1	0.0455708	1.6904233688748778
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.045500954	1.6878324705228098
JOUBERT SYNDROME 7	0.045500954	1.6878324705228098
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.045486808999999996	1.6873077696496024
SOMATOMAMMOTROPINOMA	0.0454546	1.686112994787452
ACROMEGALY	0.0454546	1.686112994787452
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.045454579999999994	1.6861122528986245
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.0454439	1.6857160842647718
KOOLEN-DE VRIES SYNDROME; KDVS	0.045401373	1.6841385689565451
LISSENCEPHALY 5; LIS5	0.045036729	1.6706123034768954
ALPORT SYNDROME, X-LINKED; ATS	0.044945389999999995	1.6672241342964185
FECHTNER SYNDROME	0.044945389999999995	1.6672241342964185
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6664866968019436
SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS	0.044839079999999996	1.6632806242341622
MALAN OVERGROWTH SYNDROME	0.04461775899999999	1.655070845375271
ERDHEIM-CHESTER DISEASE	0.044612599999999995	1.6548794751522329
TARP SYNDROME	0.044565273	1.6531239065254208
COFFIN-SIRIS SYNDROME 4; CSS4	0.044565273	1.6531239065254208
COFFIN-SIRIS SYNDROME 3; CSS3	0.044565273	1.6531239065254208
ADRENOLEUKODYSTROPHY	0.044531219000000004	1.651860692418939
COG1-CDG	0.0443063	1.6435174477599912
CONGENITAL TRACHEAL STENOSIS	0.0442684	1.6421115684319925
MACHADO-JOSEPH DISEASE TYPE 3	0.044112559999999995	1.6363307706885808
MACHADO-JOSEPH DISEASE TYPE 2	0.044112559999999995	1.6363307706885808
MACHADO-JOSEPH DISEASE TYPE 1	0.044112559999999995	1.6363307706885808
ALSTRÖM SYNDROME	0.044087793	1.6354120526591207
TARP SYNDROME; TARPS	0.044023854	1.633040271172237
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.044019719000000006	1.6328868856571637
3Q13 MICRODELETION SYNDROME	0.04393701	1.629818841505727
ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD	0.04386722	1.627230020442376
ALKAPTONURIA	0.04378788	1.6242869474639217
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.04366312900000001	1.6196593788083242
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.043614749999999994	1.6178647868291884
RING CHROMOSOME 22 SYNDROME	0.043576252999999995	1.6164367621196905
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.04357145999999999	1.6162589684621944
HYPERBILIVERDINEMIA; HBLVD	0.043498800000000004	1.613563686352106
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.043478300000000004	1.6128032503039802
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.043478300000000004	1.6128032503039802
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.043478300000000004	1.6128032503039802
16P13.11 MICRODELETION SYNDROME	0.04342432399999999	1.610801040736485
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.0432982	1.6061225414128837
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.0432982	1.6061225414128837
ZELLWEGER SYNDROME	0.04322245900000001	1.6033129713289278
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-SACCADIC INTRUSION SYNDROME	0.043165709999999996	1.601207898875508
EPISODIC ATAXIA, TYPE 8	0.043143799999999996	1.6003951596650474
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04312171000000001	1.5995757434551408
HARTNUP DISORDER	0.04275367299999999	1.5859236165359156
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.042466214	1.5752604855135637
XP22.13P22.2 DUPLICATION SYNDROME	0.042208118999999995	1.5656865956676584
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.042208118999999995	1.5656865956676584
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.042208118999999995	1.5656865956676584
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.042208118999999995	1.5656865956676584
EPISODIC ATAXIA TYPE 3	0.042208118999999995	1.5656865956676584
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.0422078	1.565674762540861
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.0422078	1.565674762540861
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.0422078	1.565674762540861
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.04206958000000001	1.5605475688544244
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.04202195399999999	1.5587809089896412
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.042019270000000004	1.5586813475089991
PELIZAEUS-MERZBACHER DISEASE	0.042018519000000004	1.5586534895835287
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.041825633	1.55149849116505
MENTAL RETARDATION, X-LINKED 98; MRX98	0.041739532999999995	1.5483046597629213
SOTOS SYNDROME	0.041706573000000004	1.5470820269753005
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.041666699999999994	1.5456029603144747
EPISODIC ATAXIA, TYPE 7; EA7	0.041666699999999994	1.5456029603144747
EPISODIC ATAXIA, TYPE 4	0.041666699999999994	1.5456029603144747
EPISODIC ATAXIA, TYPE 3	0.041666699999999994	1.5456029603144747
%613944 IGA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2	0.041666699999999994	1.5456029603144747
HAMAMY SYNDROME; HMMS	0.041666699999999994	1.5456029603144747
EPISODIC ATAXIA, TYPE 5	0.041666699999999994	1.5456029603144747
PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA	0.041666699999999994	1.5456029603144747
COMPLEMENT COMPONENT C1R DEFICIENCY	0.041666699999999994	1.5456029603144747
EPISODIC ATAXIA TYPE 7	0.041666699999999994	1.5456029603144747
BENIGN PAROXYSMAL TONIC UPGAZE OF CHILDHOOD WITH ATAXIA	0.041666699999999994	1.5456029603144747
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.041666699999999994	1.5456029603144747
%161900 RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION; RFH1;;NEPHROPATHY, FAMILIAL;;NEPHRITIS, FAMILIAL, WITHOUT DEAFNESS OR OCULAR DEFECT;;RENAL FAILURE, ADULT-ONSET; AORF	0.041666699999999994	1.5456029603144747
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1	0.041666699999999994	1.5456029603144747
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1; HNFJ1	0.041666699999999994	1.5456029603144747
DISTAL 17P13.1 MICRODELETION SYNDROME	0.041666699999999994	1.5456029603144747
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.041666699999999994	1.5456029603144747
HISTIDINEMIA	0.041666699999999994	1.5456029603144747
DYSCHONDROSTEOSIS AND NEPHRITIS	0.041666699999999994	1.5456029603144747
PAPILLARY TUMOR OF THE PINEAL REGION	0.041666699999999994	1.5456029603144747
PINEOCYTOMA	0.041666699999999994	1.5456029603144747
EPISODIC ATAXIA, TYPE 1; EA1	0.041666699999999994	1.5456029603144747
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.041661114	1.545395750764971
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.04164572	1.5448247189344904
YOU-HOOVER-FONG SYNDROME; YHFS	0.041233454	1.529531941967824
C SYNDROME	0.04116101900000001	1.5268450061070438
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.04097401	1.5199080117205082
FANCONI ANEMIA	0.040861244	1.5157250199447538
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.04082488	1.5143761176787027
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.04059248000000001	1.5057553695038515
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.04059248000000001	1.5057553695038515
TRISOMY 12P	0.040545554	1.5040146757480288
KAPUR-TORIELLO SYNDROME	0.040541419	1.503861290232956
SPINOCEREBELLAR ATAXIA 5; SCA5	0.040429914	1.4997250745477715
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.040340549999999996	1.4964101668890046
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.04031569	1.4954879990764969
DK PHOCOMELIA SYNDROME	0.04031569	1.4954879990764969
PRIMARY MYELOFIBROSIS	0.040286270000000006	1.494396680611333
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.040192729	1.4909268294709552
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.040079963	1.486743837695201
BLACKFAN-DIAMOND ANEMIA	0.04	1.483777654879772
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.04	1.483777654879772
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.04	1.483777654879772
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.04	1.483777654879772
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	0.04	1.483777654879772
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.04	1.483777654879772
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.04	1.483777654879772
NON-DISTAL TRISOMY 10Q	0.04	1.483777654879772
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.03998195300000001	1.4831082114963319
BUDD-CHIARI SYNDROMEMEMBRANOUS OBSTRUCTION OF INFERIOR VENA CAVA, INCLUDED	0.03994565	1.481761571991204
PORPHYRIA CUTANEA TARDA	0.03994565	1.481761571991204
HEMOLYTIC ANEMIA DUE TO RED CELL PYRUVATE KINASE DEFICIENCY	0.0399254	1.4810104095534211
ADAMS-OLIVER SYNDROME 6; AOS6	0.0399225	1.4809028356734426
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.03988436	1.4794880536795145
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.03988436	1.4794880536795145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.039752219000000005	1.4745863571021782
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.03970830399999999	1.4729573547093266
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.03965131	1.4708431941177715
LINEAR VERRUCOUS NEVUS SYNDROME	0.039616619000000006	1.4695563508521357
MACHADO-JOSEPH DISEASE; MJD	0.0395146	1.4657720130378058
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.039502180000000005	1.465311300075966
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.039502180000000005	1.465311300075966
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.039502180000000005	1.465311300075966
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.039502180000000005	1.465311300075966
HYPERLYSINEMIA, TYPE I	0.039483179	1.4646064685954565
SENIOR-LOKEN SYNDROME 9	0.039434454	1.4627990419396062
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4567766110050975
CONO-SPONDYLAR DYSPLASIA	0.039198829000000004	1.4540586641913302
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.03909365	1.450157107942265
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.039068579	1.4492271132026275
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.039009459999999996	1.4470341269231568
LEPRECHAUNISM	0.038888900000000004	1.4425620210713495
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.038709794	1.4359181840549766
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.038665359	1.4342698925526123
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.038665359	1.4342698925526123
AUTOSOMAL ERYTHROPOIETIC PROTOPORPHYRIA	0.03859294	1.4315835502028937
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.428926104423004
MYOCLONUS AND ATAXIA	0.0385141	1.4286590244451258
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.038455619999999996	1.4264897415136912
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.03827229	1.4196892175769638
FLOOD FACTOR DEFICIENCY	0.03827068	1.4196294955263549
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.03827068	1.4196294955263549
MACROCYTOSIS, FAMILIAL	0.03827068	1.4196294955263549
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.03827068	1.4196294955263549
COUMARIN RESISTANCE	0.03827068	1.4196294955263549
FUMARASE DEFICIENCY; FMRD	0.03819906399999999	1.4169729400130577
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.037987104	1.4091104022198502
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4052583670500167
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.037551279	1.3929437173089008
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.037221679	1.3807173894326916
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.0370879	1.3757549321603875
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.037037179999999996	1.3738735020939998
PEYRONIE DISEASE	0.037037	1.373866825094553
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.037037	1.373866825094553
POLAND SYNDROME	0.037037	1.373866825094553
RCAD (RENAL CYSTS AND DIABETES)	0.037037	1.373866825094553
CANAVAN DISEASE	0.037037	1.373866825094553
TESTICULAR TORSION	0.037037	1.373866825094553
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES;;MULTINODULAR GOITER/CYSTIC RENAL DISEASE/DIGITAL ANOMALIES;;MNG/CRD/DA	0.037037	1.373866825094553
SCIMITAR SYNDROME	0.037037	1.373866825094553
OVARIAN HYPERSTIMULATION SYNDROME	0.037037	1.373866825094553
FAMILIAL SUPERNUMERARY NIPPLES	0.037037	1.373866825094553
APOLIPOPROTEIN A-I DEFICIENCY	0.037037	1.373866825094553
HYPERVITAMINOSIS A, SUSCEPTIBILITY TO	0.037037	1.373866825094553
SITOSTEROLEMIA	0.037037	1.373866825094553
GENITOURINARY TRACT ANOMALIES	0.037037	1.373866825094553
ATRANSFERRINEMIA	0.037037	1.373866825094553
JEUNE SYNDROME	0.037037	1.373866825094553
RHYNS SYNDROME	0.037037	1.373866825094553
LABIA MINORA, INCOMPLETE ADHESION OF	0.037037	1.373866825094553
GALACTORRHEA	0.037037	1.373866825094553
GASTROINTESTINAL STROMAL TUMOR	0.037037	1.373866825094553
HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1	0.037037	1.373866825094553
ADENOMYOSIS	0.037037	1.373866825094553
CONGENITAL RESPIRATORY-BILIARY FISTULA	0.037037	1.373866825094553
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.037037	1.373866825094553
URINARY BLADDER, ATONY OF	0.037037	1.373866825094553
BUTYRYLCHOLINESTERASE DEFICIENCY	0.037037	1.373866825094553
207620 APHALANGY WITH HEMIVERTEBRAE	0.037037	1.373866825094553
LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER	0.037037	1.373866825094553
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.037037	1.373866825094553
FRYNS MICROPHTHALMIA SYNDROME	0.037037	1.373866825094553
NATHALIE SYNDROME	0.037037	1.373866825094553
SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA	0.037037	1.373866825094553
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.037037	1.373866825094553
SYSTEMIC MASTOCYTOSIS	0.03693372	1.3700357111896535
GLYCOGEN STORAGE DISEASE IA	0.03687515	1.3678630897584956
GLYCOGEN STORAGE DISEASE IB	0.03687515	1.3678630897584956
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.036859093	1.3672674643133855
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.036856813999999995	1.3671829260814985
ALPERS-HUTTENLOCHER SYNDROME	0.036842704000000004	1.3666595235137402
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.036587399	1.3571891271592629
COFS SYNDROME	0.036520229	1.3546974935323062
EVANS SYNDROME	0.03651316	1.3544352729262477
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.03629715000000001	1.3464225026454832
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.036178854	1.3420343786089417
GALACTOSEMIA	0.035846613000000006	1.329710084313069
KAPOSIFORM LYMPHANGIOMATOSIS	0.03573509	1.3255732009279397
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.035714300000000004	1.3248020074918163
PARANA HARD-SKIN SYNDROME	0.035714300000000004	1.3248020074918163
SCLERODERMA, FAMILIAL PROGRESSIVE	0.035714300000000004	1.3248020074918163
GASTRIC SNEEZING	0.035714300000000004	1.3248020074918163
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.035714300000000004	1.3248020074918163
METHANE PRODUCTION	0.035714300000000004	1.3248020074918163
GALLBLADDER, AGENESIS OF	0.035714300000000004	1.3248020074918163
%243600 JEJUNAL ATRESIA;;APPLE PEEL SYNDROME;;APPLE PEEL SMALL BOWEL SYNDROME; APSB	0.035714300000000004	1.3248020074918163
BLUE DIAPER SYNDROME	0.035714300000000004	1.3248020074918163
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.035714300000000004	1.3248020074918163
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.035714300000000004	1.3248020074918163
PANCREATIC BETA CELL AGENESIS WITH NEONATAL DIABETES MELLITUS	0.035714300000000004	1.3248020074918163
AMYLOIDOSIS, FINNISH TYPE	0.035714300000000004	1.3248020074918163
MESOMELIA-SYNOSTOSES SYNDROME	0.035714300000000004	1.3248020074918163
POLYPOSIS SYNDROME, HEREDITARY MIXED, 1	0.035714300000000004	1.3248020074918163
TERATOMA, PINEAL	0.035714300000000004	1.3248020074918163
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.035714300000000004	1.3248020074918163
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.035714300000000004	1.3248020074918163
JUVENILE ABSENCE EPILEPSY	0.03566625	1.3230196195838917
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3230196195838917
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3230196195838917
SPINOCEREBELLAR ATAXIA TYPE 35	0.03566016	1.3227937144359363
SPINOCEREBELLAR ATAXIA TYPE 23	0.03566016	1.3227937144359363
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.035470254	1.3157492574527463
JUVENILE HUNTINGTON DISEASE	0.035431529	1.3143127752106158
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.03533359999999999	1.3106801536614976
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.035220514	1.3064852916645044
COMMON VARIABLE IMMUNODEFICIENCY	0.03517157	1.3046697413259936
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.035024219	1.299203838295389
%152800 LYMPHANGIECTASIA, INTESTINAL	0.03493649	1.2959495800482652
ANGELMAN SYNDROME	0.034886473	1.2940942273741622
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.2916303032949104
MONOSOMY 22	0.0347755	1.2899777459317878
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.03475615	1.2892599684912398
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.034746612999999996	1.2889061988038748
COFFIN-SIRIS SYNDROME	0.034746612999999996	1.2889061988038748
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.034670004	1.286064430744808
DOORS SYNDROME	0.03461480399999999	1.2840168175810736
SPINOCEREBELLAR ATAXIA 12	0.03461275	1.2839406255984958
SPINOCEREBELLAR ATAXIA TYPE 1	0.03461275	1.2839406255984958
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.034540009999999996	1.2812423759330969
EOSINOPHILOPENIA	0.0344828	1.279120202942205
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.0344828	1.279120202942205
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3	0.0344828	1.279120202942205
SULFHEMOGLOBINEMIA, CONGENITAL	0.0344828	1.279120202942205
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL RECESSIVE	0.0344828	1.279120202942205
MYELOMA, MULTIPLE	0.0344828	1.279120202942205
HEMOPOIETIC PROLIFERATION	0.0344828	1.279120202942205
HEMOGLOBIN, HIGH OXYGEN SATURATION OF	0.0344828	1.279120202942205
260570 PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN	0.0344828	1.279120202942205
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	0.0344828	1.279120202942205
GIANT NEUTROPHIL LEUKOCYTES	0.0344828	1.279120202942205
LEUKOCYTE NUCLEAR APPENDAGES, HEREDITARY PREVALENCE OF	0.0344828	1.279120202942205
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2	0.0344828	1.279120202942205
ACETOPHENETIDIN SENSITIVITY	0.0344828	1.279120202942205
OCULODENTODIGITAL DYSPLASIA	0.034276619	1.271472033925686
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.034276619	1.271472033925686
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.034241732999999996	1.2701779572439824
OROFACIODIGITAL SYNDROME TYPE 14	0.034205193999999994	1.2688225634506909
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.034162859999999996	1.267252207369649
MILD CANAVAN DISEASE	0.034162859999999996	1.267252207369649
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.034162859999999996	1.267252207369649
ALG13-CDG	0.034162859999999996	1.267252207369649
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.034147369	1.2666775773783556
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.034069249999999995	1.2637797967128166
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.2637797967128166
EPILEPSY, PYRIDOXINE-DEPENDENT	0.034034004	1.2624723660322195
PIGMENTED VILLONODULAR SYNOVITIS	0.0338384	1.2552165449220918
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.033814073	1.2543141484468354
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.033700314	1.2500943218907987
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.033700313999999995	1.2500943218907985
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.033696179	1.2499409363757255
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.03365964	1.2485855425824341
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.033606344	1.2466085572350727
CONGENITAL DISORDER OF GLYCOSYLATION	0.033579943	1.2456292268884106
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.033496859999999996	1.2425473094159007
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.033410189	1.239332297087749
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.033328053999999996	1.23628554514566
SPINOCEREBELLAR ATAXIA 34; SCA34	0.03330541	1.2354455786152327
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.033272654	1.2342305130936517
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.033199679999999995	1.2315235833289715
BLOOD GROUP, DUFFY SYSTEM; FY	0.033199679999999995	1.2315235833289715
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.033038423	1.225541844996648
GAMMA-HEAVY CHAIN DISEASE	0.03295358	1.222394641307324
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.03295358	1.222394641307324
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.03295358	1.222394641307324
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.03295358	1.222394641307324
TYROSINEMIA TYPE 1	0.03295358	1.222394641307324
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.03295358	1.222394641307324
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.03293314	1.2216364309256804
CHROMOSOME 17Q12 DELETION SYNDROME	0.03285333	1.2186759235597815
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.032803653999999995	1.2168332200901861
TUBEROUS SCLEROSIS-1	0.032799519	1.216679834575113
DEND SYNDROME	0.032799519	1.216679834575113
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.216679834575113
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.032789944	1.2163246552989764
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.032785809	1.216171269783903
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.032738010000000005	1.2143981925807634
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0327271	1.2139934922253948
SPINOCEREBELLAR ATAXIA TYPE 36	0.03271165	1.2134203831061974
AMYLOIDOSIS, FAMILIAL VISCERAL	0.03254647	1.2072931232803714
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.03250841	1.2058813088417533
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO CD3DELTA/CD3EPSILON/CD3ZETA	0.032456399999999996	1.2039520269459958
KABUKI SYNDROME 1	0.032336973	1.1995219490962625
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.032336973	1.1995219490962625
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.032297983	1.1980756368271686
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.0322823	1.1974938847031316
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	1.1965961992219294
9P13 MICRODELETION SYNDROME	0.0322581	1.1965961992219294
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.0322581	1.1965961992219294
SECKEL SYNDROME 2; SCKL2	0.0322581	1.1965961992219294
SECKEL SYNDROME	0.0322581	1.1965961992219294
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.0322581	1.1965961992219294
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.0322581	1.1965961992219294
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0322581	1.1965961992219294
WEST SYNDROME	0.0322581	1.1965961992219294
DYSTONIA, JUVENILE-ONSET	0.0322581	1.1965961992219294
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	1.1965961992219294
DENT DISEASE	0.0322581	1.1965961992219294
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0322581	1.1965961992219294
ISOTRETINOIN-LIKE SYNDROME	0.0322581	1.1965961992219294
MEIER-GORLIN SYNDROME 5; MGORS5	0.0322581	1.1965961992219294
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.03214847	1.1925295356143177
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.031795554	1.1794383137430788
ACUTE INTERMITTENT PORPHYRIA	0.031791419	1.1792849282280058
LYNCH SYNDROME	0.031791419	1.1792849282280058
FAMILIAL COLORECTAL CANCER TYPE X	0.031791419	1.1792849282280058
KRABBE DISEASE	0.031791419	1.1792849282280058
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.031791419	1.1792849282280058
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.031791419	1.1792849282280058
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.031615733	1.1727679542011256
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.0315921	1.171891301268181
FAMILIAL ATRIAL MYXOMA	0.03157896	1.1714038803085534
22Q11.2 MICRODUPLICATION SYNDROME	0.031563133	1.1708167865849586
FOLLICULAR LYMPHOMA	0.0315193	1.1691908259363
NARP SYNDROME	0.031389972999999995	1.1643935131169838
SHORT SYNDROME	0.03131656	1.1616702988925418
SPINOCEREBELLAR ATAXIA 27; SCA27	0.03126091	1.1596059932301905
SPINOCEREBELLAR ATAXIA 26	0.03126091	1.1596059932301905
SPINOCEREBELLAR ATAXIA TYPE 27	0.03126091	1.1596059932301905
SPINOCEREBELLAR ATAXIA 15	0.03126091	1.1596059932301905
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.03125	1.1592012928748219
IMMUNODEFICIENCY 62; IMD62	0.03125	1.1592012928748219
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 4	0.03125	1.1592012928748219
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.03125	1.1592012928748219
SPASTIC PARAPLEGIA AND EVANS SYNDROME	0.03125	1.1592012928748219
RUIJS-AALFS SYNDROME; RJALS	0.03125	1.1592012928748219
ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	0.03125	1.1592012928748219
CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	0.03125	1.1592012928748219
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1583447822235424
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.031204628999999998	1.157518280975333
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.031135473	1.1549529777878116
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.031135473	1.1549529777878116
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.031117509999999998	1.1542866503374463
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.03093796	1.147626343389105
HUNTINGTON DISEASE-LIKE 3	0.030844418999999998	1.144156492248727
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.030844418999999998	1.144156492248727
PROPIONIC ACIDEMIA	0.030820534	1.143270491516557
TRICHOHEPATOENTERIC SYNDROME 2	0.030807429999999997	1.1427844059568184
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.030802549000000002	1.1426033479884818
14Q12 MICRODELETION SYNDROME	0.030702229	1.1388820336300434
GAUCHER DISEASE TYPE 3	0.030644029999999996	1.1367231742366344
BOHRING-OPITZ SYNDROME	0.030523613	1.132256372889943
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.030498773	1.1313349469662626
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.030393223	1.1274196286794487
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.030358049999999998	1.1261149058930715
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.030315104	1.1245218480139099
NORMAL PRESSURE HYDROCEPHALUS	0.030302999999999997	1.1240728568955431
AXONAL POLYNEUROPATHY ASSOCIATED WITH IGG/IGM/IGA MONOCLONAL GAMMOPATHY	0.030302999999999997	1.1240728568955431
CARIBBEAN PARKINSONISM	0.030302999999999997	1.1240728568955431
POLYRADICULONEUROPATHY ASSOCIATED WITH IGG/IGA/IGM MONOCLONAL GAMMOPATHY WITHOUT KNOWN ANTIBODIES	0.030302999999999997	1.1240728568955431
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.030302999999999997	1.1240728568955431
SPINOCEREBELLAR ATAXIA TYPE 29	0.030286474	1.1234598341574298
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.030286474	1.1234598341574298
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.030282339	1.1233064486423563
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.03026316	1.122595014351283
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.030248913000000002	1.1220665298450565
NEONATAL ICHTHYOSIS-SCLEROSING CHOLANGITIS SYNDROME	0.03022254	1.1210882381427527
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.030187440000000003	1.1197862232505957
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.030057663	1.1149722179326622
WHIPPLE DISEASE	0.030037899	1.1142390833933862
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.030018733	1.1135281313300505
PROTOPORPHYRIA, ERYTHROPOIETIC	0.02989729	1.1090232710865116
OPTIC ATROPHY 11; OPA11	0.029851804	1.107335993326265
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.029756883	1.103814951856794
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.029740919999999997	1.1032228132891726
SPINOCEREBELLAR ATAXIA 44; SCA44	0.029740919999999997	1.1032228132891726
ARIMA SYNDROME	0.029738723999999998	1.1031413538959196
HEREDITARY SPHEROCYTOSIS	0.029720439999999997	1.1024631191298742
GALLOWAY-MOWAT SYNDROME	0.029658373000000002	1.100160778437239
ALG1-CDG	0.029658373000000002	1.100160778437239
REFRACTORY ANEMIA WITH EXCESS BLASTS	0.02959449	1.0977910742390717
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.029478429	1.0934858562789966
7P22.1 MICRODUPLICATION SYNDROME	0.029477313999999998	1.0934444959768668
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.029470983000000003	1.0932096510685407
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0294118	1.091014290744822
MONOMELIC AMYOTROPHY	0.0294118	1.091014290744822
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0294118	1.091014290744822
IMMUNE SUPPRESSION	0.0294118	1.091014290744822
RAGWEED SENSITIVITY	0.0294118	1.091014290744822
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0294118	1.091014290744822
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0294118	1.091014290744822
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0294118	1.091014290744822
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0294118	1.091014290744822
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0294118	1.091014290744822
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0294118	1.091014290744822
MYASTHENIA GRAVIS; MG	0.0294118	1.091014290744822
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0294118	1.091014290744822
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0294118	1.091014290744822
ECHO VIRUS 11 SENSITIVITY	0.0294118	1.091014290744822
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.0294118	1.091014290744822
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0294118	1.091014290744822
NIEMANN-PICK DISEASE, TYPE C2	0.029267653	1.085667238304373
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.029267653	1.085667238304373
MENINGIOMA	0.0292549	1.0851941728935561
PENTASOMY X	0.029116954	1.080077143084055
TETRASOMY X	0.029116954	1.080077143084055
CHARGE SYNDROME	0.029116954	1.080077143084055
FETAL ALCOHOL SYNDROME	0.029116954	1.080077143084055
NORRIE DISEASE	0.029112819	1.0799237575689817
DISTAL MONOSOMY 7Q36	0.029112819	1.0799237575689817
SPINOCEREBELLAR ATAXIA TYPE 43	0.029081210000000003	1.0787512393716545
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.029081210000000003	1.0787512393716545
SPINOCEREBELLAR ATAXIA TYPE 14	0.02908121	1.0787512393716545
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.029065510000000003	1.0781688566421141
CRI-DU-CHAT SYNDROME	0.028931759999999997	1.0732074751086098
PRADER-WILLI SYNDROME	0.028923969	1.0729184723158807
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.028900869000000003	1.0720615907201878
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.028774954	1.0673908441348328
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.028760809000000002	1.0668661432616262
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.028657173	1.0630218237355982
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0617912898319648
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0617912898319648
ACRODYSOSTOSIS	0.0285714	1.059840122215798
SCHWARTZ-JAMPEL SYNDROME	0.0285714	1.059840122215798
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.0285714	1.059840122215798
COG7-CDG	0.0285714	1.059840122215798
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.0285714	1.059840122215798
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.0285714	1.059840122215798
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.0285714	1.059840122215798
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.0285714	1.059840122215798
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES DUE TO PARTIAL IRF8 DEFICIENCY	0.0285714	1.059840122215798
ALG12-CDG	0.0285714	1.059840122215798
CONGENITAL LOBAR EMPHYSEMA	0.0285714	1.059840122215798
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.0285714	1.059840122215798
CHEILITIS GLANDULARIS	0.0285714	1.059840122215798
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.028454273000000002	1.0554953615812204
SICKLE CELL ANEMIA	0.02824334	1.0476709197793015
RECOMBINANT 8 SYNDROME	0.028113973	1.0428721231823308
CHROMOSOME 16P13.3 DELETION SYNDROME	0.028113973	1.0428721231823308
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.028053713999999993	1.0406368492396956
SPINOCEREBELLAR ATAXIA TYPE 34	0.028033799999999998	1.0398981505342137
PULMONARY ARTERIAL HYPERTENSION	0.02801938	1.0393632486896298
IDIOPATHIC/HERITABLE PULMONARY ARTERIAL HYPERTENSION	0.02801938	1.0393632486896298
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.027847913000000002	1.033002776110898
SPINOCEREBELLAR ATAXIA TYPE 40	0.02783616	1.032566805141453
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.02783616	1.032566805141453
GANGLIOCYTOMA	0.027777800000000002	1.0304019735429835
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0304019735429835
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0304019735429835
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.027777800000000002	1.0304019735429835
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0304019735429835
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.027751283	1.0294183402411223
CAMPOMELIA, CUMMING TYPE	0.027740079999999997	1.0290027712144316
SPINOCEREBELLAR ATAXIA 23; SCA23	0.027692370000000004	1.027232995416574
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.027688094	1.0270743795852673
HEMORRHAGIC FEVER-RENAL SYNDROME	0.027608459999999998	1.0241204008410496
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.027572554	1.0227884878291469
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	1.0227884878291469
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.02752642	1.0210771728708914
ALPHA-1-ANTITRYPSIN DEFICIENCY	0.027374939999999997	1.0154581068918616
NIEMANN-PICK DISEASE, TYPE A	0.027249134	1.0107914036006167
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.02720447	1.009134617471178
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.027193483999999997	1.008727097938265
MILLER-DIEKER SYNDROME	0.027155458999999996	1.0073165818050949
LEGIONELLOSIS	0.027148459999999996	1.0070569578099322
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.02706593	1.0039955535635017
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.027039	1.002996600257354
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.00255146696089
SPINAL ARTERIOVENOUS METAMERIC SYNDROME	0.027027	1.00255146696089
LIPOSARCOMA	0.027027	1.00255146696089
INFANTILE MYOFIBROMATOSIS	0.027027	1.00255146696089
BARDET-BIEDL SYNDROME 11; BBS11	0.027027	1.00255146696089
BARDET-BIEDL SYNDROME 12; BBS12	0.027027	1.00255146696089
WAARDENBURG SYNDROME TYPE 2	0.027027	1.00255146696089
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.00255146696089
NIPPLES, SUPERNUMERARY	0.027027	1.00255146696089
BENIGN OCCIPITAL EPILEPSY	0.027027	1.00255146696089
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.02690476	0.9980170424475774
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.026896722999999997	0.9977189144222706
FAMILIAL MEDITERRANEAN FEVER	0.026857219	0.9962535356103114
NEONATAL LUPUS ERYTHEMATOSUS	0.02676094	0.9926821198894572
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.026752413000000003	0.9923658155878782
SSR4-CDG	0.026752413000000003	0.9923658155878782
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.026752413	0.9923658155878782
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0267523	0.9923616239160031
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.026678254000000002	0.9896149289101726
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.026678254000000002	0.9896149289101726
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.02665715	0.9888320878194579
PEHO-LIKE SYNDROME; PEHOL	0.026566684	0.9854763020862991
OCULOCEREBRORENAL SYNDROME OF LOWE	0.026547409	0.9847613067288539
SPHEROCYTOSIS, TYPE 1; SPH1	0.02653976	0.9844775713467995
HEMOGLOBIN--BETA LOCUS	0.02653976	0.9844775713467995
GLYCOGEN STORAGE DISEASE VII	0.02653976	0.9844775713467995
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II	0.02653976	0.9844775713467995
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.026501069999999998	0.983042387410117
FIBRONECTIN GLOMERULOPATHY	0.0263158	0.9761699002571277
LIPEDEMA	0.0263158	0.9761699002571277
MALIGNANT PERITONEAL MESOTHELIOMA	0.0263158	0.9761699002571277
DISTICHIASIS WITH CONGENITAL ANOMALIES OF THE HEART AND PERIPHERAL	0.0263158	0.9761699002571277
HUGHES-STOVIN SYNDROME	0.0263158	0.9761699002571277
OSTEOSCLEROSIS-ICHTHYOSIS-PREMATURE OVARIAN FAILURE SYNDROME	0.0263158	0.9761699002571277
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.0263158	0.9761699002571277
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.026285143	0.9750326959679864
OCCIPITAL HORN SYNDROME	0.026216913999999997	0.9725017793276164
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.026212779	0.9723483938125433
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.026210994	0.9722821802346944
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.026205674	0.9720848378065954
SPINOCEREBELLAR ATAXIA TYPE 19/22	0.026132700000000002	0.9693779080419155
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.026132700000000002	0.9693779080419155
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.026132700000000002	0.9693779080419155
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.026132700000000002	0.9693779080419155
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.026021600000000002	0.965256715605487
PLIN1-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.02601249	0.964918785244588
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.02586209	0.9593397812622402
WRINKLY SKIN SYNDROME	0.025849413999999994	0.9588695721234084
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.0257534	0.955307986429518
20Q11.2 MICRODUPLICATION SYNDROME	0.025719033	0.9540331617628868
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.02566544	0.9520451593664374
22Q11.2 DELETION SYNDROME	0.025642263000000002	0.9511854214987587
PEROXISOME BIOGENESIS DISORDER 10B	0.025545554	0.9475980551681146
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.025545554	0.9475980551681146
ACUTE BILIRUBIN ENCEPHALOPATHY	0.025541419000000003	0.9474446696530414
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.025541419000000003	0.9474446696530414
MENKES DISEASE	0.025541419000000003	0.9474446696530414
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.02548401	0.9453151148683164
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.025252363000000003	0.9367222988078183
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.025173479	0.9337961408946297
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.02516056	0.9333169178065448
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.025158264	0.9332317489691547
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.02511759	0.9317229696607903
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.025029288999999996	0.9284474933932018
CRIGLER-NAJJAR SYNDROME TYPE 2	0.025	0.9273610342998575
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	0.025	0.9273610342998575
GALACTOKINASE DEFICIENCY	0.025	0.9273610342998575
FARBER DISEASE	0.024976434	0.9264868666944851
MIXED CONNECTIVE TISSUE DISEASE	0.024972299	0.9263334811794119
POLYCYTHEMIA VERA	0.02495938	0.925854258091327
PORTAL HYPERTENSION, NONCIRRHOTIC	0.02495938	0.925854258091327
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.024900429	0.9236675036780067
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.02489935	0.9236274787757663
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.0247329	0.9174531090093979
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024730214	0.9173534733398726
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.02455529	0.9108647652773181
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.02446241	0.9074194335626871
PACHYDERMOPERIOSTOSIS	0.02443088	0.9062498458262281
OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	0.02443088	0.9062498458262281
CRANIOFACIOFRONTODIGITAL SYNDROME	0.02443088	0.9062498458262281
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.02443088	0.9062498458262281
JUVENILE IDIOPATHIC ARTHRITIS	0.02443088	0.9062498458262281
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.024417963999999997	0.9057707340214673
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.024417963999999997	0.9057707340214673
CHRONIC GRAFT VERSUS HOST DISEASE	0.024329769999999997	0.9024992268591057
DIGEORGE SYNDROME; DGS	0.024268333	0.9002202556645346
RHOMBENCEPHALOSYNAPSIS	0.024204399999999997	0.8978486967442988
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.02419608	0.8975400709920839
AA AMYLOIDOSIS	0.02392578	0.8875134434892339
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.023814273	0.8833771536151669
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.023814273	0.8833771536151669
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.023814273	0.8833771536151669
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.023801354	0.882897930527082
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.023797219	0.8827445450120088
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.023797219	0.8827445450120088
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.023794923	0.8826593761746188
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.023794923	0.8826593761746188
SPINOCEREBELLAR ATAXIA 46; SCA46	0.023755360000000003	0.8811918087906186
FRIEDREICH ATAXIA	0.023755360000000003	0.8811918087906186
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.023755360000000003	0.8811918087906186
X-LINKED AGAMMAGLOBULINEMIA	0.02368689	0.878651952389878
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.023666589999999998	0.8778989352300265
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.023666589999999998	0.8778989352300265
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.023666589999999998	0.8778989352300265
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.023666589999999998	0.8778989352300265
LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY	0.02361196	0.8758724658978746
SPINOCEREBELLAR ATAXIA 14	0.02361196	0.8758724658978746
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.02354609	0.8734290550447013
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.02354609	0.8734290550447013
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.02349849	0.8716633596353943
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.023459443000000003	0.8702149329831422
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.023444749999999997	0.8696699043560633
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.023272854	0.863293518261983
FETAL HYDANTOIN SYNDROME	0.023272854	0.863293518261983
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.023272854	0.863293518261983
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.023268719	0.8631401327469099
HYPOADRENOCORTICISM, FAMILIAL	0.023268719	0.8631401327469099
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.023268719	0.8631401327469099
COWDEN SYNDROME 6; CWS6	0.023268719	0.8631401327469099
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.023268719	0.8631401327469099
COWDEN SYNDROME 5; CWS5	0.023268719	0.8631401327469099
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.0232558	0.862660909658825
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 63	0.0232558	0.862660909658825
NODULAR REGENERATIVE HYPERPLASIA OF THE LIVER	0.0232558	0.862660909658825
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.0232558	0.862660909658825
CYSTINOSIS	0.0232558	0.862660909658825
WILLIAMS-BEUREN SYNDROME; WBS	0.0232558	0.862660909658825
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.023253503999999998	0.862575740821435
SPINOCEREBELLAR ATAXIA TYPE 7	0.023253503999999998	0.862575740821435
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.02309757	0.8567914562005344
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.023073089999999997	0.8558833842757478
ISOLATED COMPLEX I DEFICIENCY	0.022957033999999998	0.8515783517878798
TRISOMY 13	0.022874229	0.8485067465700719
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	0.843056497393726
OSTEOSARCOMA	0.0227273	0.843056497393726
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	0.843056497393726
FACIOSCAPULOHUMERAL DYSTROPHY	0.0227273	0.843056497393726
CRANIO-OSTEOARTHROPATHY	0.0227273	0.843056497393726
REACTIVE ARTHRITIS	0.0227273	0.843056497393726
LARSEN SYNDROME	0.0227273	0.843056497393726
ACRORENAL-MANDIBULAR SYNDROME	0.0227273	0.843056497393726
SIRENOMELIA	0.0227273	0.843056497393726
FAMILIAL AFIBRINOGENEMIA	0.0227273	0.843056497393726
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0227273	0.843056497393726
127820 DYSPLASIA EPIPHYSEALIS HEMIMELICA WITH CHONDROMAS AND OSTEOCHONDROMAS;;OSTEOCHONDROMATOSIS, DOMINANT CARPOTARSAL	0.0227273	0.843056497393726
HEMOPHILIA A	0.0227273	0.843056497393726
PREPAPILLARY VASCULAR LOOPS	0.0227273	0.843056497393726
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	0.843056497393726
AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME; AIPDS	0.0227273	0.843056497393726
MUSCULAR HYPERTONIA, LETHAL	0.0227273	0.843056497393726
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0227273	0.843056497393726
ATROPHODERMA VERMICULATA; AVA	0.0227273	0.843056497393726
RHEUMATOID FACTOR-NEGATIVE JUVENILE IDIOPATHIC ARTHRITIS	0.0227273	0.843056497393726
THYMIC TUMOR	0.0227273	0.843056497393726
CONGENITAL ATRANSFERRINEMIA	0.0227273	0.843056497393726
OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS	0.0227273	0.843056497393726
OSTEOCHONDRITIS DISSECANS	0.0227273	0.843056497393726
BLEPHAROPTOSIS-MYOPIA-ECTOPIA LENTIS SYNDROME	0.0227273	0.843056497393726
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.0227273	0.843056497393726
GAPO SYNDROME	0.0227273	0.843056497393726
SINDING-LARSEN-JOHANSSON DISEASE	0.0227273	0.843056497393726
ENTHESITIS-RELATED JUVENILE IDIOPATHIC ARTHRITIS	0.0227273	0.843056497393726
RHEUMATOID FACTOR-POSITIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS	0.0227273	0.843056497393726
LYME DISEASE	0.0227273	0.843056497393726
FATCO SYNDROME	0.0227273	0.843056497393726
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0227273	0.843056497393726
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.0227273	0.843056497393726
BETHLEM MYOPATHY 1	0.0227273	0.843056497393726
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0227273	0.843056497393726
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0227273	0.843056497393726
ARTERIES, ANOMALIES OF	0.0227273	0.843056497393726
POPLITEAL CYST	0.0227273	0.843056497393726
MACS SYNDROME	0.0227273	0.843056497393726
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	0.843056497393726
JUVENILE DERMATOMYOSITIS	0.0227273	0.843056497393726
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0227273	0.843056497393726
THYMIC CARCINOMA	0.0227273	0.843056497393726
SILVER-RUSSELL SYNDROME	0.0227273	0.843056497393726
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	0.843056497393726
NAIL-PATELLA SYNDROME	0.0227273	0.843056497393726
WATSON SYNDROME	0.0227273	0.843056497393726
THUMB DEFORMITY	0.0227273	0.843056497393726
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.0227273	0.843056497393726
ALKAPTONURIA	0.0227273	0.843056497393726
SEVERE HEMOPHILIA A	0.0227273	0.843056497393726
ATAXIA WITH VITAMIN E DEFICIENCY	0.022707949999999998	0.8423387199531779
SPINOCEREBELLAR ATAXIA 40; SCA40	0.022707949999999998	0.8423387199531779
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.022578604	0.837540702339476
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.8351147258737476
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.022513204	0.8351147258737476
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.022440573000000002	0.8324205195024583
BEHÇET DISEASE	0.022426718999999998	0.8319066131116906
XQ21 MICRODELETION SYNDROME	0.022344183	0.8288449862986118
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.022325933	0.8281680127435729
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.022324224	0.8281046183432681
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.022312959999999996	0.8276867865556539
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.022289904000000003	0.8268315371153814
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.022245459000000002	0.825182874668603
SECONDARY SHORT BOWEL SYNDROME	0.0222222	0.8243200950567319
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.022181859	0.8228236681973441
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.022163769	0.8221526297529248
PLEURAL MESOTHELIOMA	0.022111779999999998	0.820224126840436
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.021899154	0.8123368841492746
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.021895019	0.8121834986342013
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.02180921	0.8090004617145118
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.021794873	0.8084686387085616
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.021794873	0.8084686387085616
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.021794873	0.8084686387085616
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.021794873	0.8084686387085616
PITT-HOPKINS SYNDROME	0.021759883000000004	0.8071707042049556
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.021750422999999998	0.8068197907895763
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.021681113999999998	0.8042488121525246
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.02164498	0.8029084416079894
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.02164044	0.8027400328441604
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.02151033	0.7979136750772503
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.021399184	0.7937907762965185
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.021299113999999997	0.790078735548423
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7896072651985849
MYOTONIC DYSTROPHY 1	0.0212766	0.789243591295374
PANCREATIC COLIPASE DEFICIENCY	0.0212766	0.789243591295374
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.02125721	0.7885243300771709
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.02125721	0.7885243300771709
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.02125721	0.7885243300771709
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.021249319	0.7882316178403046
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.021209004	0.7867361554363926
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.021209004	0.7867361554363926
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.021135559999999998	0.7840117912842677
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02102928	0.7800693940552523
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02102928	0.7800693940552523
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02102928	0.7800693940552523
GRANULOMAS, CONGENITAL CEREBRAL	0.02102928	0.7800693940552523
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02102928	0.7800693940552523
SEVERE COMBINED IMMUNODEFICIENCY DUE TO COMPLETE RAG1/2 DEFICIENCY	0.02095204	0.7772042194036796
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.020949619	0.7771144137611178
MALIGNANT ATROPHIC PAPULOSIS	0.020949619	0.7771144137611178
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.020949619	0.7771144137611178
MYASTHENIA GRAVIS	0.020949619	0.7771144137611178
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.020848833	0.7733758133930001
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.769370244330328
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.769370244330328
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.020707899999999998	0.7681479824871207
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.020647653000000002	0.7659131536777823
LETTERER-SIWE DISEASE	0.020590050000000002	0.7637764025714313
FETAL GAUCHER DISEASE	0.020449089	0.7585475330211935
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.020421173	0.757512004595853
ADENOCARCINOMA OF OVARY	0.020408199999999998	0.757030778407934
HEPATITIS B VACCINE, RESPONSE TO	0.020408199999999998	0.757030778407934
PANCREATITIS, HEREDITARY	0.020408199999999998	0.757030778407934
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC	0.020408199999999998	0.757030778407934
LICHEN PLANOPILARIS	0.020408199999999998	0.757030778407934
OVARIAN FIBROTHECOMA	0.020408199999999998	0.757030778407934
MULTIPLE MYELOMA	0.020408199999999998	0.757030778407934
OVARIAN FIBROMA	0.020408199999999998	0.757030778407934
PRIMARY EFFUSION LYMPHOMA	0.020408199999999998	0.757030778407934
RELAPSING POLYCHONDRITIS	0.020408199999999998	0.757030778407934
NOONAN SYNDROME 8; NS8	0.020408199999999998	0.757030778407934
AUTOSOMAL AGAMMAGLOBULINEMIA	0.020408199999999998	0.757030778407934
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.020317773	0.7536764393579888
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.020307414	0.7532921780398163
GABRIELE-DE VRIES SYNDROME; GADEVS	0.020307414	0.7532921780398163
HEMOGLOBIN--ALPHA LOCUS 1; HBA1	0.020188559999999998	0.7488833553049892
AMISH LETHAL MICROCEPHALY	0.02009025	0.7452366007737086
COFFIN-LOWRY SYNDROME	0.019997029000000003	0.7417786198545699
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.019997029000000003	0.7417786198545699
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.01999064	0.7415416234686442
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.01994539	0.7398630999965614
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.01990767	0.7384638976680098
RIDDLE SYNDROME	0.019879754	0.7374283692426692
PEROXISOME BIOGENESIS DISORDER 6B	0.019879754	0.7374283692426692
MEGALENCEPHALY WITH DYSMYELINATION	0.019875619	0.737274983727596
OCULODENTODIGITAL DYSPLASIA; ODDD	0.019875619	0.737274983727596
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.019776354	0.733592804004805
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.019772219	0.7334394184897318
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.019772219	0.7334394184897318
RETT SYNDROME; RTT	0.019754129000000002	0.7327683800453124
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.01974502	0.7324304867788549
ACQUIRED GENERALIZED LIPODYSTROPHY	0.01974502	0.7324304867788549
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.019622589000000003	0.7278889772272404
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.019425544000000003	0.7205797030270957
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.019392523999999998	0.7193548445729924
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0193342	0.7171913483744122
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.019334014	0.717184448808317
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.0192308	0.7133557831365479
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.0192308	0.7133557831365479
UROCANIC ACIDURIA	0.01921271	0.7126847446921287
MARINESCO-SJOGREN SYNDROME; MSS	0.019199064000000002	0.7121785539451664
FREE SIALIC ACID STORAGE DISEASE	0.019193052999999998	0.7119555792580792
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.019120732999999997	0.7092729092580566
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.01908117	0.7078053418740565
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.019076074	0.7076163086008247
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.01894498	0.7027534499036047
LISSENCEPHALY 1; LIS1	0.018944073000000002	0.7027198052452802
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.018927923000000003	0.7021207300171226
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.01886241	0.699690561879519
HAREL-YOON SYNDROME; HAYOS	0.018852813999999996	0.6993346036201131
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.01882681	0.698369999766676
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.018823390000000002	0.6982431367771839
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.018700273000000003	0.6936761804387881
JOUBERT SYNDROME 1	0.018689354	0.6932711462334471
21Q22.11Q22.12 MICRODELETION SYNDROME	0.018661029000000003	0.6922204461815855
SPINOCEREBELLAR ATAXIA 31	0.01865351	0.6919415330769094
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.018567064	0.688734866998066
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.018558553999999998	0.6884191933019902
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.018558553999999998	0.6884191933019902
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6876029672140409
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.01848375	0.6856443807095997
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.018402654	0.6826361698920964
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.018402654	0.6826361698920964
MERCURY POISONING	0.018398519000000002	0.6824827843770233
CHROMOSOME 18Q DELETION SYNDROME	0.018398519000000002	0.6824827843770233
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.01837028	0.6814352744471194
PERMANENT NEONATAL DIABETES MELLITUS	0.018324164	0.6797246271888086
SPINOCEREBELLAR ATAXIA TYPE 13	0.018263383000000005	0.6774699899477775
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.018108773	0.6717348183672535
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.018042483	0.6692758278487039
PRIMARY LIPODYSTROPHY	0.01804144	0.6692371383463528
MOEBIUS SYNDROME; MBS	0.018033759999999996	0.6689522530366158
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.018032034	0.6688882280308078
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.01800509	0.6678887554024809
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.01794616	0.6657027799724292
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.017945994	0.6656966222951615
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.017945994	0.6656966222951615
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.017945994	0.6656966222951615
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.0178571	0.6623991490238395
NEPHROPATHIC INFANTILE CYSTINOSIS	0.0178571	0.6623991490238395
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.0178571	0.6623991490238395
SPASTIC PARAPLEGIA TYPE 7	0.0178571	0.6623991490238395
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.0178571	0.6623991490238395
PROGRESSIVE NON-FLUENT APHASIA	0.0178571	0.6623991490238395
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.0178571	0.6623991490238395
19P13.3 MICRODUPLICATION SYNDROME	0.017740653999999998	0.658079649703836
INFANTILE SIALIC ACID STORAGE DISEASE	0.017715953	0.6571633799075065
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.017535013	0.6504515116856578
PYRIDOXINE-DEPENDENT EPILEPSY	0.017531314	0.6503142993470229
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.017449573000000003	0.6472821626148348
RETICULOENDOTHELIOSIS, X-LINKED	0.01731136	0.6421552285894874
HYPERLIPOPROTEINEMIA, TYPE I	0.01731136	0.6421552285894874
ADRENOMYODYSTROPHY	0.017294618999999997	0.6415342305464786
GABRIELE-DE VRIES SYNDROME	0.01725056	0.63989988655407
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6395601014711025
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6395601014711025
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6395601014711025
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6395601014711025
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6395601014711025
PALMOMENTAL REFLEX	0.0172414	0.6395601014711025
CERVICAL RIB	0.0172414	0.6395601014711025
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6395601014711025
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6395601014711025
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6395601014711025
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6395601014711025
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6395601014711025
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6395601014711025
ERYTHERMALGIA, PRIMARY	0.0172414	0.6395601014711025
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6395601014711025
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6395601014711025
MOSAIC TRISOMY 15	0.0172414	0.6395601014711025
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6395601014711025
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6395601014711025
THUMBS, CONGENITAL CLASPED	0.0172414	0.6395601014711025
CARDIAC ARRHYTHMIA	0.0172414	0.6395601014711025
269800 SENILE PLAQUE FORMATION	0.0172414	0.6395601014711025
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6395601014711025
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6395601014711025
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6395601014711025
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6395601014711025
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6395601014711025
DIASTEMATOMYELIA	0.0172414	0.6395601014711025
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6395601014711025
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6395601014711025
MOTION SICKNESS	0.0172414	0.6395601014711025
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6395601014711025
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6395601014711025
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6395601014711025
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6395601014711025
MYOPATHY, CONGENITAL	0.0172414	0.6395601014711025
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6395601014711025
ALCOHOL DEPENDENCE	0.0172414	0.6395601014711025
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6395601014711025
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6395601014711025
NEPHRONOPHTHISIS 11; NPHP11	0.017212254	0.6384789468828744
FADD-RELATED IMMUNODEFICIENCY	0.017208119	0.6383255613678012
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.017195099999999998	0.6378426288355791
SPINOCEREBELLAR ATAXIA 20	0.017176410000000003	0.6371493337263368
SPINOCEREBELLAR ATAXIA TYPE 28	0.017176410000000003	0.6371493337263368
SPINOCEREBELLAR ATAXIA 38; SCA38	0.017176410000000003	0.6371493337263368
SPINOCEREBELLAR ATAXIA 43; SCA43	0.017176410000000003	0.6371493337263368
SPINOCEREBELLAR ATAXIA 45; SCA45	0.017176410000000003	0.6371493337263368
CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS	0.017176410000000003	0.6371493337263368
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.017176410000000003	0.6371493337263368
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.017176410000000003	0.6371493337263368
SPINOCEREBELLAR ATAXIA TYPE 8	0.017176410000000003	0.6371493337263368
SPINOCEREBELLAR ATAXIA TYPE 30	0.017176410000000003	0.6371493337263368
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.017168064	0.6368397435186459
6Q TERMINAL DELETION SYNDROME	0.017108533000000002	0.6346314743293299
JOUBERT SYNDROME 31; JBTS31	0.017039694	0.6320779300797231
SPINOCEREBELLAR ATAXIA TYPE 21	0.017033009999999998	0.6318299908335926
SPINOCEREBELLAR ATAXIA TYPE 6	0.017033009999999998	0.6318299908335926
SPINOCEREBELLAR ATAXIA TYPE 25	0.017033009999999998	0.6318299908335926
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.017033009999999998	0.6318299908335926
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.017033009999999998	0.6318299908335926
MULTIPLE SYSTEM ATROPHY	0.017033009999999998	0.6318299908335926
ARNOLD-CHIARI MALFORMATION TYPE I	0.017033009999999998	0.6318299908335926
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.017030470000000002	0.6317357709525079
TRANSIENT NEONATAL DIABETES MELLITUS	0.016847064000000002	0.6249324278382359
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.016837783999999998	0.6245881914223036
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.016745793000000002	0.6211758366660526
JABERI-ELAHI SYNDROME; JABELS	0.016731143000000004	0.620632403099953
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.016710309	0.6198595775084087
BARDET-BIEDL SYNDROME	0.0166667	0.6182419260146175
PORPHYRIA CUTANEA TARDA, TYPE I	0.0166667	0.6182419260146175
AYMÉ-GRIPP SYNDROME	0.016653794	0.6177631851542704
HB BART'S HYDROPS FETALIS	0.016628979999999998	0.6168427236860657
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.016628979999999998	0.6168427236860657
KLIPPEL-TRÉNAUNAY SYNDROME	0.016628979999999998	0.6168427236860657
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.016600112999999996	0.6157719184469803
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.016562979000000002	0.6143944534610729
ACROCALLOSAL SYNDROME; ACLS	0.016526629000000004	0.6130460705172011
RAYNAUD-CLAES SYNDROME; MRXSRC	0.016488273	0.6116232761239366
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.01647927	0.6112893148682645
MYOCLONIC-ATONIC EPILEPSY	0.016402499999999997	0.6084415746041364
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.016402499999999997	0.6084415746041364
PREECLAMPSIA/ECLAMPSIA 1	0.016362369	0.6069529375774371
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.016302692999999997	0.6047392896941218
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6046954069699788
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6046954069699788
CHÉDIAK-HIGASHI SYNDROME	0.016167033	0.5997070577775971
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.016148913999999997	0.5990349435943778
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.016148913999999997	0.5990349435943778
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.016135083	0.598521890375762
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.016128999999999998	0.598296244888896
CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE	0.016128999999999998	0.598296244888896
OPTIC ATROPHY 2	0.016128999999999998	0.598296244888896
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 27	0.016128999999999998	0.598296244888896
PRIMARY DYSTONIA, DYT4 TYPE	0.016128999999999998	0.598296244888896
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.01609337	0.596974569942812
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.016090254000000002	0.5968589836634969
INFANTILE LIVER FAILURE SYNDROME 1	0.016057913	0.5956593123350851
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.015976864	0.5926528449563264
HYPERPROLINEMIA, TYPE I	0.015963132999999997	0.5921435011818474
DUBOWITZ SYNDROME	0.015868309000000004	0.5886260578731897
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.015836080000000002	0.5874305411222116
REYNOLDS SYNDROME	0.015662389999999998	0.5809876076003098
CHOLESTERYL ESTER STORAGE DISEASE	0.015662389999999998	0.5809876076003098
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.015603359999999998	0.578797922726121
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.015603359999999998	0.578797922726121
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.015593664	0.5784382550225782
HEART AND BRAIN MALFORMATION SYNDROME	0.015544813000000001	0.5766261544671148
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.015536353999999999	0.5763123725875491
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.015536353999999999	0.5763123725875491
ADENYLOSUCCINASE DEFICIENCY	0.015527353	0.5759784855207599
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.015512359	0.5754222914668281
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.015512358999999998	0.5754222914668281
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.5738863961218207
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5738863961218207
DESMOSTEROLOSIS	0.01543131	0.5724158240880693
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.015421714	0.5720598658286637
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.015332068999999999	0.5687345346318712
TANGIER DISEASE	0.015326890000000003	0.5685424225200058
CONGENITAL TOXOPLASMOSIS	0.015253972999999999	0.565837607138484
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.015218924	0.564537484062837
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.015203773	0.56397546618161
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.015203773	0.56397546618161
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.015175699999999999	0.5629341139289739
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.015171473	0.5627773157252945
N-ACETYLASPARTATE DEFICIENCY; NACED	0.015171473	0.5627773157252945
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.015110353	0.5605101034686382
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.015089020000000002	0.5597187677508495
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.015051078999999998	0.5583113675507545
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.01504811	0.5582012341543211
SMITH-MAGENIS SYNDROME	0.015039933000000002	0.5578979129072225
FG SYNDROME TYPE 1	0.015039933000000002	0.5578979129072225
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.015039933000000002	0.5578979129072225
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.014990799999999999	0.5560753517192921
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.014970939999999999	0.5553386561136443
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.014970939999999999	0.5553386561136443
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.014970939999999999	0.5553386561136443
PHOCOMELIA, SCHINZEL TYPE	0.014925399999999998	0.5536493752535637
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5536493752535637
ACHONDROGENESIS TYPE 1A	0.014925399999999998	0.5536493752535637
ACHONDROGENESIS TYPE 1B	0.014925399999999998	0.5536493752535637
BOOMERANG DYSPLASIA	0.014925399999999998	0.5536493752535637
ACHONDROGENESIS TYPE 2	0.014925399999999998	0.5536493752535637
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC 27; CMH27	0.014925399999999998	0.5536493752535637
FRASER SYNDROME 3; FRASRS3	0.014925399999999998	0.5536493752535637
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.014925399999999998	0.5536493752535637
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.014925399999999998	0.5536493752535637
ULNAR AGENESIS AND ENDOCARDIAL FIBROELASTOSIS	0.014925399999999998	0.5536493752535637
FIBROCHONDROGENESIS 1; FBCG1	0.014925399999999998	0.5536493752535637
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.014925399999999998	0.5536493752535637
INDOMETHACIN EMBRYOFETOPATHY	0.014925399999999998	0.5536493752535637
ACHONDROGENESIS	0.014925399999999998	0.5536493752535637
UMBILICAL CORD ULCERATION-INTESTINAL ATRESIA SYNDROME	0.014925399999999998	0.5536493752535637
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5536493752535637
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.014925399999999998	0.5536493752535637
19P13.12 MICRODELETION SYNDROME	0.014747162999999999	0.5470377733067435
PEDIATRIC-ONSET GRAVES DISEASE	0.014712554	0.5457539717853002
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.014698893000000001	0.5452472246217175
ANGELMAN SYNDROME (TYPE 1)	0.014625919	0.5425402948570375
ANGELMAN SYNDROME (TYPE 2)	0.014625919	0.5425402948570375
JOUBERT SYNDROME	0.014612273000000002	0.5420341041100754
PYRUVATE DEHYDROGENASE DEFICIENCY	0.014612273000000002	0.5420341041100754
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.014612273000000002	0.5420341041100754
OROFACIODIGITAL SYNDROME TYPE 6	0.014612273000000002	0.5420341041100754
9Q21.13 MICRODELETION SYNDROME	0.014494379000000002	0.5376608920389655
ROIFMAN SYNDROME	0.014457840000000001	0.5363054982456742
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.01444966	0.5360020657152511
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.01444966	0.5360020657152511
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.014449493999999998	0.5359959080379834
RETINITIS PIGMENTOSA 71; RP71	0.014447020000000001	0.5359041363900292
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.014354333	0.5324659639025832
HEMOCHROMATOSIS, TYPE 2B	0.014320799999999998	0.5312220760000559
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.014320799999999998	0.5312220760000559
HURLER SYNDROME	0.014297334000000002	0.5303516178388208
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.014244153999999998	0.528378935446658
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.014232973	0.5279641824976778
DYSKERATOSIS CONGENITA	0.014223474	0.5276118223990852
HUNTINGTON DISEASE-LIKE 1	0.014153339000000001	0.5250102037534605
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0140845	0.5224566595038538
EPISODIC ATAXIA TYPE 5	0.0140845	0.5224566595038538
BRANCHIAL MYOCLONUS WITH SPASTIC PARAPARESIS AND CEREBELLAR ATAXIA	0.0140845	0.5224566595038538
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.014066719000000002	0.5217970832418184
SPONTANEOUS PERIODIC HYPOTHERMIA	0.014066719000000002	0.5217970832418184
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.014022063	0.5201405938679105
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.013996994	0.519210673317156
BANGSTAD SYNDROME	0.013923318999999998	0.5164777403490742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.013903939999999998	0.5157588871697264
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.013903939999999998	0.5157588871697264
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.013901653	0.5156740521823088
PIERPONT SYNDROME	0.013895643	0.515451114589663
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.013854968999999998	0.5139423352812984
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.013854968999999998	0.5139423352812984
MONOSOMY 13Q34	0.013828354000000001	0.512955066724183
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.013812913999999999	0.5123823285493992
SPINOCEREBELLAR ATAXIA TYPE 3	0.013809559999999999	0.5122579137930375
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.013808778999999998	0.5122289430343261
4Q21 MICRODELETION SYNDROME	0.013790599	0.5115545660901832
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.013751780000000002	0.5101145969705638
PERLMAN SYNDROME	0.013743433999999999	0.5098050067628731
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.5081419145784011
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.5081419145784011
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.5081419145784011
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.5081419145784011
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.5081419145784011
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.5081419145784011
SEA-BLUE HISTIOCYTOSIS	0.01360296	0.5045942022055837
PONTINE TEGMENTAL CAP DYSPLASIA	0.013572062999999999	0.503448095250513
MONOSOMY 18P	0.013561414	0.5030530765443427
ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION	0.013525300000000002	0.5017134478886346
SANDHOFF DISEASE	0.013525300000000002	0.5017134478886346
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.013516954	0.5014038576809438
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.013516954	0.5014038576809438
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.013516954	0.5014038576809438
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.013493944	0.5005503145849742
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.013480529	0.5000526926539689
1Q44 MICRODELETION SYNDROME	0.013429574	0.49816254539385896
CRONKHITE-CANADA SYNDROME	0.013356099	0.49543703131405165
COG8-CDG	0.013347498999999999	0.4951180191182525
WARBURG MICRO SYNDROME 2; WARBM2	0.013313549999999999	0.49385869992811465
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.013301314000000002	0.4934048123434871
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.013301314000000002	0.4934048123434871
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.01329795	0.4932800266427116
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.013291072999999999	0.49302492816939636
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.013267359999999999	0.4921453076811423
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.013267359999999999	0.4921453076811423
DISTAL MONOSOMY 1Q	0.013135173000000002	0.4872419047595025
KOOLEN-DE VRIES SYNDROME	0.013135173000000002	0.4872419047595025
DONNAI-BARROW SYNDROME	0.013135173000000002	0.4872419047595025
MICRO SYNDROME	0.013135173000000002	0.4872419047595025
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.013135173000000002	0.4872419047595025
SCHIZENCEPHALY	0.013135173000000002	0.4872419047595025
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.013027313	0.48324089831311917
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.012991772999999998	0.4819225618667584
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.0129714	0.48116683681268685
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.012922429	0.4793502849242589
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.01281468	0.47535339596086795
HEMOCHROMATOSIS, TYPE 3; HFE3	0.012617219999999998	0.46802872756755387
PETERS PLUS SYNDROME	0.012593754000000002	0.46715826940631877
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.012593754000000002	0.46715826940631877
OCULO-PALATO-CEREBRAL SYNDROME	0.012593754000000002	0.46715826940631877
TEMTAMY SYNDROME	0.012593754000000002	0.46715826940631877
TRISOMY 18	0.012593754000000002	0.46715826940631877
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.012589619000000002	0.46700488389124556
LINEAR NEVUS SEBACEUS SYNDROME	0.012589619000000002	0.46700488389124556
FRONTAL ENCEPHALOCELE	0.012589619000000002	0.46700488389124556
3-HYDROXYISOBUTYRIC ACIDURIA	0.012589619000000002	0.46700488389124556
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.012589619000000002	0.46700488389124556
MOWAT-WILSON SYNDROME	0.012589619000000002	0.46700488389124556
PRIMARY CUTIS VERTICIS GYRATA	0.012589619000000002	0.46700488389124556
WHIM SYNDROME	0.012589619000000002	0.46700488389124556
MICROPHTHALMIA, LENZ TYPE	0.012589619000000002	0.46700488389124556
OCULOCEREBROCUTANEOUS SYNDROME	0.012589619000000002	0.46700488389124556
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.012589619000000002	0.46700488389124556
MARBURG HEMORRHAGIC FEVER	0.01246342	0.46232360248454113
RELAPSING FEVER	0.01246342	0.46232360248454113
SECONDARY SYRINGOMYELIA	0.012446218999999998	0.46168554099850145
ALLAN-HERNDON-DUDLEY SYNDROME	0.01238101	0.45926664957107516
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.01238101	0.45926664957107516
BETA-KETOTHIOLASE DEFICIENCY	0.012342789	0.4578488629273961
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.012300984	0.4562981298058399
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.012282263	0.45560368476891483
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.012252714000000001	0.4545075811208138
OCULOECTODERMAL SYNDROME; OES	0.012198073	0.4524807037498067
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.012198073	0.4524807037498067
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.012136342999999999	0.45019086388391344
XQ28 (MECP2) DUPLICATION	0.012121323	0.4496337053745061
HARTSFIELD SYNDROME	0.012048200000000002	0.4469212485380618
PAI SYNDROME	0.012048200000000002	0.4469212485380618
INTERMEDIATE OSTEOPETROSIS	0.012048200000000002	0.4469212485380618
FRONTONASAL DYSPLASIA	0.012048200000000002	0.4469212485380618
ISOLATED DANDY-WALKER MALFORMATION	0.012048200000000002	0.4469212485380618
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.012048200000000002	0.4469212485380618
HOLZGREVE SYNDROME	0.012048200000000002	0.4469212485380618
FEMORAL-FACIAL SYNDROME	0.012048200000000002	0.4469212485380618
8Q21.11 MICRODELETION SYNDROME	0.012048200000000002	0.4469212485380618
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.012048200000000002	0.4469212485380618
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.012048200000000002	0.4469212485380618
LAURIN-SANDROW SYNDROME	0.012048200000000002	0.4469212485380618
ACROCALLOSAL SYNDROME	0.012048200000000002	0.4469212485380618
DISTAL MONOSOMY 13Q	0.012048200000000002	0.4469212485380618
CRANE-HEISE SYNDROME	0.012048200000000002	0.4469212485380618
SHORT RIB-POLYDACTYLY SYNDROME	0.012048200000000002	0.4469212485380618
FGFR2-RELATED BENT BONE DYSPLASIA	0.012048200000000002	0.4469212485380618
ANEMIA, SIDEROBLASTIC, PYRIDOXINE-RESPONSIVE, AUTOSOMAL RECESSIVE	0.012048200000000002	0.4469212485380618
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.012048200000000002	0.4469212485380618
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.012048200000000002	0.4469212485380618
HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES	0.012048200000000002	0.4469212485380618
JUNG SYNDROME	0.012048200000000002	0.4469212485380618
IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	0.012048200000000002	0.4469212485380618
BENT BONE DYSPLASIA SYNDROME; BBDS	0.012048200000000002	0.4469212485380618
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.012048200000000002	0.4469212485380618
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 12	0.012048200000000002	0.4469212485380618
UNVERRICHT-LUNDBORG DISEASE	0.012048200000000002	0.4469212485380618
LOWRY-WOOD SYNDROME	0.012048200000000002	0.4469212485380618
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.012048200000000002	0.4469212485380618
DIABETIC EMBRYOPATHY	0.012048200000000002	0.4469212485380618
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 19	0.012048200000000002	0.4469212485380618
NEUTROPHILIA, HEREDITARY	0.012048200000000002	0.4469212485380618
ACROCEPHALOPOLYDACTYLY	0.012048200000000002	0.4469212485380618
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.012048200000000002	0.4469212485380618
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.012039854	0.446611658330371
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.012039854	0.446611658330371
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012039854	0.446611658330371
BETA-UREIDOPROPIONASE DEFICIENCY	0.012039854	0.446611658330371
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.012039854	0.446611658330371
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.012039854	0.446611658330371
RING CHROMOSOME 14 SYNDROME	0.012039854	0.446611658330371
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012039854	0.446611658330371
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.012039854	0.446611658330371
SEA-BLUE HISTIOCYTE DISEASE	0.01197434	0.44418145309832624
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 4	0.011904799999999998	0.44160190564531765
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.011904799999999998	0.44160190564531765
SPINOCEREBELLAR ATAXIA TYPE 11	0.011904799999999998	0.44160190564531765
MYOPATHY AND DIABETES MELLITUS	0.011904799999999998	0.44160190564531765
SPINOCEREBELLAR ATAXIA TYPE 32	0.011904799999999998	0.44160190564531765
CEREBELLAR ATAXIA, BENIGN, WITH THERMOANALGESIA	0.011904799999999998	0.44160190564531765
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.011904799999999998	0.44160190564531765
SPINOCEREBELLAR DEGENERATION-CORNEAL DYSTROPHY SYNDROME	0.011904799999999998	0.44160190564531765
FRYNS SYNDROME	0.011885839	0.4408985579424634
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.011885839	0.4408985579424634
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.011885839	0.4408985579424634
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.011885839	0.4408985579424634
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.011835568999999999	0.43903382037469313
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.011736709	0.43536666390065787
SPINOCEREBELLAR ATAXIA 48; SCA48	0.011707160000000001	0.43427056025255684
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.011707160000000001	0.43427056025255684
SPINOCEREBELLAR ATAXIA TYPE 18	0.011707160000000001	0.43427056025255684
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.011707160000000001	0.43427056025255684
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.011707160000000001	0.43427056025255684
GLYCINE ENCEPHALOPATHY	0.0116689	0.4328513269256643
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.011656654	0.4323970683966229
CARDIOFACIOCUTANEOUS SYNDROME	0.011656654	0.4323970683966229
GERMAN SYNDROME	0.011656654	0.4323970683966229
FABRY DISEASE	0.011652519	0.4322436828815497
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.011652519	0.4322436828815497
PROTEUS SYNDROME	0.011652519	0.4322436828815497
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.011652519	0.4322436828815497
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.011652519	0.4322436828815497
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.011602933	0.43040431791167794
PITT-HOPKINS SYNDROME	0.011575769	0.4293966845062491
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.011571749	0.42924756485193366
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.426374637462114
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.426374637462114
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.011445328999999999	0.42455808557368613
HALL-RIGGS SYNDROME	0.011445328999999999	0.42455808557368613
TEMPLE-BARAITSER SYNDROME	0.011445328999999999	0.42455808557368613
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.011445328999999999	0.42455808557368613
WOLCOTT-RALLISON SYNDROME	0.011429729	0.42397941228828306
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.01135665	0.42126858760725905
BIOTINIDASE DEFICIENCY	0.011281914	0.4184962974368817
KRABBE DISEASE	0.011281914	0.4184962974368817
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.011277779	0.4183429119218085
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.011277779	0.4183429119218085
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.011184763	0.41489253536315107
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.011162423	0.4140638455429007
SCHNECKENBECKEN DYSPLASIA	0.0111111	0.41216004752836594
LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY	0.0111111	0.41216004752836594
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.0111111	0.41216004752836594
IDIOPATHIC STEROID-SENSITIVE NEPHROTIC SYNDROME	0.0111111	0.41216004752836594
LYMPHEDEMA, HEREDITARY, ID; LMPH1D	0.0111111	0.41216004752836594
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.0111111	0.41216004752836594
PROXIMAL SPINAL MUSCULAR ATROPHY	0.0111111	0.41216004752836594
TERMINAL TRANSVERSE LIMB DEFECT	0.0111111	0.41216004752836594
LYMPHEDEMA-CEREBRAL ARTERIOVENOUS ANOMALY SYNDROME	0.0111111	0.41216004752836594
DAHLBERG-BORER-NEWCOMER SYNDROME	0.0111111	0.41216004752836594
ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.0111111	0.41216004752836594
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.0111111	0.41216004752836594
GERMAN SYNDROME	0.0111111	0.41216004752836594
MELORHEOSTOSIS	0.0111111	0.41216004752836594
CHYLOUS ASCITES	0.0111111	0.41216004752836594
ALG8-CDG	0.0111111	0.41216004752836594
INFANTILE SYSTEMIC HYALINOSIS	0.0111111	0.41216004752836594
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.0111111	0.41216004752836594
DOHLE BODIES AND LEUKEMIA	0.0111111	0.41216004752836594
CAPILLARY MALFORMATION OF THE LOWER LIP, LYMPHATIC MALFORMATION OF FACE AND NECK, ASYMMETRY OF FACE AND LIMBS, AND PARTIAL/GENERALIZED OVERGROWTH	0.0111111	0.41216004752836594
CLAPO SYNDROME	0.0111111	0.41216004752836594
APLASIA CUTIS CONGENITA-INTESTINAL LYMPHANGIECTASIA SYNDROME	0.0111111	0.41216004752836594
BUSCHKE-OLLENDORFF SYNDROME	0.0111111	0.41216004752836594
LYMPHEDEMA, HEREDITARY, IB	0.0111111	0.41216004752836594
NOONAN SYNDROME 6; NS6	0.011071004	0.41067270880711443
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.01104937	0.4098702076624727
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.01104937	0.4098702076624727
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.01104937	0.4098702076624727
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.01104937	0.4098702076624727
AKT2-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.01104937	0.4098702076624727
DYSBETALIPOPROTEINEMIA	0.01104937	0.4098702076624727
FAMILIAL PARTIAL LIPODYSTROPHY, KÖBBERLING TYPE	0.01104937	0.4098702076624727
LIPE-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.01104937	0.4098702076624727
CIDEC-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.01104937	0.4098702076624727
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.010969664	0.4069135581184765
GAUCHER DISEASE TYPE 2	0.01096284	0.40666042565055394
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.01096284	0.40666042565055394
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.010930123	0.4054468068121864
WEBB-DATTANI SYNDROME; WEDAS	0.010904022999999999	0.4044786418923774
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.010904022999999999	0.4044786418923774
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.01090391	0.4044744502205023
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.01089335	0.4040827329196141
HEPATIC VENO-OCCLUSIVE DISEASE	0.01088831	0.40389577693509926
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.01088831	0.40389577693509926
PELGER-HUET ANOMALY; PHA	0.010866494	0.40308652460212785
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.01083013	0.4017376223360766
CONGENITAL RUBELLA SYNDROME	0.010786849	0.4001321378190553
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.01073636	0.3982592765686247
MERRF	0.01073636	0.3982592765686247
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.010643344	0.3948089000099673
JOUBERT SYNDROME 24	0.010621004	0.39398021018971696
OLIVER SYNDROME	0.01053875	0.3909290440091049
MEHMO SYNDROME; MEHMO	0.010529583	0.39058899926504786
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.010432763	0.38699751545141137
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.010399229999999999	0.38575362754888426
HEMOCHROMATOSIS, TYPE 2A	0.010399229999999999	0.38575362754888426
GALACTOSEMIA	0.010399229999999999	0.38575362754888426
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.010374973000000001	0.38485382768452386
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.010358468999999999	0.38424162102412035
MAJEED SYNDROME	0.01032427	0.3829730282236396
NODULAR NON-SUPPURATIVE PANNICULITIS	0.01032427	0.3829730282236396
PLAGUE	0.01032427	0.3829730282236396
OMENN SYNDROME	0.01032427	0.3829730282236396
CLASSIC MYCOSIS FUNGOIDES	0.01032427	0.3829730282236396
SÉZARY SYNDROME	0.01032427	0.3829730282236396
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.010271803	0.38102679416817514
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.010271703	0.381023084724038
BABESIOSIS	0.01024543	0.3800485024658716
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.009997444	0.3708496003277962
ACQUIRED PARTIAL LIPODYSTROPHY	0.009887209	0.3667604945831544
OROFACIODIGITAL SYNDROME TYPE 1	0.009877099	0.36638546978088354
SMITH-FINEMAN-MYERS SYNDROME	0.009853589	0.3655133794642279
CRANIOFACIAL DYSSYNOSTOSIS	0.009817049999999999	0.3641579856709366
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.36370409808630894
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.36370409808630894
ROIFMAN-CHITAYAT SYNDROME	0.009804814	0.36370409808630894
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.009804814	0.36370409808630894
INFANTILE LIVER FAILURE SYNDROME 2	0.009726149	0.360786063855781
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.009711683	0.36024945566689376
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.009711683	0.36024945566689376
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.009707663	0.3601003360125783
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.009652408999999999	0.3580507197490101
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.009652408999999999	0.3580507197490101
AICARDI-GOUTIERES SYNDROME 7	0.009565743	0.3548358928930649
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.009534144	0.3536637456401512
NIEMANN-PICK DISEASE TYPE C	0.009530813	0.3535401840559412
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.009492564	0.3521213587679037
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.009449394	0.3505199917338747
PSEUDO-TORCH SYNDROME 2	0.009445259	0.3503666062188015
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.009445259	0.3503666062188015
GALACTOSE EPIMERASE DEFICIENCY	0.009417054	0.34932035749990437
%613387 FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 2; NAFLD2	0.00934579	0.3466768592299706
AROMATASE DEFICIENCY	0.00934579	0.3466768592299706
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.00934579	0.3466768592299706
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.00934579	0.3466768592299706
PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL	0.00934579	0.3466768592299706
%613282 FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1; NAFLD1LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1, INCLUDED	0.00934579	0.3466768592299706
ATYPICAL WERNER SYNDROME	0.00934579	0.3466768592299706
PATENT DUCTUS VENOSUS	0.00934579	0.3466768592299706
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.00934579	0.3466768592299706
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00934579	0.3466768592299706
MICROCEPHALIC PRIMORDIAL DWARFISM-INSULIN RESISTANCE SYNDROME	0.00934579	0.3466768592299706
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.009338383	0.34640210070272826
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.009338383	0.34640210070272826
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.343467077218052
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.343467077218052
CARNOSINASE DEFICIENCY	0.00925926	0.343467077218052
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.343467077218052
HYDROXYLYSINURIA	0.00925926	0.343467077218052
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.343467077218052
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00925926	0.343467077218052
CARNOSINEMIA	0.00925926	0.343467077218052
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.343467077218052
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.343467077218052
PAINE SYNDROME	0.00925926	0.343467077218052
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.343467077218052
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.009241204	0.3427972999846392
SCLERODERMA	0.009237068999999999	0.342643914469566
EMANUEL SYNDROME	0.009189253	0.3408702066609227
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.009189253	0.3408702066609227
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.009170264000000001	0.34016582031370995
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.009170264000000001	0.34016582031370995
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.009166244	0.34001670065939454
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.009166244	0.34001670065939454
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.009166244	0.34001670065939454
SYSTEMIC SCLEROSIS	0.009162109	0.33986331514432133
PAPILLORENAL SYNDROME	0.009162109	0.33986331514432133
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.009162109	0.33986331514432133
FAMILIAL MULTIPLE NEVI FLAMMEI	0.009162109	0.33986331514432133
SARCOSINEMIA	0.009064904	0.33625754997075663
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.009064904	0.33625754997075663
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.009029264	0.33493550408025874
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.009029264	0.33493550408025874
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.009029264	0.33493550408025874
7Q11.23 MICRODUPLICATION SYNDROME	0.009025129	0.3347821185651855
SPINOCEREBELLAR ATAXIA 47; SCA47	0.009025129	0.3347821185651855
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.008988073	0.3334075469457049
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00894701	0.3318843378996467
ALLAN-HERNDON-DUDLEY SYNDROME	0.00888451	0.3295659353138971
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.008811863	0.32687113543154583
BARAITSER-WINTER SYNDROME 1; BRWS1	0.008811863	0.32687113543154583
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.008792829	0.3261650798344713
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00874583	0.3244216781844289
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1	0.00869565	0.3225602791163822
PULMONARY FIBROSIS, IDIOPATHIC; IPF	0.00869565	0.3225602791163822
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00869565	0.3225602791163822
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2; PFBMFT2	0.00869565	0.3225602791163822
CRANIOECTODERMAL DYSPLASIA 3	0.00869565	0.3225602791163822
SUPERFICIAL EPIDERMOLYTIC ICHTHYOSIS	0.00862069	0.3197796797911376
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.00862069	0.3197796797911376
ANTISYNTHETASE SYNDROME	0.00862069	0.3197796797911376
CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 3; FECD3	0.00862069	0.3197796797911376
WELLS SYNDROME	0.00862069	0.3197796797911376
MASTOCYTOSIS, CUTANEOUS; MASTC	0.00862069	0.3197796797911376
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.00862069	0.3197796797911376
KERATOENDOTHELIITIS FUGAX HEREDITARIA; KEFH	0.00862069	0.3197796797911376
CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA; DCWHK	0.00862069	0.3197796797911376
DISSECTING CELLULITIS OF THE SCALP	0.00862069	0.3197796797911376
%610158 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 2; FECD2;;FCD1 LOCUS;;CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET	0.00862069	0.3197796797911376
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.00862069	0.3197796797911376
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.00862069	0.3197796797911376
LIPEDEMA	0.00862069	0.3197796797911376
THORACIC OUTLET SYNDROME	0.00862069	0.3197796797911376
JOHANSON-BLIZZARD SYNDROME	0.00862069	0.3197796797911376
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00862069	0.3197796797911376
KAPOSI SARCOMA, SUSCEPTIBILITY TO	0.00862069	0.3197796797911376
OPSISMODYSPLASIA; OPSMD	0.00862069	0.3197796797911376
KNIEST-LIKE DYSPLASIA, LETHAL	0.00862069	0.3197796797911376
RARE CUTANEOUS LUPUS ERYTHEMATOSUS	0.00862069	0.3197796797911376
EOSINOPHILIC GASTROENTERITIS	0.00862069	0.3197796797911376
DERMATITIS HERPETIFORMIS	0.00862069	0.3197796797911376
WHITE SPONGE NEVUS 2; WSN2	0.00862069	0.3197796797911376
BAZEX SYNDROME	0.00862069	0.3197796797911376
CHILBLAIN LUPUS 2; CHBL2	0.00862069	0.3197796797911376
CLUSTER HEADACHE, FAMILIAL	0.00862069	0.3197796797911376
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.00862069	0.3197796797911376
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00862069	0.3197796797911376
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.00862069	0.3197796797911376
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.00862069	0.3197796797911376
DEAFNESS, UNILATERAL, WITH DELAYED ENDOLYMPHATIC HYDROPS	0.00862069	0.3197796797911376
THYMIC EPITHELIAL NEOPLASM	0.00862069	0.3197796797911376
NK-CELL ENTEROPATHY	0.00862069	0.3197796797911376
ANEURYSM OF SINUS OF VALSALVA	0.00862069	0.3197796797911376
NEPHROTIC SYNDROME, TYPE 9; NPHS9	0.00862069	0.3197796797911376
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00862069	0.3197796797911376
GLAUCOMA 3, PRIMARY CONGENITAL, E; GLC3E	0.00862069	0.3197796797911376
LETHAL CONGENITAL CONTRACTURE SYNDROME 2	0.00862069	0.3197796797911376
GENERALIZED JUVENILE POLYPOSIS/JUVENILE POLYPOSIS COLI	0.00862069	0.3197796797911376
LETHAL KNIEST-LIKE DYSPLASIA	0.00862069	0.3197796797911376
CONGENITAL ENTEROCYTE HEPARAN SULFATE DEFICIENCY	0.00862069	0.3197796797911376
LETHAL RECESSIVE CHONDRODYSPLASIA	0.00862069	0.3197796797911376
EOSINOPHILIC ESOPHAGITIS	0.00862069	0.3197796797911376
SAPHO SYNDROME	0.00862069	0.3197796797911376
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.00862069	0.3197796797911376
PIERSON SYNDROME	0.00862069	0.3197796797911376
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.008601604	0.3190716952831117
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.008520483	0.31606255710457415
MELAS	0.00851935	0.3160205291024996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.008494383	0.31509439218476504
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00848371	0.3146984832120018
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00848371	0.3146984832120018
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00848371	0.3146984832120018
MENTAL RETARDATION, X-LINKED 104; MRX104	0.008470212999999999	0.3141978195368039
LISSENCEPHALY 3; LIS3	0.008365169	0.3103012710373242
JACOBSEN SYNDROME	0.008302673	0.30798301682934004
SALLA DISEASE	0.008256713	0.3062781563038832
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.008189223	0.3037746524556873
16Q24.3 MICRODELETION SYNDROME	0.008134509	0.30174506719045996
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.008119943000000001	0.3012047495574356
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.2950107568315813
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.2950107568315813
QAZI-MARKOUIZOS SYNDROME	0.007948829	0.2948573713165081
SECKEL SYNDROME 7; SCKL7	0.007948829	0.2948573713165081
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.007948829	0.2948573713165081
HEREDITARY METHEMOGLOBINEMIA	0.007948829	0.2948573713165081
CROME SYNDROME	0.007948829	0.2948573713165081
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.007948829	0.2948573713165081
INTELLECTUAL DISABILITY, WOLFF TYPE	0.007948829	0.2948573713165081
DPM1-CDG	0.007948829	0.2948573713165081
BOWEN-CONRADI SYNDROME	0.007948829	0.2948573713165081
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.007948829	0.2948573713165081
2Q24 MICRODELETION SYNDROME	0.007948829	0.2948573713165081
1Q41Q42 MICRODELETION SYNDROME	0.007948829	0.2948573713165081
MEHMO SYNDROME	0.007948829	0.2948573713165081
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.007948829	0.2948573713165081
HENNEKAM-BEEMER SYNDROME	0.007948829	0.2948573713165081
KEPPEN-LUBINSKY SYNDROME	0.007948829	0.2948573713165081
ASPARTYLGLUCOSAMINURIA; AGU	0.007937639	0.29444228451755544
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00772489	0.28655047921010507
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.00772489	0.28655047921010507
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.00772489	0.28655047921010507
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.007665923	0.28436313128572266
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.007665923	0.28436313128572266
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.007665923	0.28436313128572266
CHOREOACANTHOCYTOSIS	0.0076436690000000005	0.28353763158743034
W SYNDROME	0.007587804	0.28146535062018385
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.28146535062018385
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.28146535062018385
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.28146535062018385
OROFACIODIGITAL SYNDROME TYPE 2	0.007587804	0.28146535062018385
X SMALL RINGS	0.007587804	0.28146535062018385
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.28131196510511064
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.28131196510511064
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.0075785240000000005	0.2811211142042518
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.0075463430000000005	0.2799273779864596
GALACTOSE EPIMERASE DEFICIENCY	0.007512294	0.27866434935218454
HEREDITARY FRUCTOSE INTOLERANCE	0.007508159	0.2785109638371114
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.007508159	0.2785109638371114
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.007508159	0.2785109638371114
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.007433623	0.27574609255500837
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.007433623	0.27574609255500837
BOHRING-OPITZ SYNDROME	0.007433623	0.27574609255500837
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.007433623	0.27574609255500837
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.007433623	0.27574609255500837
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.007433623	0.27574609255500837
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.007418183	0.27517335438022483
MONOSOMY 5P	0.00740741	0.2747737359633243
DISTAL MONOSOMY 10P	0.00740741	0.2747737359633243
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00740741	0.2747737359633243
KID SYNDROME	0.00740741	0.2747737359633243
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00740741	0.2747737359633243
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00740741	0.2747737359633243
14Q11.2 MICRODELETION SYNDROME	0.00740741	0.2747737359633243
RING CHROMOSOME 7 SYNDROME	0.00740741	0.2747737359633243
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.2747737359633243
TRISOMY XQ28	0.00740741	0.2747737359633243
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00740741	0.2747737359633243
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00740741	0.2747737359633243
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.0072157	0.2676623606078993
STEVENS-JOHNSON SYNDROME	0.00720026	0.2670896224331157
TOXIC EPIDERMAL NECROLYSIS	0.00720026	0.2670896224331157
NEUROLEPTIC MALIGNANT SYNDROME	0.00720026	0.2670896224331157
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00716792	0.2658899881991454
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.007124504	0.2642794959325389
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.007124504	0.2642794959325389
PEROXISOME BIOGENESIS DISORDER 5B	0.007124504	0.2642794959325389
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.007124504	0.2642794959325389
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.007120369	0.2641261104174657
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.007120369	0.2641261104174657
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.2612283297519269
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.2612283297519269
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.2612283297519269
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.2612283297519269
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.2612283297519269
HALLERMANN-STREIFF SYNDROME; HSS	0.00704225	0.2612283297519269
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.2612283297519269
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.2612283297519269
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.2612283297519269
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.2612283297519269
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.2612283297519269
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.2612283297519269
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00703297	0.26088409333599477
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00703297	0.26088409333599477
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00703297	0.26088409333599477
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.0069931130000000005	0.2594056201862312
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.0069931130000000005	0.2594056201862312
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.0069931130000000005	0.2594056201862312
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.0069931130000000005	0.2594056201862312
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.0069931130000000005	0.2594056201862312
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.0069931130000000005	0.2594056201862312
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.0069931130000000005	0.2594056201862312
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.0069931130000000005	0.2594056201862312
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.0069931130000000005	0.2594056201862312
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.0069931130000000005	0.2594056201862312
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.0069931130000000005	0.2594056201862312
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.0069931130000000005	0.2594056201862312
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.0069931130000000005	0.2594056201862312
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.0069931130000000005	0.2594056201862312
LISSENCEPHALY 8; LIS8	0.0069931130000000005	0.2594056201862312
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.0069931130000000005	0.2594056201862312
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.0069931130000000005	0.2594056201862312
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.0069931130000000005	0.2594056201862312
COFFIN-SIRIS SYNDROME 5	0.0069931130000000005	0.2594056201862312
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.0069931130000000005	0.2594056201862312
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.0069931130000000005	0.2594056201862312
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.0069931130000000005	0.2594056201862312
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.0069931130000000005	0.2594056201862312
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.0069931130000000005	0.2594056201862312
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.0069931130000000005	0.2594056201862312
HYPERBILIRUBINEMIA, SHUNT, PRIMARY; PSHB	0.00696674	0.2584273284839276
DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2	0.00696674	0.2584273284839276
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.00696674	0.2584273284839276
EMANUEL SYNDROME	0.006928743000000001	0.257017850995116
KLEEFSTRA SYNDROME	0.006928743000000001	0.257017850995116
GENITOPATELLAR SYNDROME	0.006928743000000001	0.257017850995116
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.006892204000000001	0.2556624572018247
CRANIOFRONTONASAL SYNDROME; CFNS	0.006892204000000001	0.2556624572018247
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.006892204000000001	0.2556624572018247
MICROPHTHALMIA, SYNDROMIC 3	0.006892204000000001	0.2556624572018247
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.006892204	0.2556624572018246
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.006888069	0.2555090716867514
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.006888069	0.2555090716867514
OCULOCEREBROCUTANEOUS SYNDROME	0.006888069	0.2555090716867514
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.0068784729999999995	0.25515311342734576
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.0068784729999999995	0.25515311342734576
CHROMOSOME 10Q26 DELETION SYNDROME	0.006779613	0.25148595695331044
CLASSIC GALACTOSEMIA	0.00674026	0.2500261794019983
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.006712123	0.24898245310511452
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.0066605499999999995	0.2470693814802366
BOUCHER-NEUHAUSER SYNDROME	0.00660531	0.24502028453884767
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00657895	0.24404247506428192
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.00657895	0.24404247506428192
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.00657895	0.24404247506428192
HUNTINGTON DISEASE-LIKE 1	0.00657895	0.24404247506428192
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00657895	0.24404247506428192
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00657895	0.24404247506428192
BEHR SYNDROME	0.00657895	0.24404247506428192
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.00657895	0.24404247506428192
JOUBERT SYNDROME WITH RENAL DEFECT	0.006501083000000001	0.24115404219796888
JOUBERT SYNDROME WITH OCULAR DEFECT	0.006501083000000001	0.24115404219796888
CHROMOSOME 16P13.2 DELETION SYNDROME	0.006488233000000001	0.24067737862633873
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.006488233000000001	0.24067737862633873
SRD5A3-CDG	0.006485643000000001	0.24058130402318528
OROFACIODIGITAL SYNDROME XIV; OFD14	0.006451694000000001	0.23932198483304742
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.006451694000000001	0.23932198483304742
HADZISELIMOVIC SYNDROME	0.006451694000000001	0.23932198483304742
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.006451694000000001	0.23932198483304742
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.006451694000000001	0.23932198483304742
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.006451694	0.2393219848330474
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.006447559	0.2391685993179742
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.006447559	0.2391685993179742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.006447559	0.2391685993179742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.006447559	0.2391685993179742
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.006447559	0.2391685993179742
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.006383189000000001	0.236780830126859
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.006383189000000001	0.236780830126859
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.0063519530000000005	0.23562214815616334
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.006351952999999999	0.23562214815616325
WARBURG MICRO SYNDROME 1	0.0063466500000000006	0.23542543633356766
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.006215183000000001	0.23054874140971568
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.006215183000000001	0.23054874140971568
PETTIGREW SYNDROME	0.006215183000000001	0.23054874140971568
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.006215183000000001	0.23054874140971568
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.006166569	0.22874543223685753
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.006166569	0.22874543223685753
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.006166569	0.22874543223685753
CLASSIC HOMOCYSTINURIA	0.006166569	0.22874543223685753
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.006166569	0.22874543223685753
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.006069243	0.2251351786358868
METHYLMALONIC ACIDURIA, CBLA TYPE	0.006069243	0.2251351786358868
GAUCHER DISEASE, TYPE II	0.006069243	0.2251351786358868
PROPIONIC ACIDEMIA	0.006069243	0.2251351786358868
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.006060573000000001	0.22481356982919165
CHROMOSOME 1P35 DELETION SYNDROME	0.006060573000000001	0.22481356982919165
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.006060573000000001	0.22481356982919165
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.006060573	0.22481356982919162
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.006060573	0.22481356982919162
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.006060573	0.22481356982919162
GAPO SYNDROME; GAPOS	0.006032879	0.2237862763698356
BRAIN-LUNG-THYROID SYNDROME	0.005959664	0.22107040684478502
LISSENCEPHALY, X-LINKED, 1; LISX1	0.005955529000000001	0.2209170213297119
ALEXANDER DISEASE	0.005955528999999999	0.2209170213297118
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.005946814	0.22059374327315492
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.005940089000000001	0.2203442831549283
ATAXIA-TELANGIECTASIA	0.005940088999999999	0.2203442831549282
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.005906140000000001	0.21908496396479044
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.005906140000000001	0.21908496396479044
FOLATE MALABSORPTION, HEREDITARY	0.005842763000000001	0.21673402955395757
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.0058417700000000005	0.21669719477367516
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.0058417700000000005	0.21669719477367516
MASA SYNDROME	0.0058417700000000005	0.21669719477367516
BARDET-BIEDL SYNDROME 21; BBS21	0.00582633	0.21612445659889157
REVESZ SYNDROME	0.005810533999999999	0.21553851280297953
THYROID HEMIAGENESIS	0.005808714	0.21547100091968255
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.005808714	0.21547100091968255
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.005808714	0.21547100091968255
THYROID ECTOPIA	0.005808714	0.21547100091968255
PERMANENT CONGENITAL HYPOTHYROIDISM	0.005808714	0.21547100091968255
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.005808714	0.21547100091968255
PRIMARY CONGENITAL HYPOTHYROIDISM	0.005808714	0.21547100091968255
PERIPHERAL HYPOTHYROIDISM	0.005808714	0.21547100091968255
THYROID HYPOPLASIA	0.005808714	0.21547100091968255
FAMILIAL THYROID DYSHORMONOGENESIS	0.005808714	0.21547100091968255
NEURONAL CEROID LIPOFUSCINOSIS	0.005806399	0.21538512728790635
ACTH DEFICIENCY, ISOLATED; IAD	0.005804579000000001	0.21531761540460934
CRIGLER-NAJJAR SYNDROME	0.005804579000000001	0.21531761540460934
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.005804579000000001	0.21531761540460934
224250 DYSMYELINATION WITH JAUNDICE	0.005804579000000001	0.21531761540460934
RIFT VALLEY FEVER	0.005804579000000001	0.21531761540460934
TRANSKETOLASE DEFICIENCY	0.005745634	0.21313108355793714
FORSYTHE-WAKELING SYNDROME; FWS	0.005729004	0.21251420299792084
LIG4 SYNDROME	0.005729003999999999	0.2125142029979208
CORNELIA DE LANGE SYNDROME 1	0.005724869	0.21236081748284763
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.005673764	0.21046510605653188
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.005673764	0.21046510605653188
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.005673764	0.21046510605653188
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.005673764	0.21046510605653188
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.005673764	0.21046510605653188
ATYPICAL JUVENILE PARKINSONISM	0.005669629000000001	0.21031172054145872
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.005669629000000001	0.21031172054145872
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.005669629000000001	0.21031172054145872
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.005669629000000001	0.21031172054145872
RAPID-ONSET DYSTONIA-PARKINSONISM	0.005669629000000001	0.21031172054145872
HUNTINGTON DISEASE; HD	0.005669629000000001	0.21031172054145872
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.005669629000000001	0.21031172054145872
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00564059	0.20923453505845732
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.005626859	0.20872519128397848
NEUROENDOCRINE TUMOR OF THE RECTUM	0.00562515	0.20866179688367373
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.00562515	0.20866179688367373
NEUROENDOCRINE TUMOR OF THE COLON	0.00562515	0.20866179688367373
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.00562515	0.20866179688367373
NEUROENDOCRINE TUMOR OF STOMACH	0.00562515	0.20866179688367373
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00562515	0.20866179688367373
GLYCINE N-METHYLTRANSFERASE DEFICIENCY	0.00562515	0.20866179688367373
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00562515	0.20866179688367373
GLYCOGEN STORAGE DISEASE IXA	0.00562515	0.20866179688367373
METHYLMALONIC ACIDURIA, CBLB TYPE	0.005527824	0.205051543282703
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.005527824	0.205051543282703
SHWACHMAN-DIAMOND SYNDROME	0.005527824	0.205051543282703
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.005527824	0.205051543282703
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.005527824	0.205051543282703
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.005527824	0.205051543282703
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.005527824	0.205051543282703
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.005527824	0.205051543282703
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.005523689	0.20489815776762985
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.005519154	0.20472993447600785
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.005519154	0.20472993447600785
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.005515019000000001	0.20457654896093466
ANGELMAN SYNDROME	0.005515019000000001	0.20457654896093466
CHIARI MALFORMATION TYPE II	0.00541411	0.20083338597652803
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.005401372999999999	0.20036091407677295
AL KAISSI SYNDROME; ALKAS	0.005401372999999999	0.20036091407677295
DESANTO-SHINAWI SYNDROME	0.005401372999999999	0.20036091407677295
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.005401372999999999	0.20036091407677295
XQ25 DUPLICATION SYNDROME	0.005401372999999999	0.20036091407677295
11Q22.2Q22.3 MICRODELETION SYNDROME	0.005401372999999999	0.20036091407677295
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.005401372999999999	0.20036091407677295
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.005401372999999999	0.20036091407677295
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.005297209	0.19649700868570055
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00526498	0.19530149193472254
REFSUM DISEASE	0.00526498	0.19530149193472254
CEREBELLOPARENCHYMAL DISORDER V	0.00526498	0.19530149193472254
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00526498	0.19530149193472254
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00526498	0.19530149193472254
46,XX GONADAL DYSGENESIS	0.00526498	0.19530149193472254
PANCREATOBLASTOMA	0.00526316	0.19523398005142553
ACETAMINOPHEN METABOLISM	0.00526316	0.19523398005142553
HEMOLYTIC ANEMIA, CONGENITAL, X-LINKED	0.00526316	0.19523398005142553
DOMINANT BETA-THALASSEMIA	0.00526316	0.19523398005142553
YELLOW FEVER	0.00526316	0.19523398005142553
SPHEROCYTOSIS, TYPE 2	0.00526316	0.19523398005142553
HEREDITARY CHRONIC PANCREATITIS	0.00526316	0.19523398005142553
CRIGLER-NAJJAR SYNDROME, TYPE II	0.00526316	0.19523398005142553
SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1; SLC4A1	0.00526316	0.19523398005142553
NEUROFIBROMATOSIS-PHEOCHROMOCYTOMA-DUODENAL CARCINOID SYNDROME	0.00526316	0.19523398005142553
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, POSSIBLY DUE TO DEFECT IN PORPHYRINMETABOLISM	0.00526316	0.19523398005142553
JAUNDICE, FAMILIAL OBSTRUCTIVE, OF INFANCY	0.00526316	0.19523398005142553
CONGENITAL PANCREATIC CYST	0.00526316	0.19523398005142553
EDINBURGH MALFORMATION SYNDROME	0.00526316	0.19523398005142553
HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATALBREASTFEEDING JAUNDICE, INCLUDED	0.00526316	0.19523398005142553
RH-NULL, REGULATOR TYPE; RHNR	0.00526316	0.19523398005142553
ROTOR SYNDROME	0.00526316	0.19523398005142553
HYPERBILIRUBINEMIA, CONJUGATED, TYPE III	0.00526316	0.19523398005142553
HYPERBILIRUBINEMIA, ROTOR TYPE	0.00526316	0.19523398005142553
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00526316	0.19523398005142553
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00526316	0.19523398005142553
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00526316	0.19523398005142553
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.00526316	0.19523398005142553
ELLIPTOCYTOSIS 1; EL1	0.00526316	0.19523398005142553
GILBERT SYNDROME	0.00526316	0.19523398005142553
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE III	0.00526316	0.19523398005142553
SPECTRIN, BETA, ERYTHROCYTIC	0.00526316	0.19523398005142553
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.00512821	0.1902280851882749
SPINOCEREBELLAR ATAXIA TYPE 20	0.00512821	0.1902280851882749
DYSTONIA, DOPA-RESPONSIVE; DRD	0.00512821	0.1902280851882749
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.00512821	0.1902280851882749
CHIARI MALFORMATION TYPE I	0.00512821	0.1902280851882749
SYRINGOMYELIA, ISOLATED	0.00512821	0.1902280851882749
SPINOCEREBELLAR ATAXIA TYPE 31	0.00512821	0.1902280851882749
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00512821	0.1902280851882749
SPINOCEREBELLAR ATAXIA TYPE 15/16	0.00512821	0.1902280851882749
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00512821	0.1902280851882749
SPINOCEREBELLAR ATAXIA TYPE 41	0.00512821	0.1902280851882749
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00512821	0.1902280851882749
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00512821	0.1902280851882749
SPINOCEREBELLAR ATAXIA TYPE 38	0.00512821	0.1902280851882749
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.00512821	0.1902280851882749
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00512821	0.1902280851882749
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.00512821	0.1902280851882749
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00512821	0.1902280851882749
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00512821	0.1902280851882749
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00512821	0.1902280851882749
CREUTZFELDT-JAKOB DISEASE; CJD	0.00512821	0.1902280851882749
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 39	0.00512821	0.1902280851882749
VICI SYNDROME	0.005023983000000001	0.18636184284739607
1Q21.1 MICRODELETION SYNDROME	0.005023983000000001	0.18636184284739607
6Q25 MICRODELETION SYNDROME	0.005023983000000001	0.18636184284739607
HOLOPROSENCEPHALY 7	0.005023983000000001	0.18636184284739607
HOLOPROSENCEPHALY 1; HPE1	0.005023983000000001	0.18636184284739607
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.005023983000000001	0.18636184284739607
MONOSOMY 9P	0.005023983000000001	0.18636184284739607
ACROMELIC FRONTONASAL DYSPLASIA	0.005023983000000001	0.18636184284739607
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.005023983000000001	0.18636184284739607
XP21 MICRODELETION SYNDROME	0.005023983000000001	0.18636184284739607
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.005023983000000001	0.18636184284739607
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.005023983000000001	0.18636184284739607
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.005023983000000001	0.18636184284739607
HOLOPROSENCEPHALY 2; HPE2	0.005023983000000001	0.18636184284739607
VICI SYNDROME; VICIS	0.005023983000000001	0.18636184284739607
TEMTAMY SYNDROME; TEMTYS	0.005023983000000001	0.18636184284739607
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.005023983000000001	0.18636184284739607
WALKER-WARBURG SYNDROME	0.005023983000000001	0.18636184284739607
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.005023983000000001	0.18636184284739607
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.005023983000000001	0.18636184284739607
PHACE SYNDROME	0.005023983000000001	0.18636184284739607
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.005023983000000001	0.18636184284739607
LISSENCEPHALY 4	0.005023983	0.18636184284739607
GABA-TRANSAMINASE DEFICIENCY	0.005023983	0.18636184284739607
BAND HETEROTOPIA; BH	0.005023983	0.18636184284739607
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.005023983	0.18636184284739607
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.005023983	0.18636184284739607
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.005023983	0.18636184284739607
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.005023983	0.18636184284739607
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.005008543000000001	0.18578910467261248
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.005008543000000001	0.18578910467261248
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.005008543000000001	0.18578910467261248
17Q12 MICRODELETION SYNDROME	0.005008543000000001	0.18578910467261248
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.005008543000000001	0.18578910467261248
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.005008543	0.18578910467261245
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00498227	0.18481452241444601
ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK	0.00498227	0.18481452241444601
FELTY SYNDROME	0.00498227	0.18481452241444601
ACQUIRED IDIOPATHIC SIDEROBLASTIC ANEMIA	0.00498227	0.18481452241444601
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.00498227	0.18481452241444601
DENGUE FEVER	0.00498227	0.18481452241444601
GAUCHER DISEASE, TYPE I	0.00498227	0.18481452241444601
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.004973712999999999	0.18449710527962587
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.004973712999999999	0.18449710527962587
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.004973712999999999	0.18449710527962587
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.004973712999999999	0.18449710527962587
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.004973712999999999	0.18449710527962587
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.004973712999999999	0.18449710527962587
MUCOLIPIDOSIS TYPE IV	0.0049736	0.18449291360775086
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.004874853	0.18082994880559053
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.004874853	0.18082994880559053
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.004859954	0.18027727872358917
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.004859954	0.18027727872358917
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.004859954	0.18027727872358917
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.004859954	0.18027727872358917
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.004859954	0.18027727872358917
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.004859954	0.18027727872358917
OKAMOTO SYNDROME	0.004859954	0.18027727872358917
FAMILIAL MULTIPLE LIPOMATOSIS	0.004855818999999999	0.18012389320851596
5Q14.3 MICRODELETION SYNDROME	0.004855818999999999	0.18012389320851596
20Q13.33 MICRODELETION SYNDROME	0.004855818999999999	0.18012389320851596
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.004855818999999999	0.18012389320851596
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.004855818999999999	0.18012389320851596
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.004583473000000001	0.17002137047861887
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.004583473000000001	0.17002137047861887
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.004583473000000001	0.17002137047861887
SCHAAF-YANG SYNDROME; SHFYNG	0.004583473000000001	0.17002137047861887
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.004583473000000001	0.17002137047861887
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.004583473000000001	0.17002137047861887
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.004583473000000001	0.17002137047861887
IMMUNODEFICIENCY 49; IMD49	0.004583473000000001	0.17002137047861887
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.004583473000000001	0.17002137047861887
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.004583473000000001	0.17002137047861887
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.004583473000000001	0.17002137047861887
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.004583473000000001	0.17002137047861887
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.004583473000000001	0.17002137047861887
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.004583473000000001	0.17002137047861887
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.004583473000000001	0.17002137047861887
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.004583473000000001	0.17002137047861887
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.004583473000000001	0.17002137047861887
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.004583473000000001	0.17002137047861887
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.004583473000000001	0.17002137047861887
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.004583473000000001	0.17002137047861887
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.004583473	0.17002137047861884
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.004583473	0.17002137047861884
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.004583473	0.17002137047861884
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.004583473	0.17002137047861884
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.004583473	0.17002137047861884
MENTAL RETARDATION, X-LINKED 103	0.004583473	0.17002137047861884
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.004583473	0.17002137047861884
MENTAL RETARDATION, X-LINKED 101; MRX101	0.004583473	0.17002137047861884
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.004583473	0.17002137047861884
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.004583473	0.17002137047861884
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.004583473	0.17002137047861884
MENTAL RETARDATION, X-LINKED 91; MRX91	0.004583473	0.17002137047861884
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.004583473	0.17002137047861884
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.004583473	0.17002137047861884
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.004583473	0.17002137047861884
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.004583473	0.17002137047861884
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.004583473	0.17002137047861884
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.004583473	0.17002137047861884
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.004583473	0.17002137047861884
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.004583473	0.17002137047861884
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.004583473	0.17002137047861884
FOIX-CHAVANY-MARIE SYNDROME	0.004583473	0.17002137047861884
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.004583473	0.17002137047861884
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.004583473	0.17002137047861884
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.004583473	0.17002137047861884
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.004583473	0.17002137047861884
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.004583473	0.17002137047861884
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.004583473	0.17002137047861884
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.004583473	0.17002137047861884
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.004583473	0.17002137047861884
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.004583473	0.17002137047861884
CRANIOTELENCEPHALIC DYSPLASIA	0.0044825640000000005	0.1662782074942123
HARTSFIELD SYNDROME; HRTFDS	0.0044825640000000005	0.1662782074942123
CRANIOTELENCEPHALIC DYSPLASIA	0.0044825640000000005	0.1662782074942123
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.0044825640000000005	0.1662782074942123
CURRY-JONES SYNDROME	0.0044825640000000005	0.1662782074942123
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0044825640000000005	0.1662782074942123
14Q22Q23 MICRODELETION SYNDROME	0.0044825640000000005	0.1662782074942123
CRANIOSYNOSTOSIS 6; CRS6	0.0044825640000000005	0.1662782074942123
DUPLICATION OF THE PITUITARY GLAND	0.0044825640000000005	0.1662782074942123
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.0044825640000000005	0.1662782074942123
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.0044825640000000005	0.1662782074942123
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.0044825640000000005	0.1662782074942123
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.0044825640000000005	0.1662782074942123
HOLOPROSENCEPHALY 11	0.0044825640000000005	0.1662782074942123
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.0044825640000000005	0.1662782074942123
GENITOPATELLAR SYNDROME; GTPTS	0.0044825640000000005	0.1662782074942123
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.0044825640000000005	0.1662782074942123
SEPTOOPTIC DYSPLASIA	0.0044825640000000005	0.1662782074942123
MARDEN-WALKER SYNDROME	0.0044825640000000005	0.1662782074942123
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.0044825640000000005	0.1662782074942123
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.0044825640000000005	0.1662782074942123
GLYCINE ENCEPHALOPATHY; GCE	0.004478429000000001	0.1661248219791391
MARDEN-WALKER SYNDROME	0.004478429000000001	0.1661248219791391
MICROFORM HOLOPROSENCEPHALY	0.004478429000000001	0.1661248219791391
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.004478429000000001	0.1661248219791391
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.004478429000000001	0.1661248219791391
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.004478429000000001	0.1661248219791391
15Q OVERGROWTH SYNDROME	0.004478429000000001	0.1661248219791391
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.004478429000000001	0.1661248219791391
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.004478429000000001	0.1661248219791391
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.004478429000000001	0.1661248219791391
BARAITSER-WINTER SYNDROME 2; BRWS2	0.004478429000000001	0.1661248219791391
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.004478429000000001	0.1661248219791391
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.004478429000000001	0.1661248219791391
15Q11Q13 MICRODUPLICATION SYNDROME	0.004468833	0.16576886371973343
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.004468833	0.16576886371973343
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.004468833	0.16576886371973343
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.004468833	0.16576886371973343
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.004468833	0.16576886371973343
DISTAL MONOSOMY 10Q	0.004468833	0.16576886371973343
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.004468833	0.16576886371973343
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.004468833	0.16576886371973343
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.004468833	0.16576886371973343
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.004468833	0.16576886371973343
PELIZAEUS-MERZBACHER DISEASE	0.004468833	0.16576886371973343
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.004468833	0.16576886371973343
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.004432294	0.16441346992644212
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.004432294	0.16441346992644212
JOUBERT SYNDROME 21	0.004432294	0.16441346992644212
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.004428158999999999	0.16426008441136888
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.004428158999999999	0.16426008441136888
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.0043656630000000005	0.16194183020338476
HEREDITARY FOLATE MALABSORPTION	0.0043656630000000005	0.16194183020338476
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.0043656630000000005	0.16194183020338476
MIRAGE SYNDROME; MIRAGE	0.0043656630000000005	0.16194183020338476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.004365663	0.16194183020338473
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.004365663	0.16194183020338473
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.004365663	0.16194183020338473
STT3B-CDG	0.004365663	0.16194183020338473
CUTIS LAXA	0.004333434	0.16074631345240675
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.004333434	0.16074631345240675
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004333434	0.16074631345240675
LARSEN-LIKE SYNDROME	0.004333434	0.16074631345240675
ICHTHYOSIS AND MALE HYPOGONADISM	0.004329299	0.16059292793733354
XYLOSIDASE DEFICIENCY	0.004329299	0.16059292793733354
HYPERLEUCINE-ISOLEUCINEMIA	0.004329299	0.16059292793733354
EPILEPSY-TELANGIECTASIA	0.004329299	0.16059292793733354
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.004329299	0.16059292793733354
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.004329299	0.16059292793733354
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.004329299	0.16059292793733354
CHROMOSOME 13Q14 DELETION SYNDROME	0.0043143999999999995	0.16004025785533219
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.0043143999999999995	0.16004025785533219
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.004267653	0.1583062040045156
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.004267653	0.1583062040045156
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.004267653	0.1583062040045156
INFANTILE REFSUM DISEASE	0.004267653	0.1583062040045156
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.004267653	0.1583062040045156
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.004267653	0.1583062040045156
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.004267653	0.1583062040045156
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.004267653	0.1583062040045156
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.004267653	0.1583062040045156
TAY-SACHS DISEASE	0.004267653	0.1583062040045156
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.004267653	0.1583062040045156
ASPARTYLGLUCOSAMINURIA	0.004149758999999999	0.15393299193340568
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.004042054000000001	0.14993773512543507
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.004042054000000001	0.14993773512543507
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.004042054000000001	0.14993773512543507
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.004042054000000001	0.14993773512543507
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.004042054000000001	0.14993773512543507
AL-RAQAD SYNDROME; ARS	0.004042054000000001	0.14993773512543507
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.004042054000000001	0.14993773512543507
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.004042054000000001	0.14993773512543507
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.004042054000000001	0.14993773512543507
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.004042054000000001	0.14993773512543507
INFANTILE DYSTONIA-PARKINSONISM	0.004042054000000001	0.14993773512543507
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.004042054000000001	0.14993773512543507
HOLMES-GANG SYNDROME	0.004042054000000001	0.14993773512543507
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.004037919000000001	0.14978434961036188
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.004037919000000001	0.14978434961036188
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.004037919000000001	0.14978434961036188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.004037919000000001	0.14978434961036188
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.004037919000000001	0.14978434961036188
CHILDHOOD DISINTEGRATIVE DISORDER	0.004037919000000001	0.14978434961036188
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.004037919000000001	0.14978434961036188
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.004037919000000001	0.14978434961036188
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.004037919000000001	0.14978434961036188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.004037919000000001	0.14978434961036188
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.004037919000000001	0.14978434961036188
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00393701	0.1460411866259553
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.00393701	0.1460411866259553
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.00393701	0.1460411866259553
AGNATHIA-HOLOPROSENCEPHALY-SITUS INVERSUS SYNDROME	0.00393701	0.1460411866259553
MIRROR MOVEMENTS 1; MRMV1	0.00393701	0.1460411866259553
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00393701	0.1460411866259553
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00393701	0.1460411866259553
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00393701	0.1460411866259553
HYDROLETHALUS	0.00393701	0.1460411866259553
SCHIZENCEPHALY	0.00393701	0.1460411866259553
MECKEL SYNDROME 12; MKS12	0.00393701	0.1460411866259553
OROFACIODIGITAL SYNDROME TYPE 5	0.00393701	0.1460411866259553
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00393701	0.1460411866259553
APERT SYNDROME	0.00393701	0.1460411866259553
MICROCEPHALY-POLYMICROGYRIA-CORPUS CALLOSUM AGENESIS SYNDROME	0.00393701	0.1460411866259553
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.00393701	0.1460411866259553
GOLDENHAR SYNDROME	0.00393701	0.1460411866259553
MASA SYNDROME	0.00393701	0.1460411866259553
HYDROLETHALUS SYNDROME 1	0.00393701	0.1460411866259553
THAKKER-DONNAI SYNDROME	0.00393701	0.1460411866259553
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.00393701	0.1460411866259553
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00393701	0.1460411866259553
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00393701	0.1460411866259553
FOCAL DERMAL HYPOPLASIA; FDH	0.00393701	0.1460411866259553
MARSHALL-SMITH SYNDROME; MRSHSS	0.00393701	0.1460411866259553
TOWNES-BROCKS SYNDROME	0.00393701	0.1460411866259553
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00393701	0.1460411866259553
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00393701	0.1460411866259553
MOSAIC TRISOMY 8	0.00393701	0.1460411866259553
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00393701	0.1460411866259553
FETAL AKINESIA SYNDROME, X-LINKED	0.00393701	0.1460411866259553
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE	0.00393701	0.1460411866259553
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00393701	0.1460411866259553
OROFACIODIGITAL SYNDROME V; OFD5	0.00393701	0.1460411866259553
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.00393701	0.1460411866259553
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00393701	0.1460411866259553
AGNATHIA-OTOCEPHALY COMPLEX	0.00393701	0.1460411866259553
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00393701	0.1460411866259553
OROFACIODIGITAL SYNDROME XV; OFD15	0.00393701	0.1460411866259553
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00393701	0.1460411866259553
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00393701	0.1460411866259553
OTOMANDIBULAR SYNDROME	0.00393701	0.1460411866259553
FAMILIAL CONGENITAL MIRROR MOVEMENTS	0.00393701	0.1460411866259553
PSEUDOTRISOMY 13 SYNDROME	0.00393701	0.1460411866259553
HEMIFACIAL MICROSOMIA	0.00393701	0.1460411866259553
CURRY-JONES SYNDROME	0.00393701	0.1460411866259553
STROMME SYNDROME; STROMS	0.00393701	0.1460411866259553
MULTIPLE EPIPHYSEAL DYSPLASIA, AL-GAZALI TYPE	0.00393701	0.1460411866259553
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00393701	0.1460411866259553
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.003927414	0.1456852283665496
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.003927414	0.1456852283665496
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.003927414	0.1456852283665496
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.003927414	0.1456852283665496
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.003927414	0.1456852283665496
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.003923279	0.1455318428514764
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.003923279	0.1455318428514764
2Q23.1 MICRODELETION SYNDROME	0.003923279	0.1455318428514764
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.00392157	0.14546844845117168
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.00392157	0.14546844845117168
MCCUNE-ALBRIGHT SYNDROME	0.00392157	0.14546844845117168
INTERSTITIAL NEPHRITIS, KARYOMEGALIC	0.00392157	0.14546844845117168
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.00392157	0.14546844845117168
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.00392157	0.14546844845117168
BECKER MUSCULAR DYSTROPHY	0.00392157	0.14546844845117168
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.00392157	0.14546844845117168
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.00392157	0.14546844845117168
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00392157	0.14546844845117168
XFE PROGEROID SYNDROME; XFEPS	0.00392157	0.14546844845117168
PRIMARY HYPEROXALURIA	0.00392157	0.14546844845117168
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.00392157	0.14546844845117168
DPM3-CDG	0.00392157	0.14546844845117168
X-LINKED SIDEROBLASTIC ANEMIA	0.00392157	0.14546844845117168
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.003824244	0.14185819485020096
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.003824244	0.14185819485020096
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.003824244	0.14185819485020096
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.003824244	0.14185819485020096
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.003824244	0.14185819485020096
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.003824244	0.14185819485020096
ROBERTS SYNDROME	0.003824244	0.14185819485020096
SMITH-KINGSMORE SYNDROME; SKS	0.003820109	0.14170480933512777
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.003820109	0.14170480933512777
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.003820109	0.14170480933512777
VIRAL HEMORRHAGIC FEVER	0.003820109	0.14170480933512777
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.003820109	0.14170480933512777
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.003820109	0.14170480933512777
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.003820109	0.14170480933512777
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.003820109	0.14170480933512777
EBOLA HEMORRHAGIC FEVER	0.003820109	0.14170480933512777
FETAL IODINE DEFICIENCY DISORDER	0.00378788	0.1405092925841498
PENDRED SYNDROME	0.00378788	0.1405092925841498
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	0.1405092925841498
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	0.1405092925841498
OSTEOMESOPYKNOSIS	0.00378788	0.1405092925841498
ONCOCYTOMA	0.00378788	0.1405092925841498
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00378788	0.1405092925841498
MYOPATHY, SPHEROID BODY	0.00378788	0.1405092925841498
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	0.1405092925841498
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00378788	0.1405092925841498
DELETED IN AZOOSPERMIA	0.00378788	0.1405092925841498
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00378788	0.1405092925841498
OVARIAN CANCER	0.00378788	0.1405092925841498
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	0.1405092925841498
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	0.1405092925841498
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00378788	0.1405092925841498
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	0.1405092925841498
SPINAL ARACHNOIDITIS	0.00378788	0.1405092925841498
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00378788	0.1405092925841498
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	0.1405092925841498
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00378788	0.1405092925841498
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	0.1405092925841498
T-SUBSTANCE ANOMALY	0.00378788	0.1405092925841498
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00378788	0.1405092925841498
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	0.1405092925841498
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	0.1405092925841498
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00378788	0.1405092925841498
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	0.1405092925841498
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00378788	0.1405092925841498
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	0.1405092925841498
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	0.1405092925841498
PACMAN DYSPLASIA	0.00378788	0.1405092925841498
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00378788	0.1405092925841498
POLYCYSTIC OVARY SYNDROME 1	0.00378788	0.1405092925841498
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	0.1405092925841498
OCULORENOCEREBELLAR SYNDROME	0.00378788	0.1405092925841498
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00378788	0.1405092925841498
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	0.1405092925841498
PERRY SYNDROME	0.00378788	0.1405092925841498
APOLIPOPROTEIN(A)	0.00378788	0.1405092925841498
EHLERS-DANLOS SYNDROME, TYPE VI	0.00378788	0.1405092925841498
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	0.1405092925841498
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	0.1405092925841498
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	0.1405092925841498
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	0.1405092925841498
BARTTER SYNDROME	0.00378788	0.1405092925841498
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	0.1405092925841498
DERMATOLEUKODYSTROPHY	0.00378788	0.1405092925841498
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00378788	0.1405092925841498
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	0.1405092925841498
ETHANOLAMINOSIS	0.00378788	0.1405092925841498
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	0.1405092925841498
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	0.1405092925841498
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	0.1405092925841498
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	0.1405092925841498
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	0.1405092925841498
KERATOSIS, FAMILIAL ACTINIC	0.00378788	0.1405092925841498
%608572 BURN-MCKEOWN SYNDROME	0.00378788	0.1405092925841498
GONADOBLASTOMA	0.00378788	0.1405092925841498
CITRULLINE TRANSPORT DEFECT	0.00378788	0.1405092925841498
AREDYLD	0.00378788	0.1405092925841498
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	0.1405092925841498
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	0.1405092925841498
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00378788	0.1405092925841498
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	0.1405092925841498
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00378788	0.1405092925841498
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	0.1405092925841498
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	0.1405092925841498
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	0.1405092925841498
PYGMY	0.00378788	0.1405092925841498
LIPASE DEFICIENCY, COMBINED	0.00378788	0.1405092925841498
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	0.1405092925841498
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	0.1405092925841498
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	0.1405092925841498
CONGENITAL ADRENAL HYPERPLASIA	0.00378788	0.1405092925841498
SCHIZOPHRENIA 4	0.00378788	0.1405092925841498
ZINC, ELEVATED PLASMA	0.00378788	0.1405092925841498
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	0.1405092925841498
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	0.1405092925841498
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	0.1405092925841498
HYPERPROGLUCAGONEMIA	0.00378788	0.1405092925841498
BEETURIA	0.00378788	0.1405092925841498
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	0.1405092925841498
ACETYLATION, SLOW	0.00378788	0.1405092925841498
WHITE SPONGE NEVUS OF CANNON	0.00378788	0.1405092925841498
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	0.1405092925841498
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	0.1405092925841498
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	0.1405092925841498
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	0.1405092925841498
ICHTHYOSIS, X-LINKED	0.00378788	0.1405092925841498
HYPOASCORBEMIA	0.00378788	0.1405092925841498
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	0.1405092925841498
CONE-ROD DYSTROPHY 1; CORD1	0.00378788	0.1405092925841498
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	0.1405092925841498
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	0.1405092925841498
CARBOXYLESTERASE 1	0.00378788	0.1405092925841498
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00378788	0.1405092925841498
OSTEOGENIC SARCOMA	0.00378788	0.1405092925841498
ALAND ISLAND EYE DISEASE	0.00378788	0.1405092925841498
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	0.1405092925841498
PREMATURE OVARIAN FAILURE 1	0.00378788	0.1405092925841498
X-LINKED ADRENOLEUKODYSTROPHY	0.00378788	0.1405092925841498
PITUITARY DWARFISM IV	0.00378788	0.1405092925841498
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	0.1405092925841498
GLOMUVENOUS MALFORMATIONS	0.00378788	0.1405092925841498
CHOROIDAL OSTEOMA, BILATERAL	0.00378788	0.1405092925841498
TRISOMY 18-LIKE SYNDROME	0.00378788	0.1405092925841498
GLUTATHIONE REDUCTASE	0.00378788	0.1405092925841498
PROGESTERONE RESISTANCE	0.00378788	0.1405092925841498
CARDIAC LIPIDOSIS, FAMILIAL	0.00378788	0.1405092925841498
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	0.1405092925841498
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	0.1405092925841498
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	0.1405092925841498
MAGNESIUM, ELEVATED RED CELL	0.00378788	0.1405092925841498
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	0.1405092925841498
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	0.1405092925841498
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	0.1405092925841498
HEINZ BODY ANEMIAS	0.00378788	0.1405092925841498
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00378788	0.1405092925841498
CATECHOL-O-METHYLTRANSFERASE	0.00378788	0.1405092925841498
LYMPHOKINE DEFICIENCY	0.00378788	0.1405092925841498
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	0.1405092925841498
LARON SYNDROME	0.00378788	0.1405092925841498
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00378788	0.1405092925841498
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	0.1405092925841498
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	0.1405092925841498
NEPHROSIALIDOSIS	0.00378788	0.1405092925841498
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	0.1405092925841498
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	0.1405092925841498
MACULAR CORNEAL DYSTROPHY	0.00378788	0.1405092925841498
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	0.1405092925841498
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	0.1405092925841498
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	0.1405092925841498
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	0.1405092925841498
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	0.1405092925841498
HOOFT DISEASE	0.00378788	0.1405092925841498
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	0.1405092925841498
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00378788	0.1405092925841498
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	0.1405092925841498
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00378788	0.1405092925841498
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	0.1405092925841498
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	0.1405092925841498
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	0.1405092925841498
PARAOXONASE 1	0.00378788	0.1405092925841498
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00378788	0.1405092925841498
CALVARIAL HYPEROSTOSIS	0.00378788	0.1405092925841498
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	0.1405092925841498
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00378788	0.1405092925841498
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	0.1405092925841498
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	0.1405092925841498
XM SYSTEM	0.00378788	0.1405092925841498
GLUTATHIONURIA	0.00378788	0.1405092925841498
OSTEOGENESIS IMPERFECTA, TYPE V	0.00378788	0.1405092925841498
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	0.1405092925841498
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00378788	0.1405092925841498
SERTOLI CELL-ONLY SYNDROME	0.00378788	0.1405092925841498
FINGERPRINT BODY MYOPATHY	0.00378788	0.1405092925841498
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	0.1405092925841498
DERMATITIS, ATOPIC	0.00378788	0.1405092925841498
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	0.1405092925841498
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00378788	0.1405092925841498
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00378788	0.1405092925841498
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0037262339999999997	0.13822256865133178
COCKAYNE SYNDROME A; CSA	0.003722099	0.1380691831362586
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.003722099	0.1380691831362586
SANDHOFF DISEASE	0.003722099	0.1380691831362586
MUCOPOLYSACCHARIDOSIS TYPE 3	0.003722099	0.1380691831362586
RETT SYNDROME	0.003722099	0.1380691831362586
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.003722099	0.1380691831362586
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.003496613	0.1297049059290531
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.003496613	0.1297049059290531
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.003496613	0.1297049059290531
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.003496613	0.1297049059290531
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.003496613	0.1297049059290531
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.003496613	0.1297049059290531
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.003496613	0.1297049059290531
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.003496613	0.1297049059290531
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.003496613	0.1297049059290531
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.003496613	0.1297049059290531
ZTTK SYNDROME; ZTTKS	0.003496613	0.1297049059290531
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.003496613	0.1297049059290531
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.003496613	0.1297049059290531
CODAS SYNDROME	0.003496613	0.1297049059290531
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.003496613	0.1297049059290531
611961 STEVENSON-CAREY SYNDROME	0.003496613	0.1297049059290531
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.003496613	0.1297049059290531
49,XXXXY SYNDROME	0.003496613	0.1297049059290531
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.003496613	0.1297049059290531
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.003496613	0.1297049059290531
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.003496613	0.1297049059290531
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.003496613	0.1297049059290531
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.003496613	0.1297049059290531
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.003496613	0.1297049059290531
MATERNAL PHENYLKETONURIA	0.003496613	0.1297049059290531
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.003496613	0.1297049059290531
MEND SYNDROME	0.003496613	0.1297049059290531
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.003496613	0.1297049059290531
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.003496613	0.1297049059290531
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.0034966129999999995	0.1297049059290531
XQ25 MICRODUPLICATION SYNDROME	0.0034966129999999995	0.1297049059290531
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.0034966129999999995	0.1297049059290531
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.0034966129999999995	0.1297049059290531
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.0034966129999999995	0.1297049059290531
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.0034966129999999995	0.1297049059290531
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.0034965000000000005	0.1297007142571781
OPTICOCOCHLEODENTATE DEGENERATION	0.0034965000000000005	0.1297007142571781
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.0034965000000000005	0.1297007142571781
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.0034965000000000005	0.1297007142571781
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.0034965000000000005	0.1297007142571781
MENTAL RETARDATION, X-LINKED 105; MRX105	0.0034965000000000005	0.1297007142571781
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.0034965000000000005	0.1297007142571781
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.0034965000000000005	0.1297007142571781
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.0033818599999999996	0.12544820749829264
WISKOTT-ALDRICH SYNDROME	0.00327869	0.12162117398194398
IMMUNE THROMBOCYTOPENIC PURPURA	0.00327869	0.12162117398194398
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00327869	0.12162117398194398
FIBULAR HEMIMELIA	0.00327869	0.12162117398194398
ACUTE MYELOMONOCYTIC LEUKEMIA	0.00327869	0.12162117398194398
IDIOPATHIC APLASTIC ANEMIA	0.00327869	0.12162117398194398
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00327869	0.12162117398194398
REFRACTORY ANEMIA	0.00327869	0.12162117398194398
SLC35A1-CDG	0.00327869	0.12162117398194398
ACUTE PROMYELOCYTIC LEUKEMIA	0.00327869	0.12162117398194398
CYCLIC NEUTROPENIA	0.00327869	0.12162117398194398
MOYAMOYA DISEASE WITH EARLY-ONSET ACHALASIA	0.00327869	0.12162117398194398
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.00327869	0.12162117398194398
TRANSCOBALAMIN DEFICIENCY	0.00327869	0.12162117398194398
NIJMEGEN BREAKAGE SYNDROME	0.00327869	0.12162117398194398
GRAY PLATELET SYNDROME	0.00327869	0.12162117398194398
OSTEOGENESIS IMPERFECTA	0.00327869	0.12162117398194398
OSTEOPETROSIS AND RELATED DISORDERS	0.00327869	0.12162117398194398
CHRONIC MYELOID LEUKEMIA	0.00327869	0.12162117398194398
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00327869	0.12162117398194398
ROCH-LERI MESOSOMATOUS LIPOMATOSIS	0.00327869	0.12162117398194398
ACQUIRED PURPURA FULMINANS	0.00327869	0.12162117398194398
IMMUNODEFICIENCY 52; IMD52	0.00327869	0.12162117398194398
STORMORKEN SYNDROME; STRMK	0.00327869	0.12162117398194398
AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE	0.00327869	0.12162117398194398
HEMANGIOMA-THROMBOCYTOPENIA SYNDROME	0.00327869	0.12162117398194398
DIAMOND-BLACKFAN ANEMIA 1	0.00327869	0.12162117398194398
FANCONI ANEMIA	0.00327869	0.12162117398194398
167850 PANCYTOPENIA AND OCCLUSIVE VASCULAR DISEASE	0.00327869	0.12162117398194398
IVIC SYNDROME	0.00327869	0.12162117398194398
BLEEDING DISORDER, PLATELET-TYPE, 20	0.00327869	0.12162117398194398
THROMBOCYTOPENIA 6	0.00327869	0.12162117398194398
PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	0.00327869	0.12162117398194398
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.00327869	0.12162117398194398
BEEMER-ERTBRUGGEN SYNDROME	0.00327869	0.12162117398194398
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.00327869	0.12162117398194398
VON WILLEBRAND DISEASE, TYPE 3; VWD3	0.00327869	0.12162117398194398
NIJMEGEN BREAKAGE SYNDROME	0.00327869	0.12162117398194398
DEAFNESS, AUTOSOMAL DOMINANT 1	0.00327869	0.12162117398194398
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00327869	0.12162117398194398
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.00327869	0.12162117398194398
THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS; THAMY	0.00327869	0.12162117398194398
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.00327869	0.12162117398194398
TUFTED ANGIOMA	0.00327869	0.12162117398194398
AREGENERATIVE ANEMIA	0.00327869	0.12162117398194398
MONOSOMY 7 OF BONE MARROW	0.00327869	0.12162117398194398
ATYPICAL HEMOLYTIC UREMIC SYNDROME	0.00327869	0.12162117398194398
EOSINOPHILIA, FAMILIAL	0.00327869	0.12162117398194398
PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID	0.00327869	0.12162117398194398
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00327869	0.12162117398194398
THROMBOCYTOPENIA 3	0.00327869	0.12162117398194398
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.00327869	0.12162117398194398
SENGERS SYNDROME	0.00327869	0.12162117398194398
GIANT PLATELET SYNDROME WITH THROMBOCYTOPENIA	0.00327869	0.12162117398194398
IMMUNODEFICIENCY, COMMON VARIABLE, 12; CVID12	0.00327869	0.12162117398194398
SCHIMKE IMMUNO-OSSEOUS DYSPLASIA	0.00327869	0.12162117398194398
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00327869	0.12162117398194398
BLEEDING DISORDER, PLATELET-TYPE, 17; BDPLT17	0.00327869	0.12162117398194398
VON WILLEBRAND DISEASE, TYPE 2; VWD2	0.00327869	0.12162117398194398
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00327869	0.12162117398194398
THROMBOCYTOPENIA 2	0.00327869	0.12162117398194398
HERMANSKY-PUDLAK SYNDROME 9	0.00327869	0.12162117398194398
ALPHA-THALASSEMIA-MYELODYSPLASTIC SYNDROME	0.00327869	0.12162117398194398
BETA-THALASSEMIA-X-LINKED THROMBOCYTOPENIA SYNDROME	0.00327869	0.12162117398194398
%614200 BLEEDING DISORDER, PLATELET-TYPE, 9; BDPLT9;;GLYCOPROTEIN IA DEFICIENCY;;GP IA DEFICIENCY;;COLLAGEN PLATELET RECEPTOR DEFICIENCY	0.00327869	0.12162117398194398
THROMBOCYTOPENIA, CYCLIC	0.00327869	0.12162117398194398
188030 THROMBOCYTOPENIC PURPURA, AUTOIMMUNE; AITP;;IMMUNE THROMBOCYTOPENIC PURPURA; ITP;;IDIOPATHIC THROMBOCYTOPENIC PURPURA	0.00327869	0.12162117398194398
WT LIMB-BLOOD SYNDROME	0.00327869	0.12162117398194398
DRUG-INDUCED LUPUS ERYTHEMATOSUS	0.00327869	0.12162117398194398
FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	0.00327869	0.12162117398194398
BLEEDING DISORDER, PLATELET-TYPE, 15; BDPLT15	0.00327869	0.12162117398194398
JACOBSEN SYNDROME	0.00327869	0.12162117398194398
IVIC SYNDROME	0.00327869	0.12162117398194398
CERNUNNOS-XLF DEFICIENCY	0.00327869	0.12162117398194398
SEBASTIAN SYNDROME	0.00327869	0.12162117398194398
PLATELET DISORDER, UNDEFINED	0.00327869	0.12162117398194398
THROMBOCYTOPENIA 5; THC5	0.00327869	0.12162117398194398
ISOLATED AGAMMAGLOBULINEMIA	0.00327869	0.12162117398194398
BEEMER LETHAL MALFORMATION SYNDROME	0.00327869	0.12162117398194398
PLATELET SIGNAL PROCESSING DEFECT	0.00327869	0.12162117398194398
HODGKIN LYMPHOMA	0.00318068	0.11798554778307484
TYPHOID	0.00318068	0.11798554778307484
CLASSIC HODGKIN LYMPHOMA	0.00318068	0.11798554778307484
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00318068	0.11798554778307484
CAMURATI-ENGELMANN DISEASE	0.00318068	0.11798554778307484
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00318068	0.11798554778307484
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.00318068	0.11798554778307484
WEAVER SYNDROME	0.002991733	0.11097666436916062
17Q11.2 MICRODUPLICATION SYNDROME	0.002991733	0.11097666436916062
11P15.4 MICRODUPLICATION SYNDROME	0.002991733	0.11097666436916062
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.002991733	0.11097666436916062
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.002991733	0.11097666436916062
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.002991733	0.11097666436916062
LANDAU-KLEFFNER SYNDROME	0.002991733	0.11097666436916062
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.002991733	0.11097666436916062
DISTAL MONOSOMY 15Q	0.002991733	0.11097666436916062
15Q14 MICRODELETION SYNDROME	0.002991733	0.11097666436916062
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.002991733	0.11097666436916062
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.002991733	0.11097666436916062
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.002991733	0.11097666436916062
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.002991733	0.11097666436916062
LUSCAN-LUMISH SYNDROME; LLS	0.002991733	0.11097666436916062
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.002991733	0.11097666436916062
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.002991733	0.11097666436916062
WIEDEMANN-STEINER SYNDROME; WDSTS	0.002991733	0.11097666436916062
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.002991733	0.11097666436916062
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.002991733	0.11097666436916062
CHROMOSOME 5Q12 DELETION SYNDROME	0.002991733	0.11097666436916062
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.002991733	0.11097666436916062
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.002991733	0.11097666436916062
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.002991733	0.11097666436916062
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.002991733	0.11097666436916062
GLASS SYNDROME	0.002991733	0.11097666436916062
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.002991733	0.11097666436916062
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.002991733	0.11097666436916062
CHROMOSOME 19P13.13 DELETION SYNDROME	0.002991733	0.11097666436916062
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.002991733	0.11097666436916062
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.002991733	0.11097666436916062
WIEACKER-WOLFF SYNDROME	0.002991733	0.11097666436916062
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.002991733	0.11097666436916062
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.002991733	0.11097666436916062
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.002991733	0.11097666436916062
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.002991733	0.11097666436916062
KLEEFSTRA SYNDROME 2; KLEFS2	0.002991733	0.11097666436916062
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.002991733	0.11097666436916062
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.002991733	0.11097666436916062
JOUBERT SYNDROME 30; JBTS30	0.002991733	0.11097666436916062
MENTAL RETARDATION, X-LINKED 9	0.002991733	0.11097666436916062
48,XXXY SYNDROME	0.002991733	0.11097666436916062
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.002991733	0.11097666436916062
SHUKLA-VERNON SYNDROME; SHUVER	0.002991733	0.11097666436916062
SHASHI-PENA SYNDROME; SHAPNS	0.002991733	0.11097666436916062
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.002991733	0.11097666436916062
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.002991733	0.11097666436916062
MENTAL RETARDATION, X-LINKED 90	0.002991733	0.11097666436916062
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.002991733	0.11097666436916062
PRADER-WILLI SYNDROME; PWS	0.002991733	0.11097666436916062
CK SYNDROME	0.002991733	0.11097666436916062
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.0029551939999999995	0.1096212705758693
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.0029551939999999995	0.1096212705758693
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.0029551939999999995	0.1096212705758693
17P13.3 MICRODUPLICATION SYNDROME	0.0029551939999999995	0.1096212705758693
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.0029551939999999995	0.1096212705758693
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.0029551939999999995	0.1096212705758693
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.0029551939999999995	0.1096212705758693
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.0029551939999999995	0.1096212705758693
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.0029551939999999995	0.1096212705758693
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.0029551939999999995	0.1096212705758693
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.0029551939999999995	0.1096212705758693
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0029551939999999995	0.1096212705758693
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.0029551939999999995	0.1096212705758693
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.0029551939999999995	0.1096212705758693
GOLDBERG-SHPRINTZEN SYNDROME	0.0029551939999999995	0.1096212705758693
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.0029551939999999995	0.1096212705758693
TYSHCHENKO SYNDROME	0.0029551939999999995	0.1096212705758693
XIA-GIBBS SYNDROME	0.0029551939999999995	0.1096212705758693
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.0029551939999999995	0.1096212705758693
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0029551939999999995	0.1096212705758693
TURNPENNY-FRY SYNDROME; TPFS	0.0029551939999999995	0.1096212705758693
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.002951059	0.10946788506079612
RETT SYNDROME, CONGENITAL VARIANT	0.002951059	0.10946788506079612
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.002951059	0.10946788506079612
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.002951059	0.10946788506079612
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.002951059	0.10946788506079612
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.002951059	0.10946788506079612
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.002951059	0.10946788506079612
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.002951059	0.10946788506079612
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.002951059	0.10946788506079612
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.002951059	0.10946788506079612
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.002951059	0.10946788506079612
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.002951059	0.10946788506079612
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.002951059	0.10946788506079612
MENTAL RETARDATION, X-LINKED 102	0.002951059	0.10946788506079612
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.002951059	0.10946788506079612
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.002951059	0.10946788506079612
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.002951059	0.10946788506079612
WARBURG MICRO SYNDROME 3; WARBM3	0.002951059	0.10946788506079612
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.002951059	0.10946788506079612
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.002790553	0.10351400465394281
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.002790553	0.10351400465394281
KAGAMI-OGATA SYNDROME	0.002790553	0.10351400465394281
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.002790553	0.10351400465394281
C SYNDROME	0.002790553	0.10351400465394281
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.002790553	0.10351400465394281
MUCOPOLYSACCHARIDOSIS TYPE 2	0.002790553	0.10351400465394281
MULTIPLE SULFATASE DEFICIENCY	0.002790553	0.10351400465394281
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.002790553	0.10351400465394281
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.002790553	0.10351400465394281
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.002790553	0.10351400465394281
HARTNUP DISEASE	0.002564073	0.09511285557201354
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.002564073	0.09511285557201354
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.002564073	0.09511285557201354
GRISCELLI SYNDROME TYPE 1	0.002564073	0.09511285557201354
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.002564073	0.09511285557201354
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.002564073	0.09511285557201354
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.002564073	0.09511285557201354
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.002564073	0.09511285557201354
MEVALONIC ACIDURIA	0.002564073	0.09511285557201354
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.002564073	0.09511285557201354
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.002564073	0.09511285557201354
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.002564073	0.09511285557201354
48,XXYY SYNDROME	0.002564073	0.09511285557201354
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.002564073	0.09511285557201354
MYHRE SYNDROME	0.002564073	0.09511285557201354
ELEJALDE DISEASE	0.002564073	0.09511285557201354
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.002564073	0.09511285557201354
CENTRAL BILATERAL MACROGYRIA	0.002564073	0.09511285557201354
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.002564073	0.09511285557201354
SULFOCYSTEINURIA	0.002564073	0.09511285557201354
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.002564073	0.09511285557201354
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.002564073	0.09511285557201354
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.002564073	0.09511285557201354
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.002564073	0.09511285557201354
COWDEN SYNDROME	0.002564073	0.09511285557201354
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.002564073	0.09511285557201354
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.002564073	0.09511285557201354
MAPLE SYRUP URINE DISEASE	0.002564073	0.09511285557201354
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.002564073	0.09511285557201354
EAST SYNDROME	0.002564073	0.09511285557201354
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.002564073	0.09511285557201354
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.002564073	0.09511285557201354
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.0025640729999999996	0.09511285557201353
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.002450314	0.09089302901597683
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.002450314	0.09089302901597683
COHEN-GIBSON SYNDROME; COGIS	0.002450314	0.09089302901597683
TONNE-KALSCHEUER SYNDROME; TOKAS	0.002450314	0.09089302901597683
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.002450314	0.09089302901597683
16P11.2P12.2 MICRODELETION SYNDROME	0.002450314	0.09089302901597683
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.002450314	0.09089302901597683
BARATELA-SCOTT SYNDROME	0.002450314	0.09089302901597683
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.002450314	0.09089302901597683
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.002450314	0.09089302901597683
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.002450314	0.09089302901597683
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.002450314	0.09089302901597683
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.002450314	0.09089302901597683
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.002450314	0.09089302901597683
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.002450314	0.09089302901597683
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.002450314	0.09089302901597683
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.002450314	0.09089302901597683
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.002450314	0.09089302901597683
48,XYYY SYNDROME	0.002450314	0.09089302901597683
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.002450314	0.09089302901597683
LAMB-SHAFFER SYNDROME	0.002450314	0.09089302901597683
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.002450314	0.09089302901597683
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.002450314	0.09089302901597683
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.002450314	0.09089302901597683
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.002450314	0.09089302901597683
1P21.3 MICRODELETION SYNDROME	0.002450314	0.09089302901597683
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.002450314	0.09089302901597683
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.002450314	0.09089302901597683
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.002450314	0.09089302901597683
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.002450314	0.09089302901597683
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.002450314	0.09089302901597683
SAUL-WILSON SYNDROME; SWILS	0.002450314	0.09089302901597683
SAY-BARBER-MILLER SYNDROME	0.002450314	0.09089302901597683
3Q29 MICRODELETION SYNDROME	0.002450314	0.09089302901597683
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.002450314	0.09089302901597683
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.002450314	0.09089302901597683
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.002450314	0.09089302901597683
DUCHENNE MUSCULAR DYSTROPHY	0.002450314	0.09089302901597683
2Q32Q33 MICRODELETION SYNDROME	0.002450314	0.09089302901597683
DISTAL MONOSOMY 6P	0.002450314	0.09089302901597683
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.002450314	0.09089302901597683
COFFIN-SIRIS SYNDROME 7; CSS7	0.002450314	0.09089302901597683
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.002450314	0.09089302901597683
CHROMOSOME 9P DELETION SYNDROME	0.002450314	0.09089302901597683
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.002450314	0.09089302901597683
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.002450314	0.09089302901597683
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.002450314	0.09089302901597683
6Q16 MICRODELETION SYNDROME	0.002450314	0.09089302901597683
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.002450314	0.09089302901597683
DESBUQUOIS DYSPLASIA 2; DBQD2	0.002450314	0.09089302901597683
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.002450314	0.09089302901597683
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.002450314	0.09089302901597683
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.002450314	0.09089302901597683
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.002450314	0.09089302901597683
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.002450314	0.09089302901597683
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.002450314	0.09089302901597683
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.002450314	0.09089302901597683
ABLEPHARON MACROSTOMIA SYNDROME	0.002450314	0.09089302901597683
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.002450314	0.09089302901597683
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.002450314	0.09089302901597683
2P15P16.1 MICRODELETION SYNDROME	0.002450314	0.09089302901597683
8P23.1 DUPLICATION SYNDROME	0.002450314	0.09089302901597683
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.002450314	0.09089302901597683
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.002450314	0.09089302901597683
TENORIO SYNDROME; TNORS	0.0024461789999999997	0.09073964350090363
17Q12 MICRODUPLICATION SYNDROME	0.0024461789999999997	0.09073964350090363
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.0024461789999999997	0.09073964350090363
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.0024461789999999997	0.09073964350090363
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.0024461789999999997	0.09073964350090363
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.0024461789999999997	0.09073964350090363
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.0024461789999999997	0.09073964350090363
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.0024461789999999997	0.09073964350090363
KLEEFSTRA SYNDROME	0.0024461789999999997	0.09073964350090363
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.0024461789999999997	0.09073964350090363
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.0024461789999999997	0.09073964350090363
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.0024461789999999997	0.09073964350090363
20P13 MICRODELETION SYNDROME	0.0024461789999999997	0.09073964350090363
COFFIN-SIRIS SYNDROME 8; CSS8	0.0024461789999999997	0.09073964350090363
PARTINGTON SYNDROME	0.0024461789999999997	0.09073964350090363
47,XYY SYNDROME	0.0024461789999999997	0.09073964350090363
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.0024461789999999997	0.09073964350090363
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.0024461789999999997	0.09073964350090363
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.0024461789999999997	0.09073964350090363
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.0024461789999999997	0.09073964350090363
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.0024461789999999997	0.09073964350090363
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.0024461789999999997	0.09073964350090363
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.0024461789999999997	0.09073964350090363
17Q24.2 MICRODELETION SYNDROME	0.0024461789999999997	0.09073964350090363
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.0024461789999999997	0.09073964350090363
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.0024461789999999997	0.09073964350090363
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.0024461789999999997	0.09073964350090363
AUTISM	0.0024461789999999997	0.09073964350090363
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.0024461789999999997	0.09073964350090363
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00240964	0.08938424970761234
PRIMROSE SYNDROME; PRIMS	0.00240964	0.08938424970761234
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00240964	0.08938424970761234
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00240964	0.08938424970761234
FRONTOFACIONASAL DYSPLASIA	0.00240964	0.08938424970761234
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00240964	0.08938424970761234
LEUKOENCEPHALOPATHY-PALMOPLANTAR KERATODERMA SYNDROME	0.00240964	0.08938424970761234
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.00240964	0.08938424970761234
CEREBROFACIOTHORACIC DYSPLASIA	0.00240964	0.08938424970761234
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00240964	0.08938424970761234
%611252 SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32	0.00240964	0.08938424970761234
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 66	0.00240964	0.08938424970761234
MONOSOMY 13Q14	0.00240964	0.08938424970761234
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00240964	0.08938424970761234
FRONTONASAL DYSPLASIA 2; FND2	0.00240964	0.08938424970761234
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 32	0.00240964	0.08938424970761234
FONTAINE PROGEROID SYNDROME; FPS	0.00240964	0.08938424970761234
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00240964	0.08938424970761234
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.00240964	0.08938424970761234
CEREBROOCULONASAL SYNDROME	0.00240964	0.08938424970761234
CRANIOFRONTONASAL DYSPLASIA	0.00240964	0.08938424970761234
ANIRIDIA	0.00240964	0.08938424970761234
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00240964	0.08938424970761234
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.00240964	0.08938424970761234
LIG4 SYNDROME	0.002249134	0.08343036930075902
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.002249134	0.08343036930075902
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.002249134	0.08343036930075902
WOLMAN DISEASE	0.002249134	0.08343036930075902
ROIFMAN SYNDROME; RFMN	0.002249134	0.08343036930075902
PEROXISOME BIOGENESIS DISORDER 3B	0.002249134	0.08343036930075902
HURLER SYNDROME	0.002249134	0.08343036930075902
ALPHA-MANNOSIDOSIS	0.002249134	0.08343036930075902
MACROCEPHALY/AUTISM SYNDROME	0.002249134	0.08343036930075902
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.002249134	0.08343036930075902
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.002249134	0.08343036930075902
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.002249134	0.08343036930075902
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.002249134	0.08343036930075902
OCULOSKELETODENTAL SYNDROME; OCSKD	0.002249134	0.08343036930075902
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.002244999	0.08327698378568583
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.002244999	0.08327698378568583
MUCOPOLYSACCHARIDOSIS, TYPE II	0.002244999	0.08327698378568583
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.002244999	0.08327698378568583
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.002244999	0.08327698378568583
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.002244999	0.08327698378568583
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.002244999	0.08327698378568583
GLUTARIC ACIDEMIA I; GA1	0.002244999	0.08327698378568583
ZIMMERMANN-LABAND SYNDROME 1	0.002244999	0.08327698378568583
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.002244999	0.08327698378568583
ZIMMERMANN-LABAND SYNDROME	0.002244999	0.08327698378568583
GAUCHER DISEASE, TYPE IIIC	0.002244999	0.08327698378568583
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.002244999	0.08327698378568583
BAKER-GORDON SYNDROME; BAGOS	0.0020226539999999996	0.07502922021882974
USHER SYNDROME TYPE 1	0.0020226539999999996	0.07502922021882974
OXOGLUTARIC ACIDURIA	0.0020226539999999996	0.07502922021882974
JOUBERT SYNDROME 25	0.0020226539999999996	0.07502922021882974
JOUBERT SYNDROME 28	0.0020226539999999996	0.07502922021882974
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.0020226539999999996	0.07502922021882974
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0020226539999999996	0.07502922021882974
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.0020226539999999996	0.07502922021882974
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.0020226539999999996	0.07502922021882974
WAARDENBURG-SHAH SYNDROME	0.0020226539999999996	0.07502922021882974
JOUBERT SYNDROME 27	0.0020226539999999996	0.07502922021882974
MARINESCO-SJÖGREN SYNDROME	0.0020226539999999996	0.07502922021882974
JOUBERT SYNDROME 35; JBTS35	0.0020226539999999996	0.07502922021882974
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.0020226539999999996	0.07502922021882974
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.0020226539999999996	0.07502922021882974
JOUBERT SYNDROME 8	0.0020226539999999996	0.07502922021882974
JOUBERT SYNDROME 17; JBTS17	0.0020226539999999996	0.07502922021882974
MECKEL SYNDROME 13; MKS13	0.0020226539999999996	0.07502922021882974
OROFACIODIGITAL SYNDROME XVI; OFD16	0.0020226539999999996	0.07502922021882974
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.0020226539999999996	0.07502922021882974
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0020226539999999996	0.07502922021882974
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0020226539999999996	0.07502922021882974
JOUBERT SYNDROME 32; JBTS32	0.0020226539999999996	0.07502922021882974
JOUBERT SYNDROME 33; JBTS33	0.0020226539999999996	0.07502922021882974
JOUBERT SYNDROME 15	0.0020226539999999996	0.07502922021882974
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.0020226539999999996	0.07502922021882974
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.0020226539999999996	0.07502922021882974
JOUBERT SYNDROME 14	0.0020226539999999996	0.07502922021882974
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.0020226539999999996	0.07502922021882974
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.0020226539999999996	0.07502922021882974
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.0020226539999999996	0.07502922021882974
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.0020226539999999996	0.07502922021882974
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.0020226539999999996	0.07502922021882974
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.0020226539999999996	0.07502922021882974
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.0020226539999999996	0.07502922021882974
PELLAGRA-LIKE SYNDROME	0.0020226539999999996	0.07502922021882974
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.0020226539999999996	0.07502922021882974
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.0020226539999999996	0.07502922021882974
RICHARDS-RUNDLE SYNDROME; RRNS	0.0020226539999999996	0.07502922021882974
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.0020226539999999996	0.07502922021882974
CEREBELLOPARENCHYMAL DISORDER II	0.002018519	0.07487583470375656
GM1 GANGLIOSIDOSIS	0.002018519	0.07487583470375656
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.002018519	0.07487583470375656
KEARNS-SAYRE SYNDROME; KSS	0.002018519	0.07487583470375656
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.002018519	0.07487583470375656
WOLFRAM SYNDROME	0.002018519	0.07487583470375656
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.002018519	0.07487583470375656
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.002018519	0.07487583470375656
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.002018519	0.07487583470375656
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.002018519	0.07487583470375656
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.002018519	0.07487583470375656
CYCLIC VOMITING SYNDROME	0.002018519	0.07487583470375656
EARLY-ONSET LAFORA BODY DISEASE	0.002018519	0.07487583470375656
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.002018519	0.07487583470375656
ALEXANDER DISEASE	0.002018519	0.07487583470375656
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.002018519	0.07487583470375656
CITRULLINEMIA TYPE I	0.002018519	0.07487583470375656
TRIPLE A SYNDROME	0.002018519	0.07487583470375656
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.002018519	0.07487583470375656
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.002018519	0.07487583470375656
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.002018519	0.07487583470375656
FAMILIAL DYSAUTONOMIA	0.002018519	0.07487583470375656
TYROSINEMIA TYPE 2	0.002018519	0.07487583470375656
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.002018519	0.07487583470375656
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.002018519	0.07487583470375656
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.002018519	0.07487583470375656
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.002018519	0.07487583470375656
LEIGH SYNDROME	0.002018519	0.07487583470375656
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.002018519	0.07487583470375656
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.002018519	0.07487583470375656
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.002018519	0.07487583470375656
DYSEQUILIBRIUM SYNDROME	0.002018519	0.07487583470375656
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.002018519	0.07487583470375656
HEREDITARY HYPEREKPLEXIA	0.002018519	0.07487583470375656
METACHROMATIC LEUKODYSTROPHY	0.002018519	0.07487583470375656
FLYNN-AIRD SYNDROME	0.002018519	0.07487583470375656
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.002018519	0.07487583470375656
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.002018519	0.07487583470375656
DIAMINOPENTANURIA	0.002018519	0.07487583470375656
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.002018519	0.07487583470375656
CAMOS SYNDROME	0.002018519	0.07487583470375656
GLUTATHIONE SYNTHETASE DEFICIENCY	0.002018519	0.07487583470375656
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.002018519	0.07487583470375656
SYMMETRICAL THALAMIC CALCIFICATIONS	0.002018519	0.07487583470375656
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.002018519	0.07487583470375656
ATYPICAL TERATOID RHABDOID TUMOR	0.002018519	0.07487583470375656
GITELMAN SYNDROME	0.002018519	0.07487583470375656
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.002018519	0.07487583470375656
SIALIDOSIS TYPE 1	0.002018519	0.07487583470375656
COCKAYNE SYNDROME	0.002018519	0.07487583470375656
CONGENITAL MYASTHENIC SYNDROME	0.002018519	0.07487583470375656
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.002018519	0.07487583470375656
KNOBLOCH SYNDROME 1; KNO1	0.002018519	0.07487583470375656
ISOLATED CEREBELLAR AGENESIS	0.002018519	0.07487583470375656
KUFOR-RAKEB SYNDROME	0.002018519	0.07487583470375656
NEUROFIBROMATOSIS, TYPE II	0.002018519	0.07487583470375656
KALLMANN SYNDROME	0.002018519	0.07487583470375656
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.002018519	0.07487583470375656
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.002018519	0.07487583470375656
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.002018519	0.07487583470375656
LHERMITTE-DUCLOS DISEASE	0.002018519	0.07487583470375656
PERRAULT SYNDROME 5; PRLTS5	0.002018519	0.07487583470375656
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.002018519	0.07487583470375656
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.002018519	0.07487583470375656
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.002018519	0.07487583470375656
XERODERMA PIGMENTOSUM	0.002018519	0.07487583470375656
FLYNN-AIRD SYNDROME	0.002018519	0.07487583470375656
EPISODIC ATAXIA TYPE 6	0.002018519	0.07487583470375656
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.002018519	0.07487583470375656
TEMPLE SYNDROME	0.00190476	0.07065600814771987
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.00190476	0.07065600814771987
CRANIOSYNOSTOSIS 7	0.00190476	0.07065600814771987
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00190476	0.07065600814771987
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00190476	0.07065600814771987
22Q11 DELETION SYNDROME (VELOCARDIOFACIAL / DIGEORGE SYNDROME)	0.00190476	0.07065600814771987
TEMPLE SYNDROME	0.00190476	0.07065600814771987
EPISODIC ATAXIA TYPE 1	0.00190476	0.07065600814771987
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00190476	0.07065600814771987
SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	0.00190476	0.07065600814771987
DYSTONIA 16; DYT16	0.00190476	0.07065600814771987
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.00190476	0.07065600814771987
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00190476	0.07065600814771987
LARYNGOTRACHEAL ANGIOMA	0.00190476	0.07065600814771987
CHITAYAT SYNDROME	0.00190476	0.07065600814771987
SPEECH-LANGUAGE DISORDER 1	0.00190476	0.07065600814771987
BETA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R4	0.00190476	0.07065600814771987
NAGER SYNDROME	0.00190476	0.07065600814771987
224550 DYSTONIA WITH RINGBINDEN	0.00190476	0.07065600814771987
BRACHYDACTYLY, TYPE A1, D	0.00190476	0.07065600814771987
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00190476	0.07065600814771987
PRIMARY CILIARY DYSKINESIA	0.00190476	0.07065600814771987
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00190476	0.07065600814771987
PROGRESSIVE SUPRANUCLEAR PALSY	0.00190476	0.07065600814771987
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00190476	0.07065600814771987
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00190476	0.07065600814771987
POSTORGASMIC ILLNESS SYNDROME	0.00190476	0.07065600814771987
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.00190476	0.07065600814771987
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00190476	0.07065600814771987
GERODERMA OSTEODYSPLASTICUM; GO	0.00190476	0.07065600814771987
DUBOWITZ SYNDROME	0.00190476	0.07065600814771987
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00190476	0.07065600814771987
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00190476	0.07065600814771987
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00190476	0.07065600814771987
MEIER-GORLIN SYNDROME 6; MGORS6	0.00190476	0.07065600814771987
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.00190476	0.07065600814771987
HYPOGLOSSIA WITH SITUS INVERSUS	0.00190476	0.07065600814771987
FG SYNDROME 2; FGS2	0.00190476	0.07065600814771987
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.00190476	0.07065600814771987
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00190476	0.07065600814771987
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00190476	0.07065600814771987
CLEFT LIP/PALATE	0.00190476	0.07065600814771987
MENTAL RETARDATION, X-LINKED 93	0.00190476	0.07065600814771987
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00190476	0.07065600814771987
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00190476	0.07065600814771987
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00190476	0.07065600814771987
MICROTRIPLICATION 11Q24.1	0.00190476	0.07065600814771987
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.00190476	0.07065600814771987
OROFACIODIGITAL SYNDROME XVII	0.00190476	0.07065600814771987
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00190476	0.07065600814771987
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00190476	0.07065600814771987
MENTAL RETARDATION, X-LINKED 95	0.00190476	0.07065600814771987
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00190476	0.07065600814771987
7Q11.23 DUPLICATION SYNDROME	0.00190476	0.07065600814771987
VERVERI-BRADY SYNDROME; VERBRAS	0.00190476	0.07065600814771987
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00190476	0.07065600814771987
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00190476	0.07065600814771987
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00190476	0.07065600814771987
ABLEPHARON-MACROSTOMIA SYNDROME	0.00190476	0.07065600814771987
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00190476	0.07065600814771987
MAXILLOFACIAL DYSOSTOSIS	0.00190476	0.07065600814771987
MENTAL RETARDATION, X-LINKED 19	0.00190476	0.07065600814771987
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00190476	0.07065600814771987
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00190476	0.07065600814771987
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00190476	0.07065600814771987
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00190476	0.07065600814771987
SOTOS SYNDROME 2	0.00190476	0.07065600814771987
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00190476	0.07065600814771987
19Q13.11 MICRODELETION SYNDROME	0.00190476	0.07065600814771987
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00190476	0.07065600814771987
FRAXE INTELLECTUAL DISABILITY	0.00190476	0.07065600814771987
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.00190476	0.07065600814771987
MICROTIA	0.00190476	0.07065600814771987
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00190476	0.07065600814771987
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00190476	0.07065600814771987
MEIER-GORLIN SYNDROME 3; MGORS3	0.00190476	0.07065600814771987
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00190476	0.07065600814771987
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.00190476	0.07065600814771987
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00190476	0.07065600814771987
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00190476	0.07065600814771987
FISH-EYE DISEASE	0.00170358	0.06319334843250204
FAMILIAL TUMORAL CALCINOSIS	0.00170358	0.06319334843250204
HYPERZINCEMIA WITH FUNCTIONAL ZINC DEPLETION	0.00170358	0.06319334843250204
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.00170358	0.06319334843250204
FAMILIAL MEDITERRANEAN FEVER; FMF	0.00170358	0.06319334843250204
CUTANEOUS MASTOCYTOSIS	0.00170358	0.06319334843250204
SCHEIE SYNDROME	0.00170358	0.06319334843250204
MAST CELL SARCOMA	0.00170358	0.06319334843250204
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00170358	0.06319334843250204
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.00170358	0.06319334843250204
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00170358	0.06319334843250204
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00170358	0.06319334843250204
APOLIPOPROTEIN C-II DEFICIENCY	0.00170358	0.06319334843250204
HYPERLIPOPROTEINEMIA, TYPE ID	0.00170358	0.06319334843250204
MACROSOMIA-MICROPHTHALMIA-CLEFT PALATE SYNDROME	0.00170358	0.06319334843250204
SCHNITZLER SYNDROME	0.00170358	0.06319334843250204
DESMOPLASTIC SMALL ROUND CELL TUMOR	0.00170358	0.06319334843250204
LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3	0.00170358	0.06319334843250204
GLYCOGEN STORAGE DISEASE II	0.00170358	0.06319334843250204
XYLT1-CDG	0.00170358	0.06319334843250204
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00170358	0.06319334843250204
HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN-BETA-THALASSEMIA SYNDROME	0.00170358	0.06319334843250204
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00170358	0.06319334843250204
COLD AGGLUTININ DISEASE	0.00170358	0.06319334843250204
MULIBREY NANISM	0.00170358	0.06319334843250204
OPSISMODYSPLASIA	0.00170358	0.06319334843250204
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00170358	0.06319334843250204
X-LINKED LYMPHOPROLIFERATIVE DISEASE	0.00170358	0.06319334843250204
HURLER-SCHEIE SYNDROME	0.00170358	0.06319334843250204
DIFFUSE CUTANEOUS MASTOCYTOSIS	0.00170358	0.06319334843250204
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.00170358	0.06319334843250204
NIEMANN-PICK DISEASE, TYPE B	0.00170358	0.06319334843250204
LCAT DEFICIENCY	0.00170358	0.06319334843250204
FETAL CYTOMEGALOVIRUS SYNDROME	0.00170358	0.06319334843250204
OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	0.00170358	0.06319334843250204
THROMBOCYTOSIS, FAMILIAL X-LINKED	0.00170358	0.06319334843250204
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00170358	0.06319334843250204
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	0.00170358	0.06319334843250204
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.00170358	0.06319334843250204
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00170358	0.06319334843250204
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL	0.00170358	0.06319334843250204
PROLIDASE DEFICIENCY	0.00170358	0.06319334843250204
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00170358	0.06319334843250204
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.00170358	0.06319334843250204
POLYMYOSITIS	0.00170358	0.06319334843250204
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.00170358	0.06319334843250204
MU-HEAVY CHAIN DISEASE	0.00170358	0.06319334843250204
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00170358	0.06319334843250204
PACHYONYCHIA CONGENITA	0.00170358	0.06319334843250204
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.00170358	0.06319334843250204
MUCKLE-WELLS SYNDROME	0.00170358	0.06319334843250204
MORQUIO SYNDROME A	0.00170358	0.06319334843250204
ALPHA-HEAVY CHAIN DISEASE	0.00170358	0.06319334843250204
SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	0.00170358	0.06319334843250204
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00170358	0.06319334843250204
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.00170358	0.06319334843250204
BRONCHIAL NEUROENDOCRINE TUMOR	0.00170358	0.06319334843250204
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.00170358	0.06319334843250204
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00170358	0.06319334843250204
TANGIER DISEASE; TGD	0.00170358	0.06319334843250204
AREDYLD SYNDROME	0.00170358	0.06319334843250204
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.00170358	0.06319334843250204
PYCNODYSOSTOSIS	0.00170358	0.06319334843250204
PFAPA SYNDROME	0.00170358	0.06319334843250204
ACROOSTEOLYSIS DOMINANT TYPE	0.00170358	0.06319334843250204
DISTAL MONOSOMY 17Q	0.00170358	0.06319334843250204
NAKAJO-NISHIMURA SYNDROME	0.00170358	0.06319334843250204
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.00170358	0.06319334843250204
HURLER-SCHEIE SYNDROME	0.00170358	0.06319334843250204
CARTILAGE-HAIR HYPOPLASIA	0.00170358	0.06319334843250204
SEVERE COMBINED IMMUNODEFICIENCY	0.00170358	0.06319334843250204
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.00170358	0.06319334843250204
THORACO-ABDOMINAL ENTERIC DUPLICATION	0.00170358	0.06319334843250204
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00170358	0.06319334843250204
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00170358	0.06319334843250204
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00170358	0.06319334843250204
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00170358	0.06319334843250204
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00170358	0.06319334843250204
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00170358	0.06319334843250204
MULTIPLE SYMMETRIC LIPOMATOSIS	0.00170358	0.06319334843250204
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.0014770999999999999	0.05479219935057278
USHER SYNDROME TYPE 2	0.0014770999999999999	0.05479219935057278
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.0014770999999999999	0.05479219935057278
SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY	0.0014770999999999999	0.05479219935057278
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.0014770999999999999	0.05479219935057278
GILLESPIE SYNDROME; GLSP	0.0014770999999999999	0.05479219935057278
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.0014770999999999999	0.05479219935057278
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.0014770999999999999	0.05479219935057278
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0014770999999999999	0.05479219935057278
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0014770999999999999	0.05479219935057278
SPINOCEREBELLAR ATAXIA 32; SCA32	0.0014770999999999999	0.05479219935057278
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.0014770999999999999	0.05479219935057278
MUSCULAR ATROPHY-ATAXIA-RETINITIS PIGMENTOSA-DIABETES MELLITUS SYNDROME	0.0014770999999999999	0.05479219935057278
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0014770999999999999	0.05479219935057278
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.0014770999999999999	0.05479219935057278
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.0014770999999999999	0.05479219935057278
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.0014770999999999999	0.05479219935057278
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.0014770999999999999	0.05479219935057278
KEARNS-SAYRE SYNDROME	0.0014770999999999999	0.05479219935057278
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.0014770999999999999	0.05479219935057278
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.0014770999999999999	0.05479219935057278
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.0014770999999999999	0.05479219935057278
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.0014770999999999999	0.05479219935057278
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.0014770999999999999	0.05479219935057278
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0014770999999999999	0.05479219935057278
CEREBELLAR HYPOPLASIA	0.0014770999999999999	0.05479219935057278
POSTERIOR COLUMN ATAXIA	0.0014770999999999999	0.05479219935057278
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.0014770999999999999	0.05479219935057278
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.0014770999999999999	0.05479219935057278
ARGININOSUCCINIC ACIDURIA	0.0014770999999999999	0.05479219935057278
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.0014770999999999999	0.05479219935057278
JOUBERT SYNDROME 3; JBTS3	0.0014770999999999999	0.05479219935057278
NEUROFERRITINOPATHY	0.0014770999999999999	0.05479219935057278
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.0014770999999999999	0.05479219935057278
NON-DISTAL MONOSOMY 10Q	0.0014770999999999999	0.05479219935057278
ABETALIPOPROTEINEMIA	0.0014770999999999999	0.05479219935057278
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.0014770999999999999	0.05479219935057278
SPINOCEREBELLAR ATAXIA 37; SCA37	0.0014770999999999999	0.05479219935057278
SPINOCEREBELLAR ATAXIA 30; SCA30	0.0014770999999999999	0.05479219935057278
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.0014770999999999999	0.05479219935057278
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.0014770999999999999	0.05479219935057278
JOUBERT SYNDROME 4	0.0014770999999999999	0.05479219935057278
USHER SYNDROME TYPE 3	0.0014770999999999999	0.05479219935057278
212835 CEREBELLAR ATAXIA AND ECTODERMAL DYSPLASIA	0.0014770999999999999	0.05479219935057278
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0014770999999999999	0.05479219935057278
RAVINE SYNDROME	0.0014770999999999999	0.05479219935057278
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.0014770999999999999	0.05479219935057278
POSTERIOR CORTICAL ATROPHY	0.0014770999999999999	0.05479219935057278
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0014770999999999999	0.05479219935057278
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0014770999999999999	0.05479219935057278
JOUBERT SYNDROME 5	0.0014770999999999999	0.05479219935057278
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.0014770999999999999	0.05479219935057278
FAMILIAL PAROXYSMAL ATAXIA	0.0014770999999999999	0.05479219935057278
CHAND SYNDROME	0.0014770999999999999	0.05479219935057278
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.0014770999999999999	0.05479219935057278
GEMIGNANI SYNDROME	0.0014770999999999999	0.05479219935057278
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.0014770999999999999	0.05479219935057278
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.0014770999999999999	0.05479219935057278
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.0014770999999999999	0.05479219935057278
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.0014770999999999999	0.05479219935057278
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.0014770999999999999	0.05479219935057278
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.0014770999999999999	0.05479219935057278
SPASTIC PARAPLEGIA TYPE 2	0.0014770999999999999	0.05479219935057278
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.0014770999999999999	0.05479219935057278
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.0014770999999999999	0.05479219935057278
USHER SYNDROME	0.0014770999999999999	0.05479219935057278
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0014770999999999999	0.05479219935057278
PENDRED SYNDROME	0.0014770999999999999	0.05479219935057278
SPINOCEREBELLAR ATAXIA TYPE 17	0.0014770999999999999	0.05479219935057278
DEMENTIA, FAMILIAL DANISH	0.0014770999999999999	0.05479219935057278
CENTRAL NEUROCYTOMA	0.0014770999999999999	0.05479219935057278
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.0014770999999999999	0.05479219935057278
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.0014770999999999999	0.05479219935057278
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.0014770999999999999	0.05479219935057278
ATAXIA-HYPOGONADISM-CHOROIDAL DYSTROPHY SYNDROME	0.0014770999999999999	0.05479219935057278
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.0014770999999999999	0.05479219935057278
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.0014770999999999999	0.05479219935057278
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.0014770999999999999	0.05479219935057278
INFANTILE ONSET SPINOCEREBELLAR ATAXIA	0.0014770999999999999	0.05479219935057278
NEUROPATHY, HEREDITARY SENSORY, ATYPICAL	0.0014770999999999999	0.05479219935057278
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.0014770999999999999	0.05479219935057278
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.0014770999999999999	0.05479219935057278
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.0014770999999999999	0.05479219935057278
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0014770999999999999	0.05479219935057278
EPISODIC ATAXIA TYPE 4	0.0014770999999999999	0.05479219935057278
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.0014770999999999999	0.05479219935057278
MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS	0.0014770999999999999	0.05479219935057278
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 30	0.0014770999999999999	0.05479219935057278
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.0014770999999999999	0.05479219935057278
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.0014770999999999999	0.05479219935057278
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.0014770999999999999	0.05479219935057278
PIEBALDISM	0.0014770999999999999	0.05479219935057278
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.0014770999999999999	0.05479219935057278
LEBER HEREDITARY OPTIC NEUROPATHY	0.0014770999999999999	0.05479219935057278
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.0014770999999999999	0.05479219935057278
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.0014770999999999999	0.05479219935057278
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.0014770999999999999	0.05479219935057278
STIMMLER SYNDROME	0.0014770999999999999	0.05479219935057278
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.0014770999999999999	0.05479219935057278
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.0014770999999999999	0.05479219935057278
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.0014770999999999999	0.05479219935057278
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.0014770999999999999	0.05479219935057278
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.0014770999999999999	0.05479219935057278
SPINOCEREBELLAR ATAXIA, X-LINKED 2	0.0014770999999999999	0.05479219935057278
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0014770999999999999	0.05479219935057278
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.0014770999999999999	0.05479219935057278
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.0014770999999999999	0.05479219935057278
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.0014770999999999999	0.05479219935057278
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.0014770999999999999	0.05479219935057278
ADULT POLYGLUCOSAN BODY DISEASE	0.0014770999999999999	0.05479219935057278
KURU, SUSCEPTIBILITY TO	0.0014770999999999999	0.05479219935057278
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.0014770999999999999	0.05479219935057278
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.0014770999999999999	0.05479219935057278
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.0014770999999999999	0.05479219935057278
164700 OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V;;OPCA WITH DEMENTIA AND EXTRAPYRAMIDAL SIGNS	0.0014770999999999999	0.05479219935057278
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.0014770999999999999	0.05479219935057278
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.0014770999999999999	0.05479219935057278
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.0014770999999999999	0.05479219935057278
WERNICKE-KORSAKOFF SYNDROME	0.0014770999999999999	0.05479219935057278
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.0014770999999999999	0.05479219935057278
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.0014770999999999999	0.05479219935057278
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF	0.0014770999999999999	0.05479219935057278
ACERULOPLASMINEMIA	0.0014770999999999999	0.05479219935057278
DE SANCTIS-CACCHIONE SYNDROME	0.0014770999999999999	0.05479219935057278
NEUROFIBROMATOSIS TYPE 2	0.0014770999999999999	0.05479219935057278
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.0014770999999999999	0.05479219935057278
TRYPTOPHANURIA WITH DWARFISM	0.0014770999999999999	0.05479219935057278
SPINOCEREBELLAR ATAXIA 41; SCA41	0.0014770999999999999	0.05479219935057278
165200 OPTIC ATROPHY WITH DEMYELINATING DISEASE OF CNS	0.0014770999999999999	0.05479219935057278
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.0014770999999999999	0.05479219935057278
272600 TAPETORETINAL DEGENERATION WITH ATAXIA	0.0014770999999999999	0.05479219935057278
OPTIC ATROPHY 1; OPA1	0.0014770999999999999	0.05479219935057278
HYDROCEPHALY-CEREBELLAR AGENESIS SYNDROME	0.0014770999999999999	0.05479219935057278
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.0014770999999999999	0.05479219935057278
RICHARDS-RUNDLE SYNDROME	0.0014770999999999999	0.05479219935057278
ABETALIPOPROTEINEMIA	0.0014770999999999999	0.05479219935057278
NYSTAGMUS, HEREDITARY VERTICAL	0.0014770999999999999	0.05479219935057278
PITUITARY CARCINOMA	0.0014770999999999999	0.05479219935057278
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.0014770999999999999	0.05479219935057278
SPINOCEREBELLAR ATAXIA TYPE 4	0.0014770999999999999	0.05479219935057278
245800 LAURENCE-MOON SYNDROME	0.0014770999999999999	0.05479219935057278
HEREDITARY SPASTIC PARAPLEGIA	0.0014770999999999999	0.05479219935057278
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.0014770999999999999	0.05479219935057278
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.0014770999999999999	0.05479219935057278
POLYMYOCLONUS, INFANTILE	0.0014770999999999999	0.05479219935057278
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	0.0014770999999999999	0.05479219935057278
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.0014770999999999999	0.05479219935057278
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.0014770999999999999	0.05479219935057278
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.0014770999999999999	0.05479219935057278
HYPOMYELINATION-HYPOGONADOTROPIC HYPOGONADISM-HYPODONTIA SYNDROME	0.0014770999999999999	0.05479219935057278
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.0014770999999999999	0.05479219935057278
ATAXIA WITH FASCICULATIONS	0.0014770999999999999	0.05479219935057278
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001086973	0.04032065622144076
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.04032065622144076
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.04032065622144076
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.04032065622144076
PALLISTER-HALL SYNDROME	0.001086973	0.04032065622144076
ALG3-CDG	0.001086973	0.04032065622144076
DPAGT1-CDG	0.001086973	0.04032065622144076
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.04032065622144076
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001086973	0.04032065622144076
KBG SYNDROME	0.001086973	0.04032065622144076
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.04032065622144076
POTOCKI-SHAFFER SYNDROME	0.001086973	0.04032065622144076
CLASSIC PHENYLKETONURIA	0.001086973	0.04032065622144076
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001086973	0.04032065622144076
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001086973	0.04032065622144076
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.001086973	0.04032065622144076
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.04032065622144076
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.001086973	0.04032065622144076
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.001086973	0.04032065622144076
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001086973	0.04032065622144076
RECOMBINANT CHROMOSOME 8 SYNDROME	0.001086973	0.04032065622144076
DISTAL MONOSOMY 19P13.3	0.001086973	0.04032065622144076
KEUTEL SYNDROME	0.001086973	0.04032065622144076
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.04032065622144076
GLYCEROL KINASE DEFICIENCY; GKD	0.001086973	0.04032065622144076
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.001086973	0.04032065622144076
GRACILE BONE DYSPLASIA; GCLEB	0.001086973	0.04032065622144076
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.04032065622144076
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.04032065622144076
TIMOTHY SYNDROME; TS	0.001086973	0.04032065622144076
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.001086973	0.04032065622144076
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.001086973	0.04032065622144076
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001086973	0.04032065622144076
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001086973	0.04032065622144076
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.04032065622144076
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001086973	0.04032065622144076
MACDERMOT-WINTER SYNDROME	0.001086973	0.04032065622144076
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.001086973	0.04032065622144076
PFEIFFER SYNDROME TYPE 2	0.001086973	0.04032065622144076
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.04032065622144076
WYBURN-MASON SYNDROME	0.001086973	0.04032065622144076
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001086973	0.04032065622144076
MUENKE SYNDROME	0.001086973	0.04032065622144076
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.001086973	0.04032065622144076
LEBER CONGENITAL AMAUROSIS	0.001086973	0.04032065622144076
CRANIOPHARYNGIOMA	0.001086973	0.04032065622144076
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.04032065622144076
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.04032065622144076
NETHERTON SYNDROME	0.001086973	0.04032065622144076
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.001086973	0.04032065622144076
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.001086973	0.04032065622144076
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001086973	0.04032065622144076
SCHINDLER DISEASE, TYPE I	0.001086973	0.04032065622144076
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.04032065622144076
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.04032065622144076
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001086973	0.04032065622144076
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001086973	0.04032065622144076
MEND SYNDROME; MEND	0.001086973	0.04032065622144076
RUBINSTEIN-TAYBI SYNDROME	0.001086973	0.04032065622144076
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001086973	0.04032065622144076
MONOSOMY 9Q22.3	0.001086973	0.04032065622144076
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001086973	0.04032065622144076
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001086973	0.04032065622144076
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.001086973	0.04032065622144076
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.04032065622144076
15Q13.3 MICRODELETION SYNDROME	0.001086973	0.04032065622144076
CORNELIA DE LANGE SYNDROME 3	0.001086973	0.04032065622144076
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001086973	0.04032065622144076
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.04032065622144076
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001086973	0.04032065622144076
PHACE ASSOCIATION	0.001086973	0.04032065622144076
15Q24 MICRODELETION SYNDROME	0.001086973	0.04032065622144076
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.04032065622144076
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.001086973	0.04032065622144076
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.001086973	0.04032065622144076
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.04032065622144076
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001086973	0.04032065622144076
WAISMAN SYNDROME; WSMN	0.001086973	0.04032065622144076
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001086973	0.04032065622144076
ARGININEMIA	0.001086973	0.04032065622144076
KBG SYNDROME	0.001086973	0.04032065622144076
COHEN SYNDROME	0.001086973	0.04032065622144076
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.04032065622144076
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.04032065622144076
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001086973	0.04032065622144076
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.04032065622144076
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.04032065622144076
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.001086973	0.04032065622144076
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001086973	0.04032065622144076
DYSTONIA-APHONIA SYNDROME	0.001086973	0.04032065622144076
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.04032065622144076
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001086973	0.04032065622144076
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001086973	0.04032065622144076
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001086973	0.04032065622144076
1Q21.1 MICRODUPLICATION SYNDROME	0.001086973	0.04032065622144076
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.001086973	0.04032065622144076
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001086973	0.04032065622144076
2P21 MICRODELETION SYNDROME	0.001086973	0.04032065622144076
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.001086973	0.04032065622144076
FILIPPI SYNDROME	0.001086973	0.04032065622144076
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001086973	0.04032065622144076
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001086973	0.04032065622144076
8P23.1 MICRODELETION SYNDROME	0.001086973	0.04032065622144076
8P11.2 DELETION SYNDROME	0.001086973	0.04032065622144076
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.04032065622144076
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001086973	0.04032065622144076
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.04032065622144076
NEPHROGENIC DIABETES INSIPIDUS	0.001086973	0.04032065622144076
2Q31.1 MICRODELETION SYNDROME	0.001086973	0.04032065622144076
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001086973	0.04032065622144076
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001086973	0.04032065622144076
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001086973	0.04032065622144076
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001086973	0.04032065622144076
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001086973	0.04032065622144076
3Q29 MICRODUPLICATION SYNDROME	0.001086973	0.04032065622144076
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.04032065622144076
MOSAIC TRISOMY 14	0.001086973	0.04032065622144076
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.04032065622144076
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.04032065622144076
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.001086973	0.04032065622144076
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.04032065622144076
HYPEREKPLEXIA 4; HKPX4	0.001086973	0.04032065622144076
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.001086973	0.04032065622144076
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001086973	0.04032065622144076
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.04032065622144076
CATEL-MANZKE SYNDROME; CATMANS	0.001086973	0.04032065622144076
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001086973	0.04032065622144076
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001086973	0.04032065622144076
SEVERE CANAVAN DISEASE	0.001086973	0.04032065622144076
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001086973	0.04032065622144076
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001086973	0.04032065622144076
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.001086973	0.04032065622144076
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001086973	0.04032065622144076
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.04032065622144076
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001086973	0.04032065622144076
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.04032065622144076
HYDRANENCEPHALY	0.001086973	0.04032065622144076
MAN1B1-CDG	0.001086973	0.04032065622144076
RUVALCABA SYNDROME	0.001086973	0.04032065622144076
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001086973	0.04032065622144076
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.04032065622144076
PRADER-WILLI-LIKE SYNDROME	0.001086973	0.04032065622144076
20P12.3 MICRODELETION SYNDROME	0.001086973	0.04032065622144076
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.04032065622144076
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.001086973	0.04032065622144076
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.04032065622144076
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.001086973	0.04032065622144076
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.04032065622144076
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001086973	0.04032065622144076
HELSMOORTEL-VAN DER AA SYNDROME	0.001086973	0.04032065622144076
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.04032065622144076
STT3A-CDG	0.001086973	0.04032065622144076
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001086973	0.04032065622144076
L1 SYNDROME	0.001086973	0.04032065622144076
TRISOMY X	0.001086973	0.04032065622144076
OPTIC PATHWAY GLIOMA	0.001086973	0.04032065622144076
2Q37 MICRODELETION SYNDROME	0.001086973	0.04032065622144076
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.001086973	0.04032065622144076
INCONTINENTIA PIGMENTI	0.001086973	0.04032065622144076
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.001086973	0.04032065622144076
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.001086973	0.04032065622144076
CANAVAN DISEASE	0.001086973	0.04032065622144076
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001086973	0.04032065622144076
DUANE RETRACTION SYNDROME	0.001086973	0.04032065622144076
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001086973	0.04032065622144076
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001086973	0.04032065622144076
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.04032065622144076
WILSON-TURNER SYNDROME	0.001086973	0.04032065622144076
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.001086973	0.04032065622144076
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.04032065622144076
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.001086973	0.04032065622144076
ADAMS-OLIVER SYNDROME 2; AOS2	0.001086973	0.04032065622144076
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001086973	0.04032065622144076
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001086973	0.04032065622144076
ADULT-ONSET DYSTONIA-PARKINSONISM	0.001086973	0.04032065622144076
DISTAL TRISOMY 17Q	0.001086973	0.04032065622144076
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.04032065622144076
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.04032065622144076
ISOVALERIC ACIDEMIA	0.001086973	0.04032065622144076
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.001086973	0.04032065622144076
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001086973	0.04032065622144076
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.04032065622144076
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001086973	0.04032065622144076
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.04032065622144076
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001086973	0.04032065622144076
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.001086973	0.04032065622144076
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001086973	0.04032065622144076
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.001086973	0.04032065622144076
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001086973	0.04032065622144076
10Q22.3Q23.3 MICRODELETION SYNDROME	0.001086973	0.04032065622144076
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.04032065622144076
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.04032065622144076
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001086973	0.04032065622144076
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.001086973	0.04032065622144076
JOUBERT SYNDROME 10	0.000545554	0.020237020868256975
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.020237020868256975
MEIER-GORLIN SYNDROME 7	0.000545554	0.020237020868256975
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.020237020868256975
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.020237020868256975
ALAZAMI-YUAN SYNDROME	0.000545554	0.020237020868256975
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.020237020868256975
TOLUENE EMBRYOPATHY	0.000545554	0.020237020868256975
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.020237020868256975
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.020237020868256975
CHAR SYNDROME	0.000545554	0.020237020868256975
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.020237020868256975
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.020237020868256975
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.020237020868256975
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020237020868256975
COLE-CARPENTER SYNDROME	0.000545554	0.020237020868256975
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.020237020868256975
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.020237020868256975
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.020237020868256975
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000545554	0.020237020868256975
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.000545554	0.020237020868256975
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.020237020868256975
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000545554	0.020237020868256975
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.020237020868256975
ABETAL34V AMYLOIDOSIS	0.000545554	0.020237020868256975
RABSON-MENDENHALL SYNDROME	0.000545554	0.020237020868256975
EAR-PATELLA-SHORT STATURE SYNDROME	0.000545554	0.020237020868256975
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.000545554	0.020237020868256975
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000545554	0.020237020868256975
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.020237020868256975
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.020237020868256975
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.020237020868256975
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.020237020868256975
MIETENS SYNDROME	0.000545554	0.020237020868256975
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.020237020868256975
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.020237020868256975
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.020237020868256975
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.000545554	0.020237020868256975
RAHMAN SYNDROME	0.000545554	0.020237020868256975
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.020237020868256975
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.020237020868256975
OGDEN SYNDROME; OGDNS	0.000545554	0.020237020868256975
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.020237020868256975
RIGID SPINE SYNDROME	0.000545554	0.020237020868256975
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.020237020868256975
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.020237020868256975
ZEBRA BODY MYOPATHY	0.000545554	0.020237020868256975
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.020237020868256975
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.020237020868256975
DYSTONIA 28, CHILDHOOD-ONSET	0.000545554	0.020237020868256975
HYDROXYKYNURENINURIA	0.000545554	0.020237020868256975
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.020237020868256975
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000545554	0.020237020868256975
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.020237020868256975
CURRARINO SYNDROME	0.000545554	0.020237020868256975
AARSKOG-SCOTT SYNDROME	0.000545554	0.020237020868256975
2Q23.1 MICRODUPLICATION SYNDROME	0.000545554	0.020237020868256975
DISTAL TRISOMY 6P	0.000545554	0.020237020868256975
FETAL TRIMETHADIONE SYNDROME	0.000545554	0.020237020868256975
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.020237020868256975
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.000545554	0.020237020868256975
VASCULAR EHLERS-DANLOS SYNDROME	0.000545554	0.020237020868256975
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.020237020868256975
TREACHER-COLLINS SYNDROME	0.000545554	0.020237020868256975
COSTELLO SYNDROME; CSTLO	0.000545554	0.020237020868256975
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.000545554	0.020237020868256975
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.020237020868256975
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.020237020868256975
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.020237020868256975
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.020237020868256975
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.020237020868256975
OROTIC ACIDURIA	0.000545554	0.020237020868256975
CONGENITAL VARICELLA SYNDROME	0.000545554	0.020237020868256975
FRIED SYNDROME	0.000545554	0.020237020868256975
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.000545554	0.020237020868256975
NOONAN SYNDROME 11; NS11	0.000545554	0.020237020868256975
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020237020868256975
POPOV-CHANG SYNDROME; POPCHAS	0.000545554	0.020237020868256975
RAINE SYNDROME	0.000545554	0.020237020868256975
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.020237020868256975
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.020237020868256975
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020237020868256975
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.020237020868256975
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.000545554	0.020237020868256975
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.020237020868256975
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.020237020868256975
AURICULOCONDYLAR SYNDROME	0.000545554	0.020237020868256975
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.020237020868256975
OROFACIODIGITAL SYNDROME TYPE 4	0.000545554	0.020237020868256975
OGDEN SYNDROME	0.000545554	0.020237020868256975
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.020237020868256975
OPITZ G/BBB SYNDROME	0.000545554	0.020237020868256975
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.020237020868256975
RING CHROMOSOME 12 SYNDROME	0.000545554	0.020237020868256975
JAWAD SYNDROME	0.000545554	0.020237020868256975
LATERAL MENINGOCELE SYNDROME	0.000545554	0.020237020868256975
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.020237020868256975
OTOFACIOCERVICAL SYNDROME	0.000545554	0.020237020868256975
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.020237020868256975
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.020237020868256975
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.020237020868256975
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.020237020868256975
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.020237020868256975
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.020237020868256975
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.020237020868256975
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.020237020868256975
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.020237020868256975
TRISOMY 8Q	0.000545554	0.020237020868256975
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.020237020868256975
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000545554	0.020237020868256975
OROFACIODIGITAL SYNDROME VI	0.000545554	0.020237020868256975
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.020237020868256975
AUSTRALIA ANTIGEN	0.000545554	0.020237020868256975
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000545554	0.020237020868256975
DISTAL TRISOMY 18Q	0.000545554	0.020237020868256975
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.000545554	0.020237020868256975
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.000545554	0.020237020868256975
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.020237020868256975
ELSAHY-WATERS SYNDROME; ESWS	0.000545554	0.020237020868256975
TRISOMY 17P	0.000545554	0.020237020868256975
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.020237020868256975
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.020237020868256975
ATHYREOSIS	0.000545554	0.020237020868256975
8Q22.1 MICRODELETION SYNDROME	0.000545554	0.020237020868256975
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.000545554	0.020237020868256975
ALG6-CDG	0.000545554	0.020237020868256975
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.020237020868256975
N SYNDROME	0.000545554	0.020237020868256975
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.020237020868256975
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.020237020868256975
BRESEK SYNDROME	0.000545554	0.020237020868256975
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.020237020868256975
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.000545554	0.020237020868256975
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.020237020868256975
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.020237020868256975
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.020237020868256975
HEREDITARY OROTIC ACIDURIA	0.000545554	0.020237020868256975
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.020237020868256975
3MC SYNDROME 2	0.000545554	0.020237020868256975
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.020237020868256975
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.020237020868256975
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.020237020868256975
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.020237020868256975
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.020237020868256975
ROTHMUND-THOMSON SYNDROME	0.000545554	0.020237020868256975
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.020237020868256975
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.020237020868256975
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.020237020868256975
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.020237020868256975
DISTAL MONOSOMY 9P	0.000545554	0.020237020868256975
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.020237020868256975
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000545554	0.020237020868256975
WEAVER SYNDROME	0.000545554	0.020237020868256975
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000545554	0.020237020868256975
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.020237020868256975
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000545554	0.020237020868256975
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.020237020868256975
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.020237020868256975
PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.020237020868256975
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.020237020868256975
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.020237020868256975
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.020237020868256975
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.020237020868256975
FRIAS SYNDROME	0.000545554	0.020237020868256975
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.020237020868256975
NOONAN SYNDROME 3; NS3	0.000545554	0.020237020868256975
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.020237020868256975
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000545554	0.020237020868256975
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000545554	0.020237020868256975
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.000545554	0.020237020868256975
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.020237020868256975
HYPERTRICHOSIS CUBITI	0.000545554	0.020237020868256975
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.020237020868256975
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.020237020868256975
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.020237020868256975
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.020237020868256975
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.020237020868256975
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.020237020868256975
SECKEL SYNDROME 8; SCKL8	0.000545554	0.020237020868256975
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.020237020868256975
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000545554	0.020237020868256975
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.020237020868256975
17Q21.31 MICRODUPLICATION SYNDROME	0.000545554	0.020237020868256975
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.020237020868256975
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.020237020868256975
ATELOSTEOGENESIS TYPE III	0.000545554	0.020237020868256975
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.020237020868256975
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.020237020868256975
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000545554	0.020237020868256975
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.020237020868256975
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.020237020868256975
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.020237020868256975
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.020237020868256975
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.020237020868256975
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.020237020868256975
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.020237020868256975
BARDET-BIEDL SYNDROME 2	0.000545554	0.020237020868256975
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.020237020868256975
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.000545554	0.020237020868256975
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000545554	0.020237020868256975
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.020237020868256975
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.020237020868256975
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.020237020868256975
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.000545554	0.020237020868256975
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020237020868256975
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.020237020868256975
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.020237020868256975
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.020237020868256975
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.020237020868256975
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.020237020868256975
TRISOMY 9P	0.000545554	0.020237020868256975
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.020237020868256975
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.020237020868256975
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.020237020868256975
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.020237020868256975
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.020237020868256975
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.000545554	0.020237020868256975
WARSAW BREAKAGE SYNDROME; WABS	0.000545554	0.020237020868256975
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.020237020868256975
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.020237020868256975
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.020237020868256975
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.020237020868256975
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.020237020868256975
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.020237020868256975
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000545554	0.020237020868256975
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.020237020868256975
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.000545554	0.020237020868256975
CHAR SYNDROME	0.000545554	0.020237020868256975
CHROMOSOME 17P13.1 DELETION SYNDROME	0.000545554	0.020237020868256975
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.020237020868256975
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.020237020868256975
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.020237020868256975
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.020237020868256975
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000545554	0.020237020868256975
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020237020868256975
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.020237020868256975
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020237020868256975
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.020237020868256975
STEEL SYNDROME; STLS	0.000545554	0.020237020868256975
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.020237020868256975
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.020237020868256975
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.020237020868256975
NOONAN SYNDROME 5; NS5	0.000545554	0.020237020868256975
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.020237020868256975
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.020237020868256975
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000545554	0.020237020868256975
ICF SYNDROME	0.000545554	0.020237020868256975
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.020237020868256975
ALAZAMI SYNDROME; ALAZS	0.000545554	0.020237020868256975
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.020237020868256975
8Q12 MICRODUPLICATION SYNDROME	0.000545554	0.020237020868256975
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.020237020868256975
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.020237020868256975
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.000545554	0.020237020868256975
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.020237020868256975
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.020237020868256975
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.020237020868256975
CULLER-JONES SYNDROME; CJS	0.000545554	0.020237020868256975
HYDROXYKYNURENINURIA	0.000545554	0.020237020868256975
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.020237020868256975
AU-KLINE SYNDROME; AUKS	0.000545554	0.020237020868256975
NOONAN SYNDROME 9; NS9	0.000545554	0.020237020868256975
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.020237020868256975
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.020237020868256975
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.020237020868256975
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.020237020868256975
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000545554	0.020237020868256975
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.020237020868256975
CDAGS SYNDROME	0.000545554	0.020237020868256975
3C SYNDROME	0.000545554	0.020237020868256975
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.020237020868256975
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.000545554	0.020237020868256975
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.000545554	0.020237020868256975
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.020237020868256975
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.020237020868256975
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.020237020868256975
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.000545554	0.020237020868256975
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.020237020868256975
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.020237020868256975
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.020237020868256975
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000545554	0.020237020868256975
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.020237020868256975
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.020237020868256975
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.020237020868256975
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.020237020868256975
ISOLATED PLAGIOCEPHALY	0.000545554	0.020237020868256975
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.020237020868256975
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.020237020868256975
GERODERMA OSTEODYSPLASTICA	0.000545554	0.020237020868256975
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.020237020868256975
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.000545554	0.020237020868256975
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020237020868256975
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.020237020868256975
JOUBERT SYNDROME 26	0.000545554	0.020237020868256975
SECKEL SYNDROME 9; SCKL9	0.000545554	0.020237020868256975
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000545554	0.020237020868256975
CHOPS SYNDROME; CHOPS	0.000545554	0.020237020868256975
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.020237020868256975
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.020237020868256975
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.020237020868256975
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000545554	0.020237020868256975
FRONTOOCULAR SYNDROME	0.000545554	0.020237020868256975
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.020237020868256975
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.020237020868256975
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.020237020868256975
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.020237020868256975
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000545554	0.020237020868256975
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.020237020868256975
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.020237020868256975
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.020237020868256975
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.020237020868256975
NOONAN SYNDROME 2; NS2	0.000545554	0.020237020868256975
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.020237020868256975
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.020237020868256975
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.020237020868256975
ZECHI-CEIDE SYNDROME	0.000545554	0.020237020868256975
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.020237020868256975
LOWRY-MACLEAN SYNDROME	0.000545554	0.020237020868256975
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.000541419	0.020083635353183783
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.020083635353183783
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.020083635353183783
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.020083635353183783
1P36 MICRODELETION SYNDROME	0.000541419	0.020083635353183783
SANJAD-SAKATI SYNDROME	0.000541419	0.020083635353183783
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.000541419	0.020083635353183783
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.020083635353183783
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020083635353183783
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.020083635353183783
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.020083635353183783
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020083635353183783
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.020083635353183783
CADASIL	0.000541419	0.020083635353183783
FRAGILE X SYNDROME	0.000541419	0.020083635353183783
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.020083635353183783
NIPAH VIRUS DISEASE	0.000541419	0.020083635353183783
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.000541419	0.020083635353183783
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.020083635353183783
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000541419	0.020083635353183783
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.020083635353183783
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020083635353183783
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020083635353183783
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.020083635353183783
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.020083635353183783
KABUKI SYNDROME	0.000541419	0.020083635353183783
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.020083635353183783
RING CHROMOSOME 10 SYNDROME	0.000541419	0.020083635353183783
DYSOSTEOSCLEROSIS	0.000541419	0.020083635353183783
2Q33.1 DELETION SYNDROME	0.000541419	0.020083635353183783
PARIETAL FORAMINA	0.000541419	0.020083635353183783
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.020083635353183783
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.000541419	0.020083635353183783
INSULINOMA	0.000541419	0.020083635353183783
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.000541419	0.020083635353183783
PINEOBLASTOMA	0.000541419	0.020083635353183783
ACROCARDIOFACIAL SYNDROME	0.000541419	0.020083635353183783
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.020083635353183783
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.020083635353183783
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.020083635353183783
PFEIFFER SYNDROME TYPE 3	0.000541419	0.020083635353183783
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.020083635353183783
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020083635353183783
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.020083635353183783
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000541419	0.020083635353183783
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.020083635353183783
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.020083635353183783
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020083635353183783
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.020083635353183783
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.020083635353183783
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.020083635353183783
CONGENITAL HYDROCEPHALUS	0.000541419	0.020083635353183783
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.020083635353183783
ACUTE ADRENAL INSUFFICIENCY	0.000541419	0.020083635353183783
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.020083635353183783
STURGE-WEBER SYNDROME	0.000541419	0.020083635353183783
DISTAL TRISOMY 15Q	0.000541419	0.020083635353183783
DARIER-WHITE DISEASE; DAR	0.000541419	0.020083635353183783
SECKEL SYNDROME 1; SCKL1	0.000541419	0.020083635353183783
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.020083635353183783
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020083635353183783
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020083635353183783
AICA-RIBOSIDURIA	0.000541419	0.020083635353183783
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020083635353183783
MOYAMOYA DISEASE	0.000541419	0.020083635353183783
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020083635353183783
MOYNAHAN SYNDROME	0.000541419	0.020083635353183783
CENTRAL DIABETES INSIPIDUS	0.000541419	0.020083635353183783
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.000541419	0.020083635353183783
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.020083635353183783
EPILEPSY, READING	0.000541419	0.020083635353183783
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.020083635353183783
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020083635353183783
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.020083635353183783
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.020083635353183783
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.000541419	0.020083635353183783
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.020083635353183783
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.020083635353183783
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.020083635353183783
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.020083635353183783
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.020083635353183783
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.020083635353183783
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.020083635353183783
HARROD SYNDROME	0.000541419	0.020083635353183783
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.020083635353183783
DERMOTRICHIC SYNDROME	0.000541419	0.020083635353183783
KNOBLOCH SYNDROME	0.000541419	0.020083635353183783
BRANCHIOOCULOFACIAL SYNDROME	0.000541419	0.020083635353183783
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020083635353183783
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.020083635353183783
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020083635353183783
HADDAD SYNDROME	0.000541419	0.020083635353183783
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000541419	0.020083635353183783
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.020083635353183783
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020083635353183783
CRISPONI SYNDROME	0.000541419	0.020083635353183783
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.020083635353183783
SNEDDON SYNDROME	0.000541419	0.020083635353183783
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.020083635353183783
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000541419	0.020083635353183783
MOMO SYNDROME	0.000541419	0.020083635353183783
ROSAÏ-DORFMAN DISEASE	0.000541419	0.020083635353183783
DISTAL MONOSOMY 3P	0.000541419	0.020083635353183783
CYSTATHIONINURIA	0.000541419	0.020083635353183783
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020083635353183783
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020083635353183783
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.000541419	0.020083635353183783
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.020083635353183783
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.000541419	0.020083635353183783
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.020083635353183783
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.000541419	0.020083635353183783
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.020083635353183783
CROUZON SYNDROME	0.000541419	0.020083635353183783
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.020083635353183783
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.020083635353183783
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.020083635353183783
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.020083635353183783
NOONAN SYNDROME 7; NS7	0.000541419	0.020083635353183783
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.020083635353183783
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.020083635353183783
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020083635353183783
WORSTER-DROUGHT SYNDROME	0.000541419	0.020083635353183783
AYME-GRIPP SYNDROME; AYGRP	0.000541419	0.020083635353183783
CHIME SYNDROME	0.000541419	0.020083635353183783
GURRIERI SYNDROME	0.000541419	0.020083635353183783
POTOCKI-SHAFFER SYNDROME	0.000541419	0.020083635353183783
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.020083635353183783
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.020083635353183783
GALACTOSIALIDOSIS	0.000541419	0.020083635353183783
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.020083635353183783
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.020083635353183783
PALLISTER-KILLIAN SYNDROME	0.000541419	0.020083635353183783
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020083635353183783
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020083635353183783
ONDINE SYNDROME	0.000541419	0.020083635353183783
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.020083635353183783
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020083635353183783
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.020083635353183783
NEVUS COMEDONICUS SYNDROME	0.000541419	0.020083635353183783
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.020083635353183783
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.020083635353183783
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000541419	0.020083635353183783
ADIPOSIS DOLOROSA	0.000541419	0.020083635353183783
CRANIOSYNOSTOSIS 2	0.000541419	0.020083635353183783
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.020083635353183783
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.020083635353183783
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.020083635353183783
FAMILIAL THROMBOCYTOSIS	0.000541419	0.020083635353183783
MENKES DISEASE	0.000541419	0.020083635353183783
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.020083635353183783
TAKAYASU ARTERITIS	0.000541419	0.020083635353183783
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.000541419	0.020083635353183783
COFFIN-LOWRY SYNDROME; CLS	0.000541419	0.020083635353183783
RABIES	0.000541419	0.020083635353183783
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.020083635353183783
TETRASOMY 18P	0.000541419	0.020083635353183783
HHHH SYNDROME	0.000541419	0.020083635353183783
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.020083635353183783
INCONTINENTIA PIGMENTI; IP	0.000541419	0.020083635353183783
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.020083635353183783
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.020083635353183783
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.020083635353183783
RENPENNING SYNDROME 1; RENS1	0.000541419	0.020083635353183783
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.020083635353183783
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.020083635353183783
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020083635353183783
PORPHYRIA	0.000541419	0.020083635353183783
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020083635353183783
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.020083635353183783
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.020083635353183783
MICROPHTHALMIA, SYNDROMIC 1	0.000541419	0.020083635353183783
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.020083635353183783
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.020083635353183783
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020083635353183783
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020083635353183783
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020083635353183783
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.000541419	0.020083635353183783
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.020083635353183783
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.020083635353183783
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.020083635353183783
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.020083635353183783
HYPOPHOSPHATASIA	0.000541419	0.020083635353183783
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.020083635353183783
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020083635353183783
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.020083635353183783
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.020083635353183783
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.000541419	0.020083635353183783
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020083635353183783
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.020083635353183783
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.020083635353183783
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.020083635353183783
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.020083635353183783
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.020083635353183783
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020083635353183783
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.020083635353183783
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.020083635353183783
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.020083635353183783
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.020083635353183783
PERRAULT SYNDROME 3	0.000541419	0.020083635353183783
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.020083635353183783
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.020083635353183783
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.020083635353183783
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.020083635353183783
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.020083635353183783
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.020083635353183783
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.020083635353183783
CENTRONUCLEAR MYOPATHY	0.000541419	0.020083635353183783
MUSCLE-EYE-BRAIN DISEASE	0.000541419	0.020083635353183783
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.020083635353183783
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020083635353183783
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020083635353183783
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.020083635353183783
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.020083635353183783
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.020083635353183783
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.020083635353183783
ALZHEIMER DISEASE 3; AD	0.000541419	0.020083635353183783
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.020083635353183783
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.020083635353183783
LIPOID PROTEINOSIS	0.000541419	0.020083635353183783
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020083635353183783
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.020083635353183783
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000541419	0.020083635353183783
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.020083635353183783
HYPERPROLINEMIA TYPE 1	0.000541419	0.020083635353183783
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.020083635353183783
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.020083635353183783
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.020083635353183783
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.020083635353183783
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.020083635353183783
ZLOTOGORA-OGUR SYNDROME	0.000541419	0.020083635353183783
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.020083635353183783
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.020083635353183783
RENPENNING SYNDROME	0.000541419	0.020083635353183783
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.020083635353183783
ROMANO-WARD SYNDROME	0.000541419	0.020083635353183783
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020083635353183783
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.020083635353183783
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020083635353183783
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.020083635353183783
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020083635353183783
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.020083635353183783
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.020083635353183783
PORENCEPHALY	0.000541419	0.020083635353183783
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020083635353183783
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020083635353183783
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.020083635353183783
PROLACTINOMA	0.000541419	0.020083635353183783
PHENYLKETONURIA	0.000541419	0.020083635353183783
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.020083635353183783
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000541419	0.020083635353183783
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.020083635353183783
ADDISON DISEASE	0.000541419	0.020083635353183783
RAMON SYNDROME	0.000541419	0.020083635353183783
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020083635353183783
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020083635353183783
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.020083635353183783
RAMON SYNDROME	0.000541419	0.020083635353183783
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.020083635353183783
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020083635353183783
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.020083635353183783
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.020083635353183783
KIFAFA SEIZURE DISORDER	0.000541419	0.020083635353183783
HYPER-BETA-ALANINEMIA	0.000541419	0.020083635353183783
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.020083635353183783
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.020083635353183783
HYPERPROLINEMIA, TYPE II	0.000541419	0.020083635353183783
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.000541419	0.020083635353183783
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020083635353183783
HYPOPHOSPHATASIA, INFANTILE	0.000541419	0.020083635353183783
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020083635353183783
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.020083635353183783
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.020083635353183783
KEUTEL SYNDROME; KTLS	0.000541419	0.020083635353183783
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.020083635353183783
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.000541419	0.020083635353183783
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.020083635353183783
NASU-HAKOLA DISEASE	0.000541419	0.020083635353183783
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.000541419	0.020083635353183783
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.020083635353183783
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020083635353183783
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.020083635353183783
BETA-MANNOSIDOSIS	0.000541419	0.020083635353183783
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.020083635353183783
OHDO SYNDROME	0.000541419	0.020083635353183783
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020083635353183783
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.020083635353183783
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.020083635353183783
FILIPPI SYNDROME; FLPIS	0.000541419	0.020083635353183783
ENCEPHALITIS LETHARGICA	0.000541419	0.020083635353183783
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.020083635353183783
ALG9-CDG	0.000541419	0.020083635353183783
ATKIN-FLAITZ SYNDROME	0.000541419	0.020083635353183783
ALG2-CDG	0.000541419	0.020083635353183783
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.020083635353183783
MPDU1-CDG	0.000541419	0.020083635353183783
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.020083635353183783
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.020083635353183783
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.020083635353183783
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020083635353183783
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.020083635353183783
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.020083635353183783
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000541419	0.020083635353183783
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020083635353183783
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020083635353183783
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.020083635353183783
CLARK-BARAITSER SYNDROME	0.000541419	0.020083635353183783
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.020083635353183783
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.020083635353183783
HEREDITARY COPROPORPHYRIA	0.000541419	0.020083635353183783
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.020083635353183783
LUJO HEMORRHAGIC FEVER	0.000541419	0.020083635353183783
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.020083635353183783
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020083635353183783
STURGE-WEBER SYNDROME	0.000541419	0.020083635353183783
MOGS-CDG	0.000541419	0.020083635353183783
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.020083635353183783
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020083635353183783
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.020083635353183783
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.000541419	0.020083635353183783
TAY-SACHS DISEASE; TSD	0.000541419	0.020083635353183783
SCRUB TYPHUS	0.000541419	0.020083635353183783
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.020083635353183783
THREONINEMIA	0.000541419	0.020083635353183783
ISOLATED SPINA BIFIDA	0.000541419	0.020083635353183783
SNEDDON SYNDROME	0.000541419	0.020083635353183783
SJÖGREN-LARSSON SYNDROME	0.000541419	0.020083635353183783
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.020083635353183783
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.020083635353183783
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.020083635353183783
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.020083635353183783
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.020083635353183783
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.020083635353183783
ZUNICH NEUROECTODERMAL SYNDROME	0.000541419	0.020083635353183783
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.020083635353183783
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.020083635353183783
ATYPICAL RETT SYNDROME	0.000541419	0.020083635353183783
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.020083635353183783
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.020083635353183783
PORPHYRIA VARIEGATA	0.000541419	0.020083635353183783
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000541419	0.020083635353183783
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020083635353183783
SAETHRE-CHOTZEN SYNDROME	0.000541419	0.020083635353183783
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.020083635353183783
